Processing 00000000.tx.1: Independent effects of APOE on cholesterol metabolism and brain A levels in an Alzheimer disease mouse model Karen M. 

Phrase: "Independent effects of APOE"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   819   C0332291:Independent of [Functional Concept]
   770   C0085862:Independent [Idea or Concept]
   770   C1280500:effects [Qualitative Concept]
   770   C1299583:Independent [Finding]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on cholesterol metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1156530:cholesterol metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "A levels in an Alzheimer disease mouse model Karen M."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   739   C0441889:Levels [Qualitative Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.2: Mann1,2, Fayanne E. 

Phrase: "Mann1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "Fayanne E."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014441:ELISA [Laboratory Procedure]
Processing 00000000.tx.3: Thorngate3, Yuko Katoh-Fukui4, Hiroki Hamanaka5, David L. 

Phrase: "Thorngate3,"

Phrase: "Yuko Katoh-Fukui4,"

Phrase: "Hiroki Hamanaka5,"

Phrase: "David L."
Processing 00000000.tx.4: Williams3, Shinobu Fujita6 and Bruce T. 

Phrase: "Williams3,"

Phrase: "Shinobu Fujita6"

Phrase: "and"

Phrase: "Bruce T."
Processing 00000000.tx.5: Lamb1,2,* 1Department of Genetics, Case Western Reserve University, Cleveland, OH 44106, USA, 2Center for Human Genetics, University Memory and Aging Center and Ireland Cancer Center, University Hospitals of Cleveland, Cleveland, OH 44106, USA, 3Department of Pharmacological Sciences, University Medical Center, Stony Brook University, Stony Brook, NY 11794, USA, 4Department of Developmental Biology, National Institute for Basic Biology, Myodaiji-cho, Okazaki 444-8585, Japan, 5Center for Neural Science, New York University, New York, NY 10003-6621, USA and 6Mitsubishi Kagaku Institute of Life Sciences, Machida, Tokyo, Japan Received March 30, 2004; 

Phrase: "Lamb1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416780:LAMB1 [Gene or Genome]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "* 1Department of Genetics,"

Phrase: "Case Western Reserve University,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0041740:University [Manufactured Object,Organization]
   812   C0868928:Case [Functional Concept]
   812   C1705493:Western [Spatial Concept]
   812   C1706255:CASE [Medical Device]
   812   C1706256:Case [Conceptual Entity]
   812   C2347957:Reserve [Activity]

Phrase: "Cleveland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454845:Cleveland [Geographic Area]

Phrase: "OH 44106,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0220853:OH- [Element, Ion, or Isotope]

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "2Center for Human Genetics,"

Phrase: "University Memory"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025260:Memory [Mental Process]
   861   C0700327:memory [Finding]
   861   C1706377:Memory [Manufactured Object]
   805 E C0679055:mnemonic [Mental Process]

Phrase: "and"

Phrase: "Aging Center"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205099:Center [Spatial Concept]

Phrase: "and"

Phrase: "Ireland Cancer Center,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1513817:Cancer Center [Health Care Related Organization]
   827   C0205099:Center [Spatial Concept]

Phrase: "University Hospitals of Cleveland,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0020028:Hospitals, University [Health Care Related Organization,Manufactured Object]
   770   C0019994:Hospitals [Health Care Related Organization,Manufactured Object]
   770   C0041740:University [Manufactured Object,Organization]
   770   C1609061:Hospitals [Intellectual Product]
   737 E C1510665:Hospital [Qualitative Concept]

Phrase: "Cleveland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454845:Cleveland [Geographic Area]

Phrase: "OH 44106,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0220853:OH- [Element, Ion, or Isotope]

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "3Department of Pharmacological Sciences,"

Phrase: "University Medical Center,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   901   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   901   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   827   C0041740:University [Manufactured Object,Organization]
   827   C0205099:Center [Spatial Concept]
   827   C0205476:Medical [Functional Concept]

Phrase: "Stony Brook University,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0041740:University [Manufactured Object,Organization]
   755   C0006736:Stone [Body Substance]
   727 E C0443312:Stoney [Qualitative Concept]

Phrase: "Stony Brook,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   789   C0006736:Stone [Body Substance]
   761 E C0443312:Stoney [Qualitative Concept]

Phrase: "NY 11794,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027976:NY [Geographic Area]
   861   C1879958:NY [Intellectual Product]

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "4Department of Developmental Biology,"

Phrase: "National Institute for Basic Biology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021622:institute [Organization]
   760   C1272753:Institute [Idea or Concept]

Phrase: "Myodaiji-cho,"

Phrase: "Okazaki 444-8585,"

Phrase: "Japan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "5Center for Neural Science,"

Phrase: "New York University,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027976:New York [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]
   827   C0205314:New [Temporal Concept]

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "NY 10003-6621,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027976:NY [Geographic Area]
   827   C1879958:NY [Intellectual Product]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "and"

Phrase: "6Mitsubishi Kagaku Institute of Life Sciences,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0021622:institute [Organization]
   753   C1272753:Institute [Idea or Concept]

Phrase: "Machida,"

Phrase: "Tokyo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: "Japan Received March 30,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0022341:Japan [Geographic Area]
   812   C1514756:Received [Qualitative Concept]

Phrase: "2004"

Phrase: ";"
Processing 00000000.tx.6: Accepted June 15, 2004  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  The APOE 4 allele is the most significant genetic risk factor associated with Alzheimer's disease to date. 

Phrase: "Accepted June 15,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2004  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The APOE 4 allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3642141:APOE*4 Allele [Gene or Genome]
   827   C0002085:Allele [Gene or Genome]
   734   C0052201:Apo E-4 [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "the most significant genetic risk factor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0035648:Risk factor [Quantitative Concept]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]

Phrase: "associated with Alzheimer's disease"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "to date."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]
Processing 00000000.tx.7: Epidemiological studies have demonstrated that inheritance of one or more 4 alleles affects both the age of onset and the severity of pathology development. 

Phrase: "Epidemiological studies"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0002783:Epidemiological Studies [Research Activity]
   861   C0014507:Epidemiological [Biomedical Occupation or Discipline]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
   789 E C0014508:epidemiology [Functional Concept]
   789 E C0699910:epidemiology [Health Care Activity]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that inheritance of one"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0242538:Inheritance [Quantitative Concept]
   770   C0728826:Inheritance [Functional Concept]

Phrase: "or"

Phrase: "more 4 alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Alleles [Gene or Genome]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "both the age of onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   862   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   760   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "the severity of pathology development."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439793:Severity [Qualitative Concept]
   760   C2983285:Severity [Intellectual Product]
Processing 00000000.tx.8: Dosage of APOE 2 and 3 alleles, however, appear to be protective against the effects of 4. 

Phrase: "Dosage of APOE 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0178602:Dosage [Quantitative Concept]

Phrase: "and"

Phrase: "3 alleles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "however,"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "protective against the effects of 4."
Processing 00000000.tx.9: Although much of the biology of APOE in peripheral cholesterol metabolism is understood, its role in brain cholesterol metabolism and its impact on AD development is less defined. 

Phrase: "Although"

Phrase: "much of the biology of APOE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0005532:Biology [Biomedical Occupation or Discipline]
   753   C0523511:APOE [Laboratory Procedure]
   753   C1412481:APOE [Gene or Genome]

Phrase: "in peripheral cholesterol metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1156530:cholesterol metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]

Phrase: "is"

Phrase: "understood"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]

Phrase: ","

Phrase: "its role in brain cholesterol metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "its impact on AD development"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1825598:IMPACT [Gene or Genome]

Phrase: "is"

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "defined."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]
Processing 00000000.tx.10: Several APOE transgenic models have been generated to study the effects of APOE alleles on APP processing and A pathology. 

Phrase: "Several APOE transgenic models"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C1519606:Transgenic Model [Experimental Model of Disease]
   812   C3161035:Models [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the effects of APOE alleles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on APP processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "A pathology."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]
Processing 00000000.tx.11: However, these models have potential limitations that confound our understanding of the effects of apolipoprotein E (APOE) levels and cholesterol metabolism on disease development. 

Phrase: "However,"

Phrase: "these models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]

Phrase: "have"

Phrase: "potential limitations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449295:limitations [Functional Concept]

Phrase: "that"

Phrase: "confound"

Phrase: "our understanding of the effects of apolipoprotein E (APOE) levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0162340:Understanding [Mental Process]

Phrase: "and"

Phrase: "cholesterol metabolism on disease development."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1156530:cholesterol metabolism [Molecular Function]
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.12: To circumvent these limitations, we have taken a genomic-based approach to better understand the relationship between APOE alleles, cholesterol and A metabolism. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "circumvent"

Phrase: "these limitations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449295:limitations [Functional Concept]

Phrase: "we"

Phrase: "have"

Phrase: "taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "a genomic-based approach to better"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   804   C0017428:Genomic [Gene or Genome]
   804   C0332272:Better [Qualitative Concept]
   804   C0449445:Approach [Spatial Concept]
   804   C0887950:genomic [Biomedical Occupation or Discipline]
   804   C1527178:Based [Functional Concept]
   804   C1705938:Based [Idea or Concept]
   771 E C0002055:base [Inorganic Chemical]
   771 E C0178499:Base [Chemical Viewed Functionally]
   771 E C0205170:Well [Qualitative Concept]
   771 E C1880279:Base [Biomedical or Dental Material]
   771 E C3146287:Well [Manufactured Object]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the relationship between APOE alleles,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "and"

Phrase: "A metabolism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.13: We have characterized APOE knock-in mice, which express each human allele under the endogenous regulatory elements, on a defined C57BL6/J background. 

Phrase: "We"

Phrase: "have"

Phrase: "characterized APOE knock-in mice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C1517676:Knock-in [Research Activity]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "which"

Phrase: "express"

Phrase: "each human allele under the endogenous regulatory elements,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0002085:Allele [Gene or Genome]

Phrase: "on a defined C57BL6/J background."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1706907:Background [Conceptual Entity]
Processing 00000000.tx.14: These mice have significantly different serum cholesterol levels and steady-state brain APOE levels, and yet have equivalent brain cholesterol levels. 

Phrase: "These mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "have"

Phrase: "significantly different serum cholesterol levels"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   851   C0587184:Serum cholesterol level [Laboratory Procedure]
           serum cholesterol
   851   C1287371:Serum cholesterol level [Laboratory or Test Result]
   840   C0201950:cholesterol levels [Laboratory Procedure]
   840   C0428466:cholesterol levels [Laboratory or Test Result]
   804   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   804   C0229671:Serum [Body Substance]
   804   C0441889:Levels [Qualitative Concept]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "steady-state brain APOE levels,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   858   C0683927:state level [Spatial Concept]
   804   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0441889:Levels [Qualitative Concept]
   804   C0523511:APOE [Laboratory Procedure]
   804   C1412481:APOE [Gene or Genome]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "yet"

Phrase: "have"

Phrase: "equivalent brain cholesterol levels."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0201950:cholesterol levels [Laboratory Procedure]
   861   C0428466:cholesterol levels [Laboratory or Test Result]
   812   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.15: However, the presence of human APOE significantly increases brain A levels in a genomic-based model of AD, irrespective of genotype. 

Phrase: "However,"

Phrase: "the presence of human APOE significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "A levels in a genomic-based model of AD,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "irrespective of genotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]
Processing 00000000.tx.16: These data indicate an independent role for APOE in cholesterol metabolism in the periphery relative to the CNS, and that the altered levels of cholesterol and APOE in these mice are insufficient to influence A metabolism in a mouse model of Alzheimer's disease.  

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "an independent role for APOE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in cholesterol metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1156530:cholesterol metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "in the periphery"

Phrase: "relative to the CNS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]

Phrase: "and"

Phrase: "that"

Phrase: "the altered levels of cholesterol"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   797   C0201950:cholesterol levels [Laboratory Procedure]
   797   C0428466:cholesterol levels [Laboratory or Test Result]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "APOE in these mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0523511:APOE [Laboratory Procedure]
   770   C1412481:APOE [Gene or Genome]

Phrase: "are"

Phrase: "insufficient to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205412:Insufficient [Qualitative Concept]
   861   C0231180:Insufficient [Qualitative Concept]
   789 E C0231179:Insufficiency [Functional Concept]

Phrase: "influence"

Phrase: "A metabolism in a mouse model of Alzheimer's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0025519:Metabolism [Organism Function]
   742   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.17: INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Apolipoprotein E (APOE) functions as a lipid chaperone and facilitates cellular uptake of cholesterol and lipoproteins through receptor-mediated endocytosis. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Apolipoprotein E (APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0523511:APOE [Laboratory Procedure]
   827   C1412481:APOE [Gene or Genome]

Phrase: ")"

Phrase: "functions as a lipid chaperone"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0023767:Lipid A [Immunologic Factor,Lipid]
   760   C0023779:Lipid [Lipid]
   760   C0031843:function [Physiologic Function]
   760   C0243041:Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "facilitates"

Phrase: "cellular uptake of cholesterol"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C2611279:cholesterol uptake [Cell Function]
   770   C0007634:Cellular [Cell]
   770   C0178539:Cellular [Functional Concept]
   770   C0243144:Uptake [Physiologic Function]
   770   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "lipoproteins through receptor-mediated endocytosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C0023820:Lipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.18: The APOE gene, located on human chromosome 19q13.2, is a polymorphic locus represented by three common alleles, 2, 3 and 4. 

Phrase: "The APOE gene,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412481:APOE gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "located on human chromosome 19q13.2,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0008643:Human Chromosome [Cell Component]
   790   C1520860:19q13.2 [Cell Component]
   783   C0008662:Chromosome 2 [Cell Component]
   753   C0008633:Chromosome [Cell Component]
   753   C0086418:Human [Human]
   753   C1520855:19q13 [Cell Component]

Phrase: "is"

Phrase: "a polymorphic locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]

Phrase: "represented by three common alleles,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0002085:Alleles [Gene or Genome]
   760   C0205214:Common [Quantitative Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C1522138:Common [Functional Concept]
   760   C3245511:common [Intellectual Product]
   726   C1882932:Represent [Activity]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "4."
Processing 00000000.tx.19: These three alleles encode three APOE isoforms of 34kDa that differ at amino acid positions 112 and 158. 

Phrase: "These three alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "encode"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "three APOE isoforms of 34kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "that"

Phrase: "differ at amino acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   833   C2917660:Amino Acid [Pharmacologic Substance]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]

Phrase: "positions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0733755:Position [Spatial Concept]

Phrase: "112"

Phrase: "and"

Phrase: "158."
Processing 00000000.tx.20: These two amino acid substitutions confer slightly different functions for the respective proteins. 

Phrase: "These two amino acid substitutions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0525038:Substitutions, Amino Acid [Genetic Function,Molecular Biology Research Technique]
   779   C1555721:Substitution [Idea or Concept]
   779   C1706204:Substitution [Activity]

Phrase: "confer"

Phrase: "slightly different functions for the respective proteins."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   774   C0815043:functions proteins [Amino Acid, Peptide, or Protein]
   748   C0542341:Functions [Functional Concept]
   741 E C1527118:Protein Function [Molecular Function]
   714 E C0031843:function [Physiologic Function]
   714 E C0700205:FUNCTION [Classification]
   714 E C1705273:Function [Intellectual Product]
Processing 00000000.tx.21: The E2 isoform, encoded by the 2 allele, contains a Cys at position 158, in comparison with the Arg found in the E3 and E4 isoforms. 

Phrase: "The E2 isoform,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "encoded by the 2 allele,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002085:Allele [Gene or Genome]
   760   C0679058:encoded [Mental Process]
   760   C2700640:Encoded [Activity]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a Cys at position 158,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0010654:Cys [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "with the Arg"

Phrase: "found in the E3"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0150312:Found [Quantitative Concept]
   770   C1537525:E3 [Gene or Genome]
   737 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "E4 isoforms."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.22: The substitution of Cys for Arg alters the positive ion potential within the receptor-binding domain, and thus decreases the affinity of the E2 protein for the LDL receptor to 1% of the normal binding capacity (1,2). 

Phrase: "The substitution of Cys"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1555721:Substitution [Idea or Concept]
   770   C1706204:Substitution [Activity]

Phrase: "for Arg"

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the positive ion potential within the receptor-binding domain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C2986841:Binding Potential [Phenomenon or Process]
   742   C3245505:Potential [Qualitative Concept]

Phrase: "and"

Phrase: "thus"

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the affinity of the E2 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "for the LDL receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034821:LDL Receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1149327:LDL receptor [Molecular Function]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "to 1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "of the normal binding capacity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0439155:Binding capacity [Quantitative Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1516240:Capacity [Quantitative Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.23: Consequently, the level of circulating E2 protein is significantly higher than that of E3. 

Phrase: "Consequently,"

Phrase: "the level of circulating E2 protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0428479:Protein level [Laboratory or Test Result]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "significantly higher than that of E3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.24: In contrast, the level of E4 protein is significantly lower than that of E3, presumably a consequence of the isoform-specific differences in lipid binding and uptake. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the level of E4 protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0428479:Protein level [Laboratory or Test Result]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "significantly lower than that of E3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0441994:Lower [Spatial Concept]
   753   C1548802:Lower [Body Location or Region]
   753   C2003888:Lower [Activity]

Phrase: "presumably"

Phrase: "a consequence of the isoform-specific differences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "in lipid binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1148636:Lipid Binding [Molecular Function]
   861   C0023779:Lipid [Lipid]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "uptake."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243144:Uptake [Physiologic Function]
  1000   C0347980:% uptake [Quantitative Concept]
Processing 00000000.tx.25: The ability of APOE to bind its receptors, which include LDLr, LRP, VLDLr and megalin, members of the LDL receptor family, dictates the efficiency with which these molecules are delivered to the appropriate cells and turned over. 

Phrase: "The ability of APOE to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "its receptors,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "which"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "LDLr,"

Phrase: "LRP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540560:LRP [Gene or Genome]

Phrase: "VLDLr"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421455:VLDLR [Gene or Genome]

Phrase: "and"

Phrase: "megalin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0284555:Megalin [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1416914:MEGALIN [Gene or Genome]

Phrase: "members of the LDL receptor family,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   783   C0086282:Family Members [Family Group]
   767 E C1611821:Family Member [Intellectual Product]
   753   C0680022:members [Population Group]
   719 E C2698041:Member [Professional or Occupational Group]

Phrase: "dictates"

Phrase: "the efficiency with which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0013682:Efficiency [Quantitative Concept]

Phrase: "these molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:molecules [Substance]
   916 E C1521991:Molecular [Qualitative Concept]

Phrase: "are"

Phrase: "delivered to the appropriate cells"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C1548787:Appropriate [Qualitative Concept]
   760   C1705822:Delivered [Activity]
   760   C3282337:Cells [Cell]
   726 E C0308779:DELIVER [Organic Chemical,Pharmacologic Substance]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1874964:DELIVER [Pharmacologic Substance]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "turned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0541749:turned [Finding]
   966 E C1709743:Turn [Spatial Concept]

Phrase: "over."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205136:Over [Spatial Concept]
Processing 00000000.tx.26: APOE 4 was first shown through association studies to be a genetic risk factor for cardiovascular disease, presumably through its role in conferring high circulating cholesterol levels, mainly in the form of LDL, in individuals with one or more copies of the allele (3,4). 

Phrase: "APOE 4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0052201:Apo E-4 [Amino Acid, Peptide, or Protein]
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "was"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "shown through association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0004083:Association [Mental Process]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]
   756   C1547282:Show [Intellectual Product]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a genetic risk factor for cardiovascular disease,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   804   C0814299:factor genetic risk [Qualitative Concept]
   804   C0850624:cardiovascular risk factor [Disease or Syndrome]
   804   C0850664:disease risk factor [Finding]
   778   C0035648:Risk factor [Quantitative Concept]
   774   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   774   C0679238:disease factor [Functional Concept]
   774   C0960756:factor A [Organic Chemical]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]

Phrase: "presumably through its role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in conferring high circulating cholesterol levels,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   872   C1522133:high cholesterol level [Finding]
           high cholesterol
   840   C0201950:cholesterol levels [Laboratory Procedure]
   840   C0428466:cholesterol levels [Laboratory or Test Result]
   804   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "mainly in the form of LDL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "in individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "with one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "or"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "copies of the allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0002085:Allele [Gene or Genome]
   770   C1948062:Copies [Manufactured Object]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.27: Subsequently, APOE 4 was found to be associated with increased risk for late-onset Alzheimer's disease (LOAD) (5,6). 

Phrase: "Subsequently,"

Phrase: "APOE 4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0052201:Apo E-4 [Amino Acid, Peptide, or Protein]
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with increased risk"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0035647:Risk [Qualitative Concept]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for late-onset Alzheimer's disease (LOAD)"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.28: Furthermore, the presence of one or more 4 alleles decreases the age of disease onset by as much as 10 years (7). 

Phrase: "Furthermore,"

Phrase: "the presence of one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "more 4 alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002085:Alleles [Gene or Genome]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the age of disease onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   760   C0001779:Age [Organism Attribute]

Phrase: "by"

Phrase: "as"

Phrase: "much as 10 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0439234:years [Temporal Concept]
   737 E C0439508:/year [Temporal Concept]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.29: One hypothesis as to the link between APOE genotype, cardiovascular disease and AD involves the contribution of cholesterol homeostasis to both diseases and the role of APOE in this process. 

Phrase: "One hypothesis as to the link"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1512571:Hypothesis [Idea or Concept]

Phrase: "between APOE genotype,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "cardiovascular disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0007222:Cardiovascular disease [Disease or Syndrome]
   861   C0007226:Cardiovascular [Body System]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "AD"

Phrase: "involves"

Phrase: "the contribution of cholesterol homeostasis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880177:Contribution [Activity]

Phrase: "to both diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "the role of APOE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in this process."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.30: Several studies have implicated a role for cholesterol in the production of A, the primary constituent of senile plaques in the AD brain (812). 

Phrase: "Several studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "implicated"

Phrase: "a role for cholesterol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in the production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "of A,"

Phrase: "the primary constituent of senile plaques"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0729650:constituent [Substance]

Phrase: "in the AD brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(812"

Phrase: ")."
Processing 00000000.tx.31: High serum cholesterol levels in mice transgenic for APP, the precursor protein for the A peptide, correlate with increased brain A levels and a more severe plaque load (13,14). 

Phrase: "High serum cholesterol levels in mice"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   820   C0587184:cholesterol levels serum [Laboratory Procedure]
           serum cholesterol
   820   C1287371:cholesterol levels serum [Laboratory or Test Result]
   804   C1522133:high cholesterol level [Finding]
           high cholesterol
   790   C0201950:cholesterol levels [Laboratory Procedure]
   790   C0428466:cholesterol levels [Laboratory or Test Result]
   753   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   753   C0229671:Serum [Body Substance]
   753   C0441889:Levels [Qualitative Concept]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "transgenic for APP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0003069:Transgenic [Animal]

Phrase: "the precursor protein for the"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "A peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "correlate with increased brain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "A levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "a more severe plaque load"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1550025:Load [Idea or Concept]
   812   C1704782:Load [Manufactured Object]
   812   C1708715:Load [Activity]

Phrase: "(13,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.32: Retrospective epidemiological studies have demonstrated a decreased AD risk in human populations on statin therapy to lower cholesterol levels (reviewed in 15), although this effect may be indirect, as several studies have shown that statins do not alter the A levels in serum (16,17). 

Phrase: "Retrospective epidemiological studies"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   913   C0035363:Retrospective Studies [Research Activity]
   901   C0002783:Epidemiological Studies [Research Activity]
   827   C0014507:Epidemiological [Biomedical Occupation or Discipline]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   755 E C0014508:epidemiology [Functional Concept]
   755 E C0699910:epidemiology [Health Care Activity]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "a decreased AD risk in human populations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0242444:population risk [Population Group]
   774   C2987720:Population risk [Quantitative Concept]
   748   C0035647:Risk [Qualitative Concept]

Phrase: "on statin therapy to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0039798:therapy [Functional Concept]
   827   C0087111:Therapy [Therapeutic or Preventive Procedure]
   827   C1363945:Therapy [Finding]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "cholesterol levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0201950:cholesterol levels [Laboratory Procedure]
  1000   C0428466:cholesterol levels [Laboratory or Test Result]
   861   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "("

Phrase: "reviewed in 15"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0282443:reviewed [Intellectual Product]
   790   C1709940:Reviewed [Qualitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "indirect,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439852:Indirect [Qualitative Concept]

Phrase: "as"

Phrase: "several studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that statins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0360714:Statins [Organic Chemical,Pharmacologic Substance]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the A levels in serum"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "(16,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.33: Several studies have reported an association of elevated serum cholesterol levels with AD risk and levels of A (18,19), independent of APOE genotype. 

Phrase: "Several studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "an association of elevated serum cholesterol levels"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "with AD risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035647:Risk [Qualitative Concept]

Phrase: "and"

Phrase: "levels of A (18,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "19"

Phrase: ")"

Phrase: ","

Phrase: "independent of APOE genotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]
Processing 00000000.tx.34: Other studies, however, have failed to demonstrate a correlation between serum cholesterol levels and AD development (20). 

Phrase: "Other studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "however,"

Phrase: "have"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "a correlation between serum cholesterol levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "AD development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.35: APOE 4 may affect AD risk by conferring high cholesterol levels and thereby increasing A production. 

Phrase: "APOE 4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0052201:Apo E-4 [Amino Acid, Peptide, or Protein]
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "may"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "AD risk by conferring high cholesterol levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0332167:High Risk [Qualitative Concept]
   774   C3272283:High Risk [Finding]
   748   C0035647:Risk [Qualitative Concept]

Phrase: "and"

Phrase: "thereby"

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "A production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]
Processing 00000000.tx.36: AD patients with an 4 allele have increased levels of A140 in their brains and CSF, and have more extensive plaque pathology (21,22). 

Phrase: "AD patients with an 4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030705:Patients [Patient or Disabled Group]

Phrase: "have"

Phrase: "increased levels of A140"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in their brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "CSF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "have"

Phrase: "more extensive plaque pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0030664:Pathology [Biomedical Occupation or Discipline]
   812   C0205469:pathology [Functional Concept]
   812   C0677042:pathology [Pathologic Function]
   741 E C1521733:Pathologic [Functional Concept]

Phrase: "(21,"

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.37: Interestingly, the 2 allele, which confers low cholesterol levels, is also considered to be protective against AD development (7). 

Phrase: "Interestingly,"

Phrase: "the 2 allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "which"

Phrase: "confers"

Phrase: "low cholesterol levels,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0856966:low cholesterol levels [Finding]
   901   C0201950:cholesterol levels [Laboratory Procedure]
   901   C0428466:cholesterol levels [Laboratory or Test Result]
   901   C0860920:Low cholesterol [Finding]
   827   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "also"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "protective against AD development"

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.38: Several APOE transgenic mouse models have been generated in efforts to gain insight into the role of APOE in AD (2326). 

Phrase: "Several APOE transgenic mouse models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   836   C1519606:Transgenic Model [Experimental Model of Disease]
   823   C2986594:Mouse Model [Experimental Model of Disease]
   804   C3161035:Models [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "generated in efforts to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C3146294:Generated [Activity]
   737   C0015264:Effort [Organism Function]

Phrase: "gain"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1517378:Gain [Quantitative Concept]
   944 E C0205217:Increased [Quantitative Concept]
   944 E C0439661:Acquired [Temporal Concept]
   944 E C0442805:Increase [Functional Concept]
   944 E C0442808:Increasing [Functional Concept]
   944 E C1301820:Obtain [Functional Concept]
   944 E C1706701:Acquire [Activity]
   944 E C3245488:acquired [Intellectual Product]

Phrase: "insight into the role of APOE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0233820:Insight [Mental Process]

Phrase: "in AD (2326"

Phrase: ")."
Processing 00000000.tx.39: These models utilize various promoters to drive the expression of human APOE cDNAs in neurons and glia. 

Phrase: "These models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]

Phrase: "utilize"

Phrase: "various promoters to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086860:promoters [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "drive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013126:Drive [Mental Process]

Phrase: "the expression of human APOE cDNAs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1515563:cDNA Expression [Molecular Biology Research Technique]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "glia."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027836:Glia [Cell]
  1000   C1087003:Glia [Plant]
Processing 00000000.tx.40: This approach has several limitations concerning the regulation of APOE in both the brain and the periphery. 

Phrase: "This approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "has"

Phrase: "several limitations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449295:limitations [Functional Concept]

Phrase: "concerning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2699424:Concern [Idea or Concept]

Phrase: "the regulation of APOE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "in both"

Phrase: "the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "the periphery."
Processing 00000000.tx.41: First, most APOE transgenic studies have attempted to normalize APOE levels in the APOE 3 or 4 transgenic lines with respect to each other (23) or to endogenous levels (24). 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "most APOE transgenic studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "attempted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1516084:Attempt [Event]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "normalize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalize [Research Activity]

Phrase: "APOE levels in the APOE 3"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   783   C0052199:Apo E-3 [Amino Acid, Peptide, or Protein]
   767   C0456949:Level 3 [Intellectual Product]
   753   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0441889:Levels [Qualitative Concept]
   753   C0523511:APOE [Laboratory Procedure]
   753   C1412481:APOE [Gene or Genome]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "or"

Phrase: "4 transgenic lines with respect to each other"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   744   C0003069:Transgenic [Animal]
   744   C0205132:lines [Spatial Concept]
   711 E C1550648:Line [Substance]
   711 E C1552960:Line [Quantitative Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "or to endogenous levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0205227:Endogenous [Functional Concept]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.42: However, several human studies suggest that levels of APOE vary with genotype and may impact AD pathogenesis. 

Phrase: "However,"

Phrase: "several human studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0178693:human studies [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that levels of APOE"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "vary with genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0017431:Genotype [Organism Attribute]

Phrase: "and"

Phrase: "may"

Phrase: "impact AD pathogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0543483:pathogenesis [Functional Concept]
   827   C0699748:Pathogenesis [Pathologic Function]
Processing 00000000.tx.43: Second, all APOE transgenic lines have been bred onto the Apoe-null background, which confers high circulating cholesterol levels. 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "all APOE transgenic lines"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0003069:Transgenic [Animal]
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "bred onto the Apoe-null background,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0456148:Null [Quantitative Concept]
   753   C0523511:APOE [Laboratory Procedure]
   753   C1412481:APOE [Gene or Genome]
   753   C1706907:Background [Conceptual Entity]
   719   C0006159:breed [Organism Function]
   719   C1704650:Breed [Classification]

Phrase: "which"

Phrase: "confers"

Phrase: "high circulating cholesterol levels."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   906   C1522133:high cholesterol level [Finding]
           high cholesterol
   861   C0201950:cholesterol levels [Laboratory Procedure]
   861   C0428466:cholesterol levels [Laboratory or Test Result]
   812   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.44: Given the role of Apoe in peripheral cholesterol metabolism and the growing evidence for cholesterol levels influencing brain A metabolism, it is unclear how the absence of Apoe affects AD pathology in these animals. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the role of Apoe"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in peripheral cholesterol metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1156530:cholesterol metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "the growing evidence for cholesterol levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0393009:evidence level [Finding]
   753   C0332120:Evidence [Functional Concept]

Phrase: "influencing"

Phrase: "brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "A metabolism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "it"

Phrase: "is"

Phrase: "unclear how"

Phrase: "the absence of Apoe"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "AD pathology in these animals."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030664:Pathology [Biomedical Occupation or Discipline]
   760   C0205469:pathology [Functional Concept]
   760   C0677042:pathology [Pathologic Function]
Processing 00000000.tx.45: Importantly, there has been no consensus about the impact of APOE genotype on AD pathogenesis from these studies, perhaps owing to the complications of different promoters and altered levels of APOE in the brain, combined with the complications of a mixed genetic background in these models. 

Phrase: "Importantly,"

Phrase: "there"

Phrase: "has"

Phrase: "been"

Phrase: "no consensus about the impact of APOE genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0376298:Consensus [Social Behavior]

Phrase: "on AD pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0543483:pathogenesis [Functional Concept]
   861   C0699748:Pathogenesis [Pathologic Function]

Phrase: "from these studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "perhaps owing to the complications of different promoters"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   744   C0009566:Complications [Pathologic Function]
   744   C0086860:promoters [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C1171258:complications [Pathologic Function]
   744   C1705242:Different [Qualitative Concept]
   711 E C2362589:Complication [Idea or Concept]

Phrase: "and"

Phrase: "altered levels of APOE"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "combined with the complications of a mixed genetic background"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   742   C0009566:Complications [Pathologic Function]
   742   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   742   C0205195:Combined [Qualitative Concept]
   742   C0205430:Mixed [Functional Concept]
   742   C0314603:Genetic [Functional Concept]
   742   C1171258:complications [Pathologic Function]
   742   C1706907:Background [Conceptual Entity]
   742   C3160715:Mixed [Finding]
   717   C2825536:Birth Complication [Finding]
   708 E C0336789:Combine [Manufactured Object]
   708 E C2362589:Complication [Idea or Concept]

Phrase: "in these models."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]
Processing 00000000.tx.46: APOE knock-in (KI) mice provide unique model for understanding how each APOE allele behaves in the development of Alzheimer's disease. 

Phrase: "APOE knock-in (KI) mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1517676:Knock-in [Research Activity]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "unique model for understanding how"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "each APOE allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "behaves in the development of Alzheimer's disease."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1527148:Development [Functional Concept]
Processing 00000000.tx.47: We have obtained these mice, previously published by Hamanaka etal. 

Phrase: "We"

Phrase: "have"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "these mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "previously"

Phrase: "published by Hamanaka etal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0034037:Published [Occupational Activity]
   770   C1704324:Published [Intellectual Product]
Processing 00000000.tx.48: (27), in order to further characterize the behavior of human APOE alleles in a defined genetic background. 

Phrase: "(27"

Phrase: ")"

Phrase: ","

Phrase: "in order"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1705175:Order [Intellectual Product]
  1000   C1705176:Order [Qualitative Concept]
  1000   C1705177:Order [Classification]
  1000   C1705178:Order [Activity]
  1000   C1882348:Order [Qualitative Concept]

Phrase: "to further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "characterize"

Phrase: "the behavior of human APOE alleles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0004927:Behavior [Individual Behavior]
   753   C2707008:Behavior [Clinical Attribute]

Phrase: "in a defined genetic background."
Meta Candidates (Total=17; Excluded=14; Pruned=0; Remaining=3)
   827   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   827   C0314603:Genetic [Functional Concept]
   827   C1706907:Background [Conceptual Entity]
   771 E C0005615:Birth [Organism Function]
   771 E C0035150:Reproduction [Organism Function]
   771 E C0079946:origin [Classification]
   771 E C0439659:Origin [Temporal Concept]
   771 E C1550512:origin [Intellectual Product]
   771 E C1550722:birth [Idea or Concept]
   771 E C3245487:birth [Intellectual Product]
   743 E C0454729:Natal [Geographic Area]
   743 E C0559522:Genital [Body System]
   743 E C1546649:Genital [Intellectual Product]
   743 E C1550642:Genital [Body Substance]
   734 E C0205313:Original [Idea or Concept]
   734 E C2347409:Original [Occupational Activity]
   716 E C0598240:originality [Mental Process]
Processing 00000000.tx.49: We present APOE protein abundance, cholesterol and lipoprotein data from young animals expressing APOE 2, 3 and 4 on a defined C57BL/6J background. 

Phrase: "We"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "APOE protein abundance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2346714:Abundance [Qualitative Concept]

Phrase: "cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "and"

Phrase: "lipoprotein data from young animals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0597710:animal data [Intellectual Product]
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]

Phrase: "expressing"

Phrase: "APOE 2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0052198:Apo E-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "4 on a defined C57BL/6J background."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0025921:C57BL [Mammal]
   748   C1704788:Defined [Conceptual Entity]
   748   C1706907:Background [Conceptual Entity]
   748   C3539106:Defined [Intellectual Product]
Processing 00000000.tx.50: We demonstrate significant differences in protein abundance, which mirrors the human data, as well as significant differences in serum cholesterol levels in the absence of an effect on APP processing. 

Phrase: "We"

Phrase: "demonstrate"

Phrase: "significant differences in protein abundance,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "which"

Phrase: "mirrors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0181868:Mirror [Manufactured Object]
  1000   C1706183:Mirror [Manufactured Object]

Phrase: "the human data,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596723:human data [Intellectual Product,Research Activity]
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "as well as"

Phrase: "significant differences in serum cholesterol levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of an effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "on APP processing."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]
Processing 00000000.tx.51: The presence of APOE significantly increases levels of both A and cholesterol in brain, irrespective of allele. 

Phrase: "The presence of APOE significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "levels of both"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0441889:Levels [Qualitative Concept]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]

Phrase: "A"

Phrase: "and"

Phrase: "cholesterol in brain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "irrespective of allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.52: This genomic-based mouse model provides evidence that neither cholesterol levels nor APOE abundance alone is sufficient to influence A metabolism in young animals.  

Phrase: "This genomic-based mouse model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2986594:Mouse Model [Experimental Model of Disease]
   812   C3161035:Model [Intellectual Product]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "neither cholesterol levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0201950:cholesterol levels [Laboratory Procedure]
  1000   C0428466:cholesterol levels [Laboratory or Test Result]
   861   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "nor"

Phrase: "APOE abundance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346714:Abundance [Qualitative Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "is"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "influence"

Phrase: "A metabolism in young animals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.53: RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Generation of genetically defined APOE KI mice The APOE 4 allele is the most significant genetic risk factor for Alzheimer's disease identified to-date, Much work has been done in the mouse to understand how the different alleles of APOE affect the onset and development of pathology in an AD mouse model; 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Generation of genetically defined APOE KI mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0079411:Generation [Temporal Concept]
   744   C3146294:Generation [Activity]

Phrase: "The APOE 4 allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3642141:APOE*4 Allele [Gene or Genome]
   827   C0002085:Allele [Gene or Genome]
   734   C0052201:Apo E-4 [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "the most significant genetic risk factor for Alzheimer's disease"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   784   C0814299:factor genetic risk [Qualitative Concept]
   784   C0850664:disease risk factor [Finding]
   764   C0035648:Risk factor [Quantitative Concept]
   762   C0679238:disease factor [Functional Concept]
   742   C1521761:Factor [Functional Concept]
   742   C2827422:Factor [Conceptual Entity]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "to-date,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011008:Date [Temporal Concept]
   861   C2348077:Date [Food]

Phrase: "Much"

Phrase: "work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "has"

Phrase: "been"

Phrase: "done in the mouse to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C1272695:Done [Qualitative Concept]
   760   C2746065:Done [Temporal Concept]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "how"

Phrase: "the different alleles of APOE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0002085:Alleles [Gene or Genome]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "and"

Phrase: "development of pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0243107:development [Physiologic Function]
   790   C0678723:Development [Organism Function]
   790   C1527148:Development [Functional Concept]
   718 E C0458003:Developmental [Qualitative Concept]

Phrase: "in an AD mouse model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2986594:Mouse Model [Experimental Model of Disease]
   827   C3161035:Model [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.54: however, these transgenic models have several limitations that confound the study of APOE gene regulation and gene function in mouse models of AD. 

Phrase: "however,"

Phrase: "these transgenic models"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1519606:Transgenic Model [Experimental Model of Disease]
   861   C3161035:Models [Intellectual Product]

Phrase: "have"

Phrase: "several limitations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449295:limitations [Functional Concept]

Phrase: "that"

Phrase: "confound"

Phrase: "the study of APOE gene regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "gene function in mouse"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0314627:Gene function [Genetic Function]
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "models of AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3161035:Model [Intellectual Product]
Processing 00000000.tx.55: To circumvent these limitations, we took advantage of APOE KI animals generated at the Mitsubishi Kagaku Institute of Life Science, Japan (27). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "circumvent"

Phrase: "these limitations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449295:limitations [Functional Concept]

Phrase: "we"

Phrase: "took"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515187:Take [Health Care Activity]

Phrase: "advantage of APOE KI animals"

Phrase: "generated at the Mitsubishi Kagaku Institute of Life Science,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0005526:Science, Life [Occupation or Discipline]
   742   C0021622:institute [Organization]
   742   C0036397:Science [Occupation or Discipline]
   742   C0376558:Life [Idea or Concept]
   742   C1272753:Institute [Idea or Concept]
   742   C3146294:Generated [Activity]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.56: The targeted allele placed the human cDNA for each APOE allele in-frame with the endogenous exon 1 sequence and part of exon 2. 

Phrase: "The targeted allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "placed"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0442504:Place [Spatial Concept]
   966   C1704765:Place [Functional Concept]
   966   C1882509:Place [Activity]
   966   C3496241:place [Disease or Syndrome]

Phrase: "the human cDNA for each APOE allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in-frame with the endogenous exon 1 sequence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0080089:Frame [Nucleotide Sequence]
   744   C0180979:Frame [Medical Device]
   744   C1705858:Frame [Manufactured Object]

Phrase: "and"

Phrase: "part of exon 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1292711:Part of [Spatial Concept]
   770   C0449719:Part [Spatial Concept]
   770   C1709471:Part [Quantitative Concept]
Processing 00000000.tx.57: This allowed for control of human APOE expression by endogenous regulatory elements, while at the same time removing the mouse Apoe coding sequence. 

Phrase: "This"

Phrase: "allowed for control of human APOE expression"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   748   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0086418:Human [Human]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0243148:control [Qualitative Concept]
   748   C0523511:APOE [Laboratory Procedure]
   748   C0683607:allowed [Social Behavior]
   748   C1412481:APOE [Gene or Genome]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "by endogenous regulatory elements,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   867   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Elements [Element, Ion, or Isotope]
   827   C0220905:regulatory [Regulation or Law]
   827   C1704735:Regulatory [Conceptual Entity]
   793 E C1705248:Element [Conceptual Entity]

Phrase: "while at the same time"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0040223:Time [Temporal Concept]
   760   C0445247:Same [Qualitative Concept]
   760   C0750519:while [Idea or Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "removing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0849355:remove [Qualitative Concept]
   966   C1883720:Remove [Activity]
   966   C3244314:remove [Functional Concept]

Phrase: "the mouse Apoe coding sequence."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   861   C0079941:Coding Sequence [Gene or Genome]
   812   C0004793:Sequence [Nucleotide Sequence]
   812   C0009219:Coding [Occupational Activity]
   812   C0162326:Sequence [Nucleotide Sequence]
   812   C0162327:Sequence [Nucleotide Sequence]
   812   C1519249:Sequence [Functional Concept]
   779 E C0805701:Code [Intellectual Product]
   741 E C1548958:Sequential [Idea or Concept]
   741 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.58: APOE 4 KI mice generated by this strategy were previously published (27). 

Phrase: "APOE 4 KI mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C1517676:Knock-in [Research Activity]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "generated by this strategy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0679199:strategy [Mental Process]
   770   C3146294:Generated [Activity]

Phrase: "were"

Phrase: "previously"

Phrase: "published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.59: It was demonstrated that human APOE in these mice is expressed in serum and in astrocytes in the correct histological pattern. 

Phrase: "It"

Phrase: "was"

Phrase: "demonstrated"

Phrase: "that human APOE in these mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0523511:APOE [Laboratory Procedure]
   753   C1412481:APOE [Gene or Genome]

Phrase: "is"

Phrase: "expressed in serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0229671:Serum [Body Substance]
   790   C1546774:Serum [Intellectual Product]
   790   C1550100:Serum [Body Substance]

Phrase: "and in astrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0004112:Astrocytes [Cell]
   790   C1515981:And [Idea or Concept]

Phrase: "in the correct histological pattern."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449774:Pattern [Spatial Concept]
Processing 00000000.tx.60: The APOE KI mice were originally maintained on a mixed C57BL/6;129P2 background and contained a neo selection cassette in the targeted allele. 

Phrase: "The APOE KI mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1517676:Knock-in [Research Activity]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "originally"

Phrase: "maintained on a mixed C57BL/6"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C1521751:C57BL/6 [Mammal]
   753   C0025921:C57BL [Mammal]
   753   C0205430:Mixed [Functional Concept]
   753   C1314677:Maintained [Functional Concept]
   753   C3160715:Mixed [Finding]
   719 E C0024501:Maintain [Activity]

Phrase: ";129P2 background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706907:Background [Conceptual Entity]

Phrase: "and"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "a neo selection cassette in the targeted allele."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0450240:Cassette [Medical Device]
   744   C1706210:Cassette [Manufactured Object]
Processing 00000000.tx.61: Work from our lab and others has demonstrated that genetic background can greatly influence phenotypic expression, particularly with regards to A generation and deposition (28). 

Phrase: "Work from our lab"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0043227:Work [Occupational Activity]

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "has"

Phrase: "demonstrated"

Phrase: "that genetic background"
Meta Candidates (Total=17; Excluded=14; Pruned=0; Remaining=3)
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   861   C1706907:Background [Conceptual Entity]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "can"

Phrase: "greatly"

Phrase: "influence"

Phrase: "phenotypic expression,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotypic expression [Organism Attribute]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "particularly with"

Phrase: "regards to A generation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0079411:Generation [Temporal Concept]
   770   C3146294:Generation [Activity]

Phrase: "and"

Phrase: "deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposition [Functional Concept]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.62: In addition, several lines of evidence have shown that the strong promoter of neo can influence the expression of both the targeted locus as well as the neighboring genes (29,30). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "several lines of evidence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205132:lines [Spatial Concept]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the strong promoter of neo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "can"

Phrase: "influence"

Phrase: "the expression of both"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "the targeted locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]

Phrase: "as well as"

Phrase: "the neighboring genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "(29,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.63: For these reasons, the APOE KI lines were backcrossed onto the defined C57BL/6J (B6) inbred background and also mated to ZP3-cre transgenic mice congenic on the B6 background (31) to remove the neo cassette through cre-mediated loxP excision. 

Phrase: "For these reasons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392360:reasons [Idea or Concept]

Phrase: "the APOE KI lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205132:lines [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "backcrossed onto the defined C57BL/6J"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0025921:C57BL [Mammal]
   753   C1704788:Defined [Conceptual Entity]
   753   C3539106:Defined [Intellectual Product]

Phrase: "(B6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0507115:B6 [Body Part, Organ, or Organ Component]
  1000   C1521751:B6 [Mammal]

Phrase: ")"

Phrase: "inbred background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706907:Background [Conceptual Entity]

Phrase: "and"

Phrase: "also"

Phrase: "mated to ZP3-cre transgenic mice"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   790   C0025936:Mice, Transgenic [Mammal]
   753   C0003069:Transgenic [Animal]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0597698:ZP3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1254211:mated [Pharmacologic Substance]
   753   C1260875:Mated [Organism Function]
   753   C1421866:ZP3 [Gene or Genome]
   753   C1511573:CRE [Gene or Genome]
   719 E C0682323:mate [Family Group]

Phrase: "congenic on the B6 background"

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "the neo cassette through cre-mediated loxP excision."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0450240:Cassette [Medical Device]
   744   C1706210:Cassette [Manufactured Object]
Processing 00000000.tx.64: The cre transgene was transferred onto the APOE KI background such that the expression of cre in the mouse oocytes of APOE KI females excised the floxed neo cassette in the targeted allele. 

Phrase: "The cre transgene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282641:Transgene [Gene or Genome]

Phrase: "was"

Phrase: "transferred onto the APOE KI background"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   778   C1517676:Knock-in [Research Activity]
   748   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0348011:transferred [Functional Concept]
   748   C0523511:APOE [Laboratory Procedure]
   748   C1412481:APOE [Gene or Genome]
   748   C1706907:Background [Conceptual Entity]
   714 E C0040671:Transfer [Mental Process]
   714 E C1705822:Transfer [Activity]

Phrase: "such"

Phrase: "that"

Phrase: "the expression of cre"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the mouse oocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029045:Oocytes [Cell]

Phrase: "of APOE KI females"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0015780:Females [Finding]
   812   C0086287:Females [Population Group]
   779 E C0043210:female [Population Group]
   779 E C1705497:Female [Qualitative Concept]
   779 E C1705498:Female [Qualitative Concept]

Phrase: "excised"

Phrase: "the floxed neo cassette in the targeted allele."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0450240:Cassette [Medical Device]
   744   C1706210:Cassette [Manufactured Object]
Processing 00000000.tx.65: These females were mated to B6 males, and the resulting offspring inherited the targeted allele lacking the neo tag, as demonstrated by both polymerase chain reaction (PCR) assay, using primers to neo, and by Southern blot (data not shown). 

Phrase: "These females"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0015780:Females [Finding]
  1000   C0086287:Females [Population Group]
   966 E C0043210:female [Population Group]
   966 E C1705497:Female [Qualitative Concept]
   966 E C1705498:Female [Qualitative Concept]

Phrase: "were"

Phrase: "mated to B6 males,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   770   C0024554:Males [Finding]
   770   C0086582:Males [Population Group]
   770   C0507115:B6 [Body Part, Organ, or Organ Component]
   770   C1254211:mated [Pharmacologic Substance]
   770   C1260875:Mated [Organism Function]
   770   C1521751:B6 [Mammal]
   737 E C0682323:mate [Family Group]
   737 E C1706180:Male [Qualitative Concept]
   737 E C1706428:Male [Qualitative Concept]
   737 E C1706429:Male [Organism Attribute]

Phrase: "and"

Phrase: "the resulting offspring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680063:Offspring [Family Group]

Phrase: "inherited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439660:Inherited [Functional Concept]

Phrase: "the targeted allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "the neo tag,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037293:Tag [Neoplastic Process]
   861   C0181496:Tag [Manufactured Object]
   861   C1710492:TAG [Gene or Genome]

Phrase: "as"

Phrase: "demonstrated by both polymerase chain reaction (PCR) assay,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0243073:assay [Qualitative Concept]
   748   C0337112:Chain [Manufactured Object]
   748   C0443286:Reaction [Functional Concept]
   748   C1114821:Reaction [Clinical Attribute]
   748   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1510438:Assay [Laboratory Procedure]
   748   C1524075:Chain [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers to neo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and by Southern blot"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0005862:Southern Blot [Molecular Biology Research Technique]
   833   C1148472:Blot, Southern [Laboratory or Test Result]
   770   C1515981:And [Idea or Concept]
   770   C1710133:Southern [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.66: Animals lacking the cre transgene were identified in subsequent progeny. 

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "the cre transgene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282641:Transgene [Gene or Genome]

Phrase: "were"

Phrase: "identified in subsequent progeny."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205396:Identified [Qualitative Concept]
   770   C0332282:Subsequent [Temporal Concept]
   770   C0680063:Progeny [Family Group]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
Processing 00000000.tx.67: Once each APOE KI line was backcrossed five generations (N5, incipient congenic, >98% homogeneous) (32), animals were intercrossed to obtain populations of APOE 2/2, 3/3 and 4/4 mice (hereafter referred to as 2 KI, 3 KI and 4 KI, respectively). 

Phrase: "Once"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720092:Once [Intellectual Product]
  1000   C1948045:Once [Temporal Concept]

Phrase: "each APOE KI line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205132:Line [Spatial Concept]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]

Phrase: "was"

Phrase: "backcrossed"

Phrase: "five generations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0079411:Generations [Temporal Concept]
   827 E C3146294:Generation [Activity]
   761 E C1414672:Genesis [Gene or Genome]
   761 E C2984892:Genesis [Gene or Genome]

Phrase: "(N5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442785:N5 [Finding]

Phrase: "incipient congenic,"

Phrase: ">98% homogeneous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1881065:Homogeneous [Qualitative Concept]

Phrase: ")"

Phrase: "(32"

Phrase: ")"

Phrase: ","

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "intercrossed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "populations of APOE 2/2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0032659:Population [Quantitative Concept]
   760   C1257890:Population [Population Group]

Phrase: "3/3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "4/4 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(hereafter"

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to as 2 KI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1517676:Knock-in [Research Activity]
   760   C1883351:To [Qualitative Concept]

Phrase: "3 KI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1517676:Knock-in [Research Activity]

Phrase: "and"

Phrase: "4 KI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1517676:Knock-in [Research Activity]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.68: Animals were PCR genotyped on the basis of the presence of human APOE, using human-specific primers, and the absence of the endogenous Apoe locus, demonstrated by PCR using mouse Apoe-specific primers (data not shown). 

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "PCR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0337112:Chain [Manufactured Object]
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1524075:Chain [Idea or Concept]

Phrase: "genotyped on the basis of the presence of human APOE,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   739   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0086418:Human [Human]
   739   C0392148:Presence [Therapeutic or Preventive Procedure]
   739   C0523511:APOE [Laboratory Procedure]
   739   C1412481:APOE [Gene or Genome]
   739   C1527178:Basis [Functional Concept]
   739   C1874451:Basis [Pharmacologic Substance]
   706   C0017431:Genotype [Organism Attribute]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "human-specific primers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "the absence of the endogenous Apoe locus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332197:absence [Quantitative Concept]
   748   C1689985:Absence [Anatomical Abnormality]

Phrase: "demonstrated by PCR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0337112:Chain [Manufactured Object]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1524075:Chain [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "mouse Apoe-specific primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.69: These mice were then characterized at 68 weeks of age for a variety of parameters in order to understand how each APOE allele behaves in the mouse with respect to steady-state protein levels and cholesterol metabolism, and how each impacts APP processing and A metabolism. 

Phrase: "These mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "characterized at 68 weeks of age"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0001779:Age [Organism Attribute]
   753   C0439230:weeks [Temporal Concept]
   753   C0450387:68 [Intellectual Product]
   753   C1880022:Characterized [Activity]
   719 E C0332174:/week [Temporal Concept]

Phrase: "for a variety"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1883525:Variety [Conceptual Entity]
  1000   C2346866:Variety [Conceptual Entity]

Phrase: "of parameters"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0449381:Parameters [Finding]
   966 E C0549193:Parameter [Spatial Concept]
   966 E C1704769:Parameter [Conceptual Entity]
   966 E C2350001:Parameter [Quantitative Concept]

Phrase: "in order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "how"

Phrase: "each APOE allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "behaves in the mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]

Phrase: "with respect to steady-state protein levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   858   C0683927:state level [Spatial Concept]
   827   C0428479:Protein level [Laboratory or Test Result]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "cholesterol metabolism,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1156530:cholesterol metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "how"

Phrase: "each"

Phrase: "impacts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1825598:IMPACT [Gene or Genome]

Phrase: "APP processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "A metabolism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.70: Protein abundance in APOE KI mice The levels of steady-state APOE in brain, liver and serum of the three KI mouse lines were determined by western blot analysis using a human-specific APOE antibody. 

Phrase: "Protein abundance in APOE KI mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2346714:Abundance [Qualitative Concept]

Phrase: "The levels of steady-state APOE"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C0683927:state level [Spatial Concept]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "serum of the three KI mouse lines"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0229671:Serum [Body Substance]
   744   C1546774:Serum [Intellectual Product]
   744   C1550100:Serum [Body Substance]

Phrase: "were"

Phrase: "determined by western blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a human-specific APOE antibody."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.71: Parallel western blots of recombinant E2, E3 and E4 serial dilutions (6.25, 12.5, 25, 50g of protein) were run to determine the affinity of this antibody for each isoform. 

Phrase: "Parallel western blots of recombinant E2,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0949466:Western Blots [Laboratory Procedure]
   756 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   753   C1705493:Western [Spatial Concept]

Phrase: "E3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1537525:E3 [Gene or Genome]

Phrase: "and"

Phrase: "E4 serial dilutions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0031082:serial [Intellectual Product,Manufactured Object]
   827   C0079240:dilutions [Laboratory Procedure]
   793 E C1948037:Dilution [Functional Concept]

Phrase: "(6.25,"

Phrase: "12.5,"

Phrase: "25,"

Phrase: "50g of protein"

Phrase: ")"

Phrase: "were"

Phrase: "run"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035953:run [Daily or Recreational Activity]
  1000   C0600140:run [Finding]
  1000   C1704688:Run [Functional Concept]
  1000   C2346414:Run [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the affinity of this antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0003255:Antibody Affinity [Molecular Function]
   760   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "for each isoform."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597298:Isoform [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.72: Standard curves of fluorescent units for each isoform revealed little difference in detection. 

Phrase: "Standard curves of fluorescent units"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0205134:Curve [Spatial Concept]

Phrase: "for each isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "little difference in detection."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.73: E4 appeared to be detected slightly less well (data not shown). 

Phrase: "E4"

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "slightly less well"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205170:Well [Qualitative Concept]
   827   C0750482:Slightly [Idea or Concept]
   827   C3146287:Well [Manufactured Object]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.74: Levels of APOE protein in each KI animal were compared with a standard homogenate (or serum standard) from a homozygous 3 KI animal. 

Phrase: "Levels of APOE protein"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   802   C0428479:Protein level [Laboratory or Test Result]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in each KI animal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003062:Animal [Animal]
   734   C1517676:Knock-in [Research Activity]

Phrase: "were"

Phrase: "compared with a standard homogenate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1442989:Standard [Qualitative Concept]
   760   C1707455:Compared [Activity]
   760   C2828392:Standard [Intellectual Product]

Phrase: "("

Phrase: "or"

Phrase: "serum standard"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1442989:Standard [Qualitative Concept]
   861   C2828392:Standard [Intellectual Product]

Phrase: ")"

Phrase: "from a homozygous 3 KI animal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0003062:Animal [Animal]
Processing 00000000.tx.75: Figure 1 illustrates the differences in APOE levels compared across lines as the ratio of steady-state levels of each sample relative to the standard. 

Phrase: "Figure 1"

Phrase: "illustrates"

Phrase: "the differences in APOE levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "compared across lines"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205132:lines [Spatial Concept]
   790   C1707455:Compared [Activity]
   756 E C1550648:Line [Substance]
   756 E C1552960:Line [Quantitative Concept]

Phrase: "as the ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456603:Ratio [Quantitative Concept]
  1000   C1547037:Ratio [Intellectual Product]

Phrase: "of steady-state levels"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C0678587:steady state [Natural Phenomenon or Process]
   884   C0683927:state level [Spatial Concept]
   827   C0205361:Steady [Qualitative Concept]
   827   C0441889:Levels [Qualitative Concept]
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "of each"

Phrase: "sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "relative to the standard."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.76: APOE 2 KI animals had an average 2-fold higher steady-state level of APOE in both brain and fasted liver when compared with 3 KI and 4 KI animals (Fig.1A and B, P<0.001). 

Phrase: "APOE 2 KI animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0003062:Animals [Animal]

Phrase: "had"

Phrase: "an average 2-fold higher steady-state level of APOE"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0678587:steady state [Natural Phenomenon or Process]
   760   C0683927:state level [Spatial Concept]
   757   C0456948:Level 2 [Intellectual Product]
   739   C0205361:Steady [Qualitative Concept]
   739   C0441889:Level [Qualitative Concept]
   739   C0456079:Level [Classification]
   739   C1301808:State [Geographic Area]
   739   C1442792:State [Functional Concept]
   739   C1547707:Level [Geographic Area]
   739   C2946261:Level [Pharmacologic Substance]
   739   C3148680:State [Geographic Area]

Phrase: "in both brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "fasted liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]

Phrase: "when"

Phrase: "compared with 3 KI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1517676:Knock-in [Research Activity]
   760   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "4 KI animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "(Fig.1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.77: All three lines had significantly different levels of APOE in the brain. 

Phrase: "All three lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "had"

Phrase: "significantly different levels of APOE"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.78: Levels of steady-state APOE in brain were confirmed by a human-specific APOE ELISA, using a standard curve of recombinant E2, E3 or E4 to quantitate levels of each isoform. 

Phrase: "Levels of steady-state APOE"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   781   C0683927:state level [Spatial Concept]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "confirmed by a human-specific APOE ELISA,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   748   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0014441:ELISA [Laboratory Procedure]
   748   C0086418:Human [Human]
   748   C0205369:Specific [Qualitative Concept]
   748   C0523511:APOE [Laboratory Procedure]
   748   C0750484:Confirmed [Idea or Concept]
   748   C1412481:APOE [Gene or Genome]
   748   C1552740:specific [Intellectual Product]
   714 E C1456348:Confirm [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a standard curve of recombinant E2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205134:Curve [Spatial Concept]

Phrase: "E3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1537525:E3 [Gene or Genome]

Phrase: "or"

Phrase: "E4 to"

Phrase: "quantitate"

Phrase: "levels of each isoform."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.79: 2 KI animals demonstrated a 2-fold increase in the level of brain APOE by this method as well (P<0.001), although E3 and E4 were not significantly different. 

Phrase: "2 KI animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "demonstrated"

Phrase: "a 2-fold increase in the level of brain APOE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0442805:Increase [Functional Concept]

Phrase: "by this method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "as well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "(P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "E3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1537525:E3 [Gene or Genome]

Phrase: "and"

Phrase: "E4"

Phrase: "were"

Phrase: "not significantly different."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705242:Different [Qualitative Concept]
   755 E C1705241:*Difference [Quantitative Concept]
   727 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.80: The difference shown by western blotting in the 3 and 4 lines may be explained by the slightly lower affinity of the antibody for recombinant E4. 

Phrase: "The difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "shown by western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]
   737   C1547282:Show [Intellectual Product]

Phrase: "in the 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "4 lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "explained by the slightly lower affinity of the antibody"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   762   C0003255:Antibody Affinity [Molecular Function]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0441994:Lower [Spatial Concept]
   742   C0750482:Slightly [Idea or Concept]
   742   C1510827:Affinity [Natural Phenomenon or Process]
   742   C1548802:Lower [Body Location or Region]
   742   C2003888:Lower [Activity]

Phrase: "for recombinant E4."
Processing 00000000.tx.81: The level of APOE in fasted serum of 2 KI animals was also significantly higher than those found in 3 KI and 4 KI animals by western blotting (Fig.1D, P<0.01). 

Phrase: "The level of APOE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "in fasted serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "of 2 KI animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "was"

Phrase: "also significantly higher than those"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "found in 3 KI"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C1517676:Knock-in [Research Activity]
   760   C0150312:Found [Quantitative Concept]
   726 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "4 KI animals by western blotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0003062:Animals [Animal]

Phrase: "(Fig.1D, P<0.01"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0349966:Fig [Food]
   804   C1337208:FIG [Food]
   804   C1416886:1D [Gene or Genome]
   804   C1442449:1D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.82: The relationship between genotype and APOE levels in the KI mice recapitulates that observed in human serum (3335). 

Phrase: "The relationship between genotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439849:Relationship [Qualitative Concept]
   770   C1705630:Relationship [Idea or Concept]
   770   C1706279:Relationship [Idea or Concept]
   770   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "APOE levels in the KI mice"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   748   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0441889:Levels [Qualitative Concept]
   748   C0523511:APOE [Laboratory Procedure]
   748   C1412481:APOE [Gene or Genome]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "recapitulates"

Phrase: "that"

Phrase: "observed in human serum"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0086418:Human [Human]
   770   C0229671:Serum [Body Substance]
   770   C1441672:Observed [Functional Concept]
   770   C1546774:Serum [Intellectual Product]
   770   C1550100:Serum [Body Substance]

Phrase: "(3335"

Phrase: ")."
Processing 00000000.tx.83: View larger version (25K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(25K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.84: Analysis of APOE abundance in APOE KI animals. 

Phrase: "Analysis of APOE abundance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "in APOE KI animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]
Processing 00000000.tx.85: Relative levels of APOE in brain, fasted liver and fasted serum in the APOE KI lines were assayed in both males and females 68 weeks of age. 

Phrase: "Relative levels of APOE"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "fasted liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "fasted serum in the APOE KI lines"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0229671:Serum [Body Substance]
   744   C1546774:Serum [Intellectual Product]
   744   C1550100:Serum [Body Substance]

Phrase: "were"

Phrase: "assayed in both males"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0024554:Males [Finding]
   770   C0086582:Males [Population Group]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]
   737 E C1706180:Male [Qualitative Concept]
   737 E C1706428:Male [Qualitative Concept]
   737 E C1706429:Male [Organism Attribute]

Phrase: "and"

Phrase: "females 68 weeks of age."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0439230:weeks [Temporal Concept]
   726 E C0332174:/week [Temporal Concept]
Processing 00000000.tx.86: Protein extracts of both brain and fasted liver were made in 1% CHAPS with protease inhibitors. 

Phrase: "Protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "extracts of both brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C2828366:Extract [Substance]

Phrase: "and"

Phrase: "fasted liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]

Phrase: "were"

Phrase: "made in 1% CHAPS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0047101:CHAPS [Pharmacologic Substance,Steroid]
   737 E C0950540:chap [Therapeutic or Preventive Procedure]
   737   C1881534:Make [Functional Concept]

Phrase: "with protease inhibitors."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   966 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1947941:Protease [Enzyme]
   827 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.87: APOE levels in brain (A, n=8), fasted liver (B, n=8) and fasted serum (D, n=6) were assayed by western blot analysis using a human-specific APOE antibody (Calbiochem). 

Phrase: "APOE levels in brain"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0441889:Levels [Qualitative Concept]
   770   C0523511:APOE [Laboratory Procedure]
   770   C1412481:APOE [Gene or Genome]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "(A,"

Phrase: "n=8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "fasted liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]

Phrase: "(B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "n=8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "fasted serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "(D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "n=6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "assayed by western blot analysis"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western blot assay
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a human-specific APOE antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Calbiochem"

Phrase: ")."
Processing 00000000.tx.88: APOE quantitation is expressed as a ratio of APOE abundance in each sample relative to that in a standard of the same total protein concentration. 

Phrase: "APOE quantitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709793:Quantitation [Quantitative Concept]

Phrase: "is"

Phrase: "expressed as a ratio of APOE abundance"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0456603:Ratio [Quantitative Concept]
   748   C0523511:APOE [Laboratory Procedure]
   748   C1412481:APOE [Gene or Genome]
   748   C1547037:Ratio [Intellectual Product]
   748   C2346714:Abundance [Qualitative Concept]

Phrase: "in each"

Phrase: "sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "relative to that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "in a standard"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1442989:Standard [Qualitative Concept]
  1000   C2828392:Standard [Intellectual Product]

Phrase: "of the same total protein concentration."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   861   C0427716:Protein concentration [Laboratory Procedure]
   861   C0555903:Total protein [Laboratory Procedure]
   861   C1261360:total protein [Laboratory or Test Result]
   861   C1304757:Protein concentration [Laboratory or Test Result]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086045:Concentration [Mental Process]
   812   C0439175:% total [Quantitative Concept]
   812   C0439810:Total [Qualitative Concept]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.89: 2 KI APOE levels are significantly increased in both brain (A) and fasted liver (B) (P<0.001, one-factor ANOVA with post-Tukey) when compared with 3 KI and 4 KI levels. 

Phrase: "2 KI APOE levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   897   C0456948:2 levels [Intellectual Product]
   804   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0441889:Levels [Qualitative Concept]
   804   C0523511:APOE [Laboratory Procedure]
   804   C1412481:APOE [Gene or Genome]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "significantly"

Phrase: "increased in both brain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(A)"

Phrase: "and"

Phrase: "fasted liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]

Phrase: "(B) (P<0.001,"

Phrase: "one-factor ANOVA with post-Tukey"

Phrase: ")"

Phrase: "when"

Phrase: "compared with 3 KI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1517676:Knock-in [Research Activity]
   760   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "4 KI levels."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   902   C0456950:4 levels [Qualitative Concept]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.90: 2 KI APOE levels are also significantly increased in fasted serum (D) (P<0.01, one-factor ANOVA followed by Dunn's post-test). 

Phrase: "2 KI APOE levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   897   C0456948:2 levels [Intellectual Product]
   804   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0441889:Levels [Qualitative Concept]
   804   C0523511:APOE [Laboratory Procedure]
   804   C1412481:APOE [Gene or Genome]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "also significantly"

Phrase: "increased in fasted serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0205217:Increased [Quantitative Concept]
   770   C0229671:Serum [Body Substance]
   770   C0442805:Increased [Functional Concept]
   770   C1546774:Serum [Intellectual Product]
   770   C1550100:Serum [Body Substance]
   737   C0015663:Fast [Finding]
   737   C0456962:Fast [Qualitative Concept]

Phrase: "(D) (P<0.01,"

Phrase: "one-factor ANOVA"

Phrase: "followed by Dunn's"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C0332283:Followed by [Temporal Concept]
           followed
   756 E C1719822:Follow [Intellectual Product]

Phrase: "post-test"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]
   861   C0687676:Post [Temporal Concept]
   861   C1704687:Post [Manufactured Object]
   789 E C1514253:Postal [Functional Concept]

Phrase: ")."
Processing 00000000.tx.91: 3 KI levels in brain are significantly increased over 4 KI levels (P<0.01, one-factor ANOVA with post-Tukey). 

Phrase: "3 KI levels in brain"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   783   C0456949:3 levels [Intellectual Product]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "significantly"

Phrase: "increased over 4 KI levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C1517676:Knock-in [Research Activity]
   767   C0456950:Level 4 [Qualitative Concept]
   753   C0205217:Increased [Quantitative Concept]
   753   C0441889:Levels [Qualitative Concept]
   753   C0442805:Increased [Functional Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "(P<0.01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "one-factor ANOVA with post-Tukey"

Phrase: ")."
Processing 00000000.tx.92: A representative western blot of APOE abundance in brain and fasted liver (C) demonstrates the relative 4-fold increase in APOE in liver versus brain and the 2-fold higher levels in 2 KI homogenates compared with 3 KI and 4 KI homogenates. 

Phrase: "A representative western blot of APOE abundance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   778   C0949466:Western Blot [Laboratory Procedure]
   748   C1705493:Western [Spatial Concept]

Phrase: "in brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "fasted liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "demonstrates"

Phrase: "the relative 4-fold increase in APOE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "in liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "versus"

Phrase: "brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "the 2-fold higher levels in 2 KI homogenates"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   741   C0456948:Level 2 [Intellectual Product]
   739   C0441889:Levels [Qualitative Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "compared with 3 KI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1517676:Knock-in [Research Activity]
   760   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "4 KI homogenates."
Processing 00000000.tx.93: APOE brain levels were also measured by human-specific ELISA (E); 

Phrase: "APOE brain levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0441889:Levels [Qualitative Concept]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "also"

Phrase: "measured by human-specific ELISA (E)"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0014441:ELISA [Laboratory Procedure]
   760   C0086418:Human [Human]
   760   C0205369:Specific [Qualitative Concept]
   760   C0444706:Measured [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: ";"
Processing 00000000.tx.94: 2 KI levels are significantly increased over 3 KI and 4 KI levels (P<0.001, one-factor ANOVA with post-Tukey).  

Phrase: "2 KI levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   902   C0456948:2 levels [Intellectual Product]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "significantly"

Phrase: "increased over 3 KI"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1517676:Knock-in [Research Activity]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]

Phrase: "and"

Phrase: "4 KI levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   902   C0456950:4 levels [Qualitative Concept]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "(P<0.001,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "one-factor ANOVA with post-Tukey"

Phrase: ")."
Processing 00000000.tx.95: Cholesterol metabolism in APOE KI mice To examine how each allele affects cholesterol metabolism in the mouse, serum cholesterol and triglyceride levels were measured after a 6h fast using an enzymatic assay. 

Phrase: "Cholesterol metabolism in APOE KI mice To"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1156530:cholesterol metabolism [Molecular Function]
   744   C0025519:Metabolism [Organism Function]
   744   C0025520:metabolism [Functional Concept]

Phrase: "examine"

Phrase: "how"

Phrase: "each allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Allele [Gene or Genome]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "cholesterol metabolism in the mouse,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1156530:cholesterol metabolism [Molecular Function]
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]

Phrase: "serum cholesterol"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0587184:serum cholesterol [Laboratory Procedure]
   861   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "triglyceride levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C0428475:Triglyceride level [Laboratory or Test Result]
   861   C0041004:Triglyceride [Biologically Active Substance,Lipid]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "measured after a 6h fast"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0015663:Fast [Finding]
   760   C0444706:Measured [Qualitative Concept]
   760   C0456962:Fast [Qualitative Concept]
   760   C1292428:6H [Temporal Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an enzymatic assay."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2717977:Enzymatic Assay [Laboratory Procedure]
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.96: Analysis of cholesterol levels in more than 20 animals of each genotype and of mixed sex demonstrated an inverse relationship between genotype and phenotype relative to the human data. 

Phrase: "Analysis of cholesterol levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "in more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "than 20 animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "of each genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: "and of mixed sex"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0009253:Sex [Organism Function]
   770   C0036864:Sex [Behavior]
   770   C0079399:sex [Organism Attribute]
   770   C0205430:Mixed [Functional Concept]
   770   C1314687:Sex [Finding]
   770   C1515981:And [Idea or Concept]
   770   C1522384:sex [Organism Attribute]
   770   C3160715:Mixed [Finding]

Phrase: "demonstrated"

Phrase: "an inverse relationship between genotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotype [Organism Attribute]
  1000   C1285572:Phenotype [Laboratory Procedure]

Phrase: "relative to the human data."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.97: The 2 KI animals had both the highest cholesterol (mean 234mg/dl) and triglycerides (mean 115mg/dl). 

Phrase: "The 2 KI animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "had"

Phrase: "both the highest cholesterol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1522133:high cholesterol [Finding]
   861   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "(mean 234mg/dl)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3642216:/dL [Quantitative Concept]

Phrase: "and"

Phrase: "triglycerides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041004:Triglycerides [Biologically Active Substance,Lipid]

Phrase: "(mean 115mg/dl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3642216:/dL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.98: In contrast, the 4 KI animals had the lowest cholesterol (mean 67mg/dl), whereas the 3 KI animals did not significantly differ from B6 wild-type animals (Table 1). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the 4 KI animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "had"

Phrase: "the lowest cholesterol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0860920:Low cholesterol [Finding]
   861   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "(mean 67mg/dl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3642216:/dL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "the 3 KI animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "did"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "differ from B6 wild-type animals"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1883559:Wild Type [Organism Attribute]
   783   C0003070:Animals, Wild [Animal]
   753   C0003062:Animals [Animal]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C0507115:B6 [Body Part, Organ, or Organ Component]
   753   C1521751:B6 [Mammal]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.99: Triglyceride levels in the 3 KI, 4 KI and B6 animals were statistically indistinguishable. 

Phrase: "Triglyceride levels in the 3 KI,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   774   C0428475:levels triglyceride [Laboratory or Test Result]
   757   C0456949:Level 3 [Intellectual Product]
   748   C0041004:Triglyceride [Biologically Active Substance,Lipid]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "4 KI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1517676:Knock-in [Research Activity]

Phrase: "and"

Phrase: "B6 animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "statistically indistinguishable."
Processing 00000000.tx.100: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.101: Fasted serum cholesterol and triglyceride levels by APOE genotype  To further understand how the different APOE isoforms participate in peripheral cholesterol metabolism in the mouse, we generated lipoprotein profiles by FPLC for each KI line. 

Phrase: "Fasted serum cholesterol"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0587184:serum cholesterol [Laboratory Procedure]
   827   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   827   C0229671:Serum [Body Substance]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "triglyceride levels by APOE genotype"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   797   C0428475:levels triglyceride [Laboratory or Test Result]
   760   C0041004:Triglyceride [Biologically Active Substance,Lipid]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "To further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "how"

Phrase: "the different APOE isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "participate in peripheral cholesterol metabolism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1156530:cholesterol metabolism [Molecular Function]
   760   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]
   760   C0205100:Peripheral [Spatial Concept]

Phrase: "in the mouse,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "we"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "lipoprotein profiles by FPLC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1979963:Profile [Laboratory Procedure]
   737   C2003903:Profile [Functional Concept]

Phrase: "for each KI line."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   734   C1517676:Knock-in [Research Activity]
Processing 00000000.tx.102: The distribution of APOE and cholesterol was analyzed for each profile. 

Phrase: "The distribution of APOE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0520511:distribution [Idea or Concept]
   770   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "was"

Phrase: "analyzed for each profile."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0936012:Analyzed [Research Activity]
   770   C1979963:Profile [Laboratory Procedure]
   770   C2003903:Profile [Functional Concept]
Processing 00000000.tx.103: Fasted serum from three animals of the same sex was pooled for analysis of each genotype; 

Phrase: "Fasted serum from three animals of the same sex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0229671:Serum [Body Substance]
   742   C1546774:Serum [Intellectual Product]
   742   C1550100:Serum [Body Substance]

Phrase: "was"

Phrase: "pooled for analysis of each genotype"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0017431:Genotype [Organism Attribute]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   753   C1709595:Pooled [Conceptual Entity]
   753   C2349200:Pooled [Functional Concept]
   719 E C0337051:Pool [Geographic Area]
   719 E C1509144:pool [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.104: no sex difference was apparent (data not shown). 

Phrase: "no sex difference"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0036866:Sex Difference [Organism Attribute]
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "apparent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750489:apparent [Idea or Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.105: The profiles for each genotype are shown in Figure 2. 

Phrase: "The profiles for each genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1979963:Profile [Laboratory Procedure]
   726   C2003903:Profile [Functional Concept]

Phrase: "are"

Phrase: "shown in Figure 2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.106: APOE 3 KI and 4 KI profiles do not differ from that of B6 wild-type animals, in that the majority of circulating cholesterol is found in the HDL fraction, whereas the VLDL and LDL/IDL fractions are minimal. 

Phrase: "APOE 3 KI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517676:Knock-in [Research Activity]

Phrase: "and"

Phrase: "4 KI profiles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1979963:Profile [Laboratory Procedure]
   779   C2003903:Profile [Functional Concept]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "differ from that of B6 wild-type animals,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C1883559:Wild Type [Organism Attribute]
   767   C0003070:Animals, Wild [Animal]
   744   C0003062:Animals [Animal]
   744   C0332307:Type [Qualitative Concept]
   744   C0445392:Wild [Intellectual Product]
   744   C0507115:B6 [Body Part, Organ, or Organ Component]
   744   C1521751:B6 [Mammal]
   744   C1547052:*Type [Quantitative Concept]

Phrase: "in"

Phrase: "that"

Phrase: "the majority of circulating cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "is"

Phrase: "found in the HDL fraction,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0150312:Found [Quantitative Concept]
   760   C1264633:Fraction [Quantitative Concept]
   760   C1554103:Fraction [Idea or Concept]
   726 E C0243095:Find [Finding]

Phrase: "whereas"

Phrase: "the VLDL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0523560:VLDL [Laboratory Procedure]

Phrase: "and"

Phrase: "LDL/IDL fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "are"

Phrase: "minimal."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0547040:Minimal [Qualitative Concept]
  1000   C1524031:MINIMAL [Qualitative Concept]
  1000   C2945599:Minimal [Qualitative Concept]
   928 E C1552614:minimum [Idea or Concept]
   928 E C2826545:MINIMUM [Quantitative Concept]
Processing 00000000.tx.107: In contrast, the 2 KI profiles demonstrated that, although the levels of HDL cholesterol remained equal to that found in the other lines, the cholesterol distribution extended to the LDL/IDL fraction and had the highest level in the VLDL fraction. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the 2 KI profiles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1979963:Profile [Laboratory Procedure]
   779   C2003903:Profile [Functional Concept]

Phrase: "demonstrated"

Phrase: "that,"

Phrase: "although"

Phrase: "the levels of HDL cholesterol"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   797   C0201950:cholesterol levels [Laboratory Procedure]
   797   C0428466:cholesterol levels [Laboratory or Test Result]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "remained"

Phrase: "equal to that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0205163:Equal To [Qualitative Concept]
           Equal
   790   C1549782:Equal [Idea or Concept]

Phrase: "found in the"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]

Phrase: "other lines,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205132:lines [Spatial Concept]
   966 E C1550648:Line [Substance]
   966 E C1552960:Line [Quantitative Concept]

Phrase: "the cholesterol distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]

Phrase: "extended to the LDL/IDL fraction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0231448:Extended [Functional Concept]
   753   C0231449:Extended [Spatial Concept]
   753   C0439792:extended [Spatial Concept]
   753   C1264633:Fraction [Quantitative Concept]
   753   C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "had"

Phrase: "the highest level in the VLDL fraction."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.108: Thus, the increased total cholesterol levels in the 2 KI mice were due to an increase in VLDL and LDL/IDL cholesterol. 

Phrase: "Thus,"

Phrase: "the increased total cholesterol levels in the 2 KI mice"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   775   C1522133:Increased total cholesterol [Finding]
   756   C0201950:Total Cholesterol [Laboratory Procedure]
           cholesterol levels
   756   C0428466:cholesterol levels [Laboratory or Test Result]
   756   C0543421:Total cholesterol [Steroid]
   754 E C1442946:Cholesterol.total [Laboratory or Test Result]
   754   C3276464:Increased cholesterol [Finding]
   738   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   738   C0439175:% total [Quantitative Concept]
   738   C0439810:Total [Qualitative Concept]
   738   C0441889:Levels [Qualitative Concept]
   737   C0456948:Level 2 [Intellectual Product]
   704 E C0456079:Level [Classification]
   704 E C1547707:Level [Geographic Area]
   704 E C2946261:Level [Pharmacologic Substance]

Phrase: "were due to an increase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0442805:Increase [Functional Concept]
   760   C3146286:Due [Idea or Concept]

Phrase: "in VLDL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0523560:VLDL [Laboratory Procedure]

Phrase: "and"

Phrase: "LDL/IDL cholesterol."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0023824:Cholesterol, LDL [Biologically Active Substance,Steroid]
   913   C0202117:LDL Cholesterol [Laboratory Procedure]
   901   C0123167:IDL cholesterol [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   827   C0008377:Cholesterol [Biologically Active Substance,Steroid]
Processing 00000000.tx.109: View larger version (25K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(25K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.110: FPLC analysis of lipoprotein profiles of APOE KI animals. 

Phrase: "FPLC analysis of lipoprotein profiles of APOE KI animals."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0936012:Analysis [Research Activity]
   739   C1524024:analysis [Functional Concept]
Processing 00000000.tx.111: Fasted serum from three animals of the same sex and APOE line was pooled and fractionated by FPLC on a Superose 6 column. 

Phrase: "Fasted serum from three animals of the same sex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0229671:Serum [Body Substance]
   742   C1546774:Serum [Intellectual Product]
   742   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "APOE line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "was"

Phrase: "pooled"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1709595:Pooled [Conceptual Entity]
  1000   C2349200:Pooled [Functional Concept]
   966 E C0337051:Pool [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]

Phrase: "and"

Phrase: "fractionated by FPLC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0599209:FPLC [Laboratory Procedure]
   790   C1979893:Fractionated [Qualitative Concept]

Phrase: "on a Superose 6 column."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]
Processing 00000000.tx.112: FPLC profiles were generated for both males and females of each line in two separate experiments; 

Phrase: "FPLC profiles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1979963:Profile [Laboratory Procedure]
   827   C2003903:Profile [Functional Concept]

Phrase: "were"

Phrase: "generated for both males"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0024554:Males [Finding]
   770   C0086582:Males [Population Group]
   770   C3146294:Generated [Activity]
   737 E C1706180:Male [Qualitative Concept]
   737 E C1706428:Male [Qualitative Concept]
   737 E C1706429:Male [Organism Attribute]

Phrase: "and"

Phrase: "females of each line"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0015780:Females [Finding]
   770   C0086287:Females [Population Group]
   737 E C0043210:female [Population Group]
   737 E C1705497:Female [Qualitative Concept]
   737 E C1705498:Female [Qualitative Concept]

Phrase: "in two separate experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.113: representative results are shown in this figure. 

Phrase: "representative results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "are"

Phrase: "shown in this figure."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.114: The VLDL peak at around 20min for (A) B6 with endogenous Apoe (Apoewt) (B) 4 KI and (C) 3 KI profiles contains little cholesterol when compared with the VLDL fraction in (D) from the 2 KI profile. 

Phrase: "The VLDL peak at"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0444505:Peak [Quantitative Concept]

Phrase: "around 20min"

Phrase: "for"

Phrase: "(A) B6 with endogenous Apoe"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0507115:B6 [Body Part, Organ, or Organ Component]
   760   C1521751:B6 [Mammal]

Phrase: "(Apoewt"

Phrase: ")"

Phrase: "(B) 4 KI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517676:Knock-in [Research Activity]

Phrase: "and ("

Phrase: "C) 3 KI profiles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C1979963:Profile [Laboratory Procedure]
   771   C2003903:Profile [Functional Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "little cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "when"

Phrase: "compared with the VLDL fraction in (D)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0523560:VLDL [Laboratory Procedure]
   748   C1264633:Fraction [Quantitative Concept]
   748   C1554103:Fraction [Idea or Concept]
   748   C1707455:Compared [Activity]

Phrase: "from the 2 KI profile."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1979963:Profile [Laboratory Procedure]
   812   C2003903:Profile [Functional Concept]
Processing 00000000.tx.115: The large peak at 40min represents the HDL fraction; 

Phrase: "The large peak at 40min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0442810:Large peak [Qualitative Concept]
   760   C0444505:Peak [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the HDL fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.116: the cholesterol levels for all four groups are relatively equal in this fraction. 

Phrase: "the cholesterol levels for all four groups"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   778   C0201950:cholesterol levels [Laboratory Procedure]
   778   C0428466:cholesterol levels [Laboratory or Test Result]
   748   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "relatively equal in this fraction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205163:Equal [Qualitative Concept]
   760   C1549782:Equal [Idea or Concept]
Processing 00000000.tx.117: (E) The distribution of APOE in the lipoprotein fractions was analyzed by western blot analysis using a human-specific APOE antibody (Calbiochem). 

Phrase: "(E)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014441:ELISA [Laboratory Procedure]

Phrase: "The distribution of APOE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0520511:distribution [Idea or Concept]
   770   C1704711:Distribution [Functional Concept]

Phrase: "in the lipoprotein fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "analyzed by western blot analysis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
           Analyzed
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a human-specific APOE antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Calbiochem"

Phrase: ")."
Processing 00000000.tx.118: Five fractions for each lipoprotein peak were pooled and equal volumes of the combined fractions were loaded in each lane; 

Phrase: "Five fractions for each lipoprotein peak"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1264633:Fractions [Quantitative Concept]
   719 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "pooled"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1709595:Pooled [Conceptual Entity]
  1000   C2349200:Pooled [Functional Concept]
   966 E C0337051:Pool [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]

Phrase: "and"

Phrase: "equal volumes of the combined fractions"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0449468:volumes [Quantitative Concept]
   750   C1264666:*Volume Fraction [Quantitative Concept]
   719 E C1690016:% volume [Qualitative Concept]
   719 E C1705102:Volume [Intellectual Product]
   719 E C2700258:Volume [Laboratory Procedure]

Phrase: "were"

Phrase: "loaded in each lane"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C1708639:Lane [Spatial Concept]
   770   C1708715:Loaded [Activity]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]

Phrase: ";"
Processing 00000000.tx.119: a representative western blot of APOE abundance is shown. 

Phrase: "a representative western blot of APOE abundance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   778   C0949466:Western Blot [Laboratory Procedure]
   748   C1705493:Western [Spatial Concept]

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.120: The absence of APOE in the VLDL fractions of Apoewt, 3 KI and 4 KI is distinct compared with the abundance of APOE in the 2 KI profile. 

Phrase: "The absence of APOE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "in the VLDL fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "of Apoewt,"

Phrase: "3 KI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1517676:Knock-in [Research Activity]

Phrase: "and"

Phrase: "4 KI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1517676:Knock-in [Research Activity]

Phrase: "is"

Phrase: "distinct"

Phrase: "compared with the abundance of APOE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0523511:APOE [Laboratory Procedure]
   753   C1412481:APOE [Gene or Genome]
   753   C1707455:Compared [Activity]
   753   C2346714:Abundance [Qualitative Concept]

Phrase: "in the 2 KI profile."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1979963:Profile [Laboratory Procedure]
   812   C2003903:Profile [Functional Concept]
Processing 00000000.tx.121: The majority of APOE in the 4 KI profile is found in the HDL fraction in contrast to the 3 KI and Apoewt profiles, which show the majority of APOE and Apoe in the LDL/IDL fraction.  

Phrase: "The majority of APOE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680220:majority [Social Behavior]

Phrase: "in the 4 KI profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1979963:Profile [Laboratory Procedure]
   812   C2003903:Profile [Functional Concept]

Phrase: "is"

Phrase: "found in the HDL fraction"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0150312:Found [Quantitative Concept]
   760   C1264633:Fraction [Quantitative Concept]
   760   C1554103:Fraction [Idea or Concept]
   726 E C0243095:Find [Finding]

Phrase: "in contrast to the 3 KI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1517676:Knock-in [Research Activity]

Phrase: "and"

Phrase: "Apoewt profiles,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1979963:Profile [Laboratory Procedure]
   827   C2003903:Profile [Functional Concept]

Phrase: "which"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the majority of APOE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680220:majority [Social Behavior]

Phrase: "and"

Phrase: "Apoe in the LDL/IDL fraction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0523511:APOE [Laboratory Procedure]
   753   C1412481:APOE [Gene or Genome]
Processing 00000000.tx.122: The distribution of APOE protein in each lipoprotein fraction was determined by western blot analysis. 

Phrase: "The distribution of APOE protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0872250:protein distribution [Cell Function]
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "in each lipoprotein fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "determined by western blot analysis."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]
Processing 00000000.tx.123: Five fractions for each lipoprotein class, including the peak fraction, were pooled and run under the same conditions as for the APOE quantitation in tissues. 

Phrase: "Five fractions for each lipoprotein class,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1264633:Fractions [Quantitative Concept]
   719 E C1554103:Fraction [Idea or Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the peak fraction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "pooled"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1709595:Pooled [Conceptual Entity]
  1000   C2349200:Pooled [Functional Concept]
   966 E C0337051:Pool [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]

Phrase: "and"

Phrase: "run under the same conditions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0035953:run [Daily or Recreational Activity]
   760   C0600140:run [Finding]
   760   C1704688:Run [Functional Concept]
   760   C2346414:Run [Finding]

Phrase: "as for the APOE quantitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709793:Quantitation [Quantitative Concept]

Phrase: "in tissues."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.124: The resulting data are shown in Figure 2E. 

Phrase: "The resulting data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "shown in Figure 2E."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.125: No APOE was detected in the VLDL fractions for 3 KI, 4 KI and non-transgenic control profiles, which reflected the low levels of cholesterol in this fraction. 

Phrase: "No APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "was"

Phrase: "detected in the VLDL fractions"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0442726:Detected [Finding]
   760   C0523560:VLDL [Laboratory Procedure]
   760   C1264633:Fractions [Quantitative Concept]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "for 3 KI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1517676:Knock-in [Research Activity]

Phrase: "4 KI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1517676:Knock-in [Research Activity]

Phrase: "and"

Phrase: "non-transgenic control profiles,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1979963:Profile [Laboratory Procedure]
   779   C2003903:Profile [Functional Concept]

Phrase: "which"

Phrase: "reflected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflected [Mental Process]

Phrase: "the low levels of cholesterol"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   835   C0856966:cholesterol levels low [Finding]
   797   C0201950:cholesterol levels [Laboratory Procedure]
   797   C0428466:cholesterol levels [Laboratory or Test Result]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in this fraction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.126: Levels of APOE were highest in the LDL/IDL fraction, followed by the HDL fraction. 

Phrase: "Levels of APOE"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0441889:Levels [Qualitative Concept]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "highest in the LDL/IDL fraction,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C1522410:Highest [Qualitative Concept]
   719 E C0205250:High [Qualitative Concept]
   719 E C1299351:High [Qualitative Concept]
   719 E C2700149:HIGH [Intellectual Product]

Phrase: "followed by the HDL fraction."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C1264633:Fraction [Quantitative Concept]
   760   C1554103:Fraction [Idea or Concept]
   726 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.127: 4 KI profiles demonstrated the highest levels of APOE in the HDL fraction. 

Phrase: "4 KI profiles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1979963:Profile [Laboratory Procedure]
   779   C2003903:Profile [Functional Concept]

Phrase: "demonstrated"

Phrase: "the highest levels of APOE"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the HDL fraction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.128: This may reflect preferential binding of E4 for larger lipoproteins; 

Phrase: "This"

Phrase: "may"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "preferential binding of E4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "for larger lipoproteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023820:Lipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.129: mouse plasma is enriched in a large, Apoe-rich HDL that is absent in normal human plasma (36). 

Phrase: "mouse plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032105:Plasma [Body Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "is"

Phrase: "enriched in a large, Apoe-rich HDL"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0052207:HDL-APO E [Amino Acid, Peptide, or Protein]
   748   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0359583:enriched [Food]
   748   C0523511:APOE [Laboratory Procedure]
   748   C0549177:Large [Quantitative Concept]
   748   C0699759:Rich [Qualitative Concept]
   748   C1412481:APOE [Gene or Genome]

Phrase: "that"

Phrase: "is"

Phrase: "absent in normal human plasma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0332444:Normal absence [Qualitative Concept]
   760   C0332197:Absent [Quantitative Concept]
   760   C2699517:ABSENT [Finding]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.130: In contrast to these profiles, high levels of APOE were observed in all fractions of the 2 KI profile, which was consistent with the high levels of cholesterol found to be distributed in all fractions. 

Phrase: "In contrast to these profiles,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1979963:Profile [Laboratory Procedure]
   966   C2003903:Profile [Functional Concept]

Phrase: "high levels of APOE"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "observed in all fractions of the 2 KI profile,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   757   C1517676:Knock-in [Research Activity]
   743   C1264633:Fraction of [Quantitative Concept]
           Fractions
   739   C1441672:Observed [Functional Concept]
   739   C1979963:Profile [Laboratory Procedure]
   739   C2003903:Profile [Functional Concept]
   706 E C1554103:Fraction [Idea or Concept]

Phrase: "which"

Phrase: "was"

Phrase: "consistent with the high levels of cholesterol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "distributed in all fractions."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1264633:Fractions [Quantitative Concept]
   770   C1704711:Distributed [Functional Concept]
   737 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.131: APP processing, A metabolism and brain cholesterol in APOE KI mice To examine the effects of the different APOE alleles on APP biochemistry, APOE KI mice were crossed to the R1.40 APP transgenic line congenic on the B6 background. 

Phrase: "APP processing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]

Phrase: "A metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "brain cholesterol in APOE KI mice To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "examine"

Phrase: "the effects of the different APOE alleles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on APP biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "APOE KI mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1517676:Knock-in [Research Activity]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "crossed to the R1.40 APP transgenic line"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   744   C0003069:Transgenic [Animal]
   744   C0205132:Line [Spatial Concept]
   744   C0205203:Crossed [Spatial Concept]
   744   C0439509:/40 [Temporal Concept]
   744   C1335648:R1 [Gene or Genome]
   744   C1550648:Line [Substance]
   744   C1552960:Line [Quantitative Concept]
   744   C1824685:R1 [Gene or Genome]
   744   C2697937:R1 [Quantitative Concept]
   744   C3538722:APP [Laboratory Procedure]
   711 E C2828360:Cross [Conceptual Entity]

Phrase: "congenic on the B6 background."
Processing 00000000.tx.132: The R1.40 line is a YAC-based transgenic model of AD that over-expresses APPSwe in the proper spatial and temporal manner (37). 

Phrase: "The R1.40 line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: "is"

Phrase: "a YAC-based transgenic model of AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C1519606:Transgenic Model [Experimental Model of Disease]
   748   C3161035:Model [Intellectual Product]

Phrase: "that"

Phrase: "over-expresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205136:Over [Spatial Concept]

Phrase: "APPSwe in the proper spatial"

Phrase: "and"

Phrase: "temporal manner"

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.133: Homozygous R1.40 transgenic animals display A deposition at 13.5 months of age. 

Phrase: "Homozygous R1.40 transgenic animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0003069:Animals, Transgenic [Animal]
   804   C0003062:Animals [Animal]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "A deposition at 13.5 months of age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0333562:Deposition [Functional Concept]
Processing 00000000.tx.134: APOE KI animals were crossed to R1.40 transgenic animals to generate animals homozygous for each APOE allele and hemizygous for APP. 

Phrase: "APOE KI animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "crossed to R1.40 transgenic animals to"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   778   C0003069:Animals, Transgenic [Animal]
           Transgenic
   748   C0003062:Animals [Animal]
   748   C0205203:Crossed [Spatial Concept]
   748   C0439509:/40 [Temporal Concept]
   748   C1335648:R1 [Gene or Genome]
   748   C1824685:R1 [Gene or Genome]
   748   C2697937:R1 [Quantitative Concept]
   714 E C2828360:Cross [Conceptual Entity]

Phrase: "generate"

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "homozygous for each APOE allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019904:Homozygous [Organism Attribute]

Phrase: "and"

Phrase: "hemizygous for APP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1881036:Hemizygous [Qualitative Concept]
Processing 00000000.tx.135: Brains from 28-day-old APOE/APOE; 

Phrase: "Brains from 28-day-old APOE/APOE"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0006104:Brains [Body Part, Organ, or Organ Component]
   714 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.136: R1.40/ animals (subsequently denoted as APOE;R1.40 or 2;R1.40, etc.) were utilized to examine the levels of APP processing intermediates and A. 

Phrase: "R1.40/ animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "(subsequently"

Phrase: "denoted as APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0523511:APOE [Laboratory Procedure]
   790   C1412481:APOE [Gene or Genome]

Phrase: ";R1.40"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439509:/40 [Temporal Concept]
   861   C1335648:R1 [Gene or Genome]
   861   C1824685:R1 [Gene or Genome]
   861   C2697937:R1 [Quantitative Concept]

Phrase: "or"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ";R1.40,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439509:/40 [Temporal Concept]
   861   C1335648:R1 [Gene or Genome]
   861   C1824685:R1 [Gene or Genome]
   861   C2697937:R1 [Quantitative Concept]

Phrase: "etc.)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548556:etc. [Idea or Concept]

Phrase: "were"

Phrase: "utilized"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the levels of APP processing intermediates"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "A."
Processing 00000000.tx.137: The levels of APP holo protein and C-terminal fragments (CTFs) were determined using 369, an APP C-terminal antibody. 

Phrase: "The levels of APP holo protein"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C0428479:Protein level [Laboratory or Test Result]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "C-terminal fragments (CTFs)"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "369,"

Phrase: "an APP C-terminal antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.138: No differences in holo APP were observed between lines (Fig.3A and B). 

Phrase: "No differences in holo APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "were"

Phrase: "observed between lines"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205132:lines [Spatial Concept]
   790   C1441672:Observed [Functional Concept]
   756 E C1550648:Line [Substance]
   756 E C1552960:Line [Quantitative Concept]

Phrase: "(Fig.3A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.139: In addition, the relative amount of APP CTFs (expressed as the ratio of CTF/total CTFs) was determined for each APOE;R1.40 line and R1.40 animals with endogenous Apoe (Fig.3C). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the relative amount of APP CTFs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1265611:Amount [Quantitative Concept]

Phrase: "("

Phrase: "expressed as the ratio of CTF/total CTFs"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   760   C1707271:C-Terminal [Amino Acid Sequence]
   739   C0205088:Terminal [Temporal Concept]
   739   C0332255:fragments [Functional Concept]
   739   C0439175:% total [Quantitative Concept]
   739   C0439810:Total [Qualitative Concept]
   739   C0456603:Ratio [Quantitative Concept]
   739   C0486805:Fragments [Body Substance]
   739   C1547037:Ratio [Intellectual Product]
   739   C1705314:Terminal [Manufactured Object]
   739   C1705315:Terminal [Spatial Concept]
   706 E C1708096:Fragment [Qualitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "determined for each APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0523511:APOE [Laboratory Procedure]
   770   C1412481:APOE [Gene or Genome]

Phrase: ";R1.40 line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "R1.40 animals with endogenous Apoe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0003062:Animals [Animal]

Phrase: "(Fig.3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.140: Despite significant differences in serum cholesterol among the three APOE;R1.40 lines (Fig.4A), there was no difference in the ratios of CTF/total CTFs. 

Phrase: "Despite significant differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "in serum cholesterol"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0587184:serum cholesterol [Laboratory Procedure]
   861   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "among the three APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: ";R1.40 lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "(Fig.4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "there"

Phrase: "was"

Phrase: "no difference in the ratios of CTF/total CTFs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1705241:*Difference [Quantitative Concept]
   738   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.141: Likewise, the APP CTF ratios were unchanged in the presence of APOE or Apoe in animals of 28 days of age. 

Phrase: "Likewise,"

Phrase: "the APP CTF ratios"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0456603:Ratios [Quantitative Concept]
   827   C1610540:*Ratios [Quantitative Concept]
   793 E C1547037:Ratio [Intellectual Product]

Phrase: "were"

Phrase: "unchanged in the presence of APOE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0442739:Unchanged [Finding]
   753   C2346711:Unchanged [Qualitative Concept]

Phrase: "or"

Phrase: "Apoe in animals of 28 days of age."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0523511:APOE [Laboratory Procedure]
   744   C1412481:APOE [Gene or Genome]
Processing 00000000.tx.142: View larger version (29K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(29K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.143: APP processing in APOE;R1.40 animals. 

Phrase: "APP processing in APOE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709694:Processing [Activity]

Phrase: ";R1.40 animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]
Processing 00000000.tx.144: APP processing products were analyzed in 6M urea homogenates of half-brains from APOE;R1.40 animals at 28 days of age. 

Phrase: "APP processing products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "analyzed in 6M urea"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0041942:Urea [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   770   C0936012:Analyzed [Research Activity]
   770   C3171719:6M [Quantitative Concept]
   715 E C0728794:Ureaphil [Organic Chemical,Pharmacologic Substance]

Phrase: "homogenates of half-brains"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0006104:Brains [Body Part, Organ, or Organ Component]
   770   C2825407:Half [Quantitative Concept]
   737 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "from APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: ";R1.40 animals at 28 days of age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0003062:Animals [Animal]
Processing 00000000.tx.145: Western blotting with an APP antibody (369) was used to assay levels of both holo APP and CTFs in each APOE;R1.40 line (n=5 for each line), as well as in R1.40 animals with endogenous Apoe (n=3). 

Phrase: "Western blotting with an APP antibody"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   773 E C0949466:Western Blot [Laboratory Procedure]
   753   C1705493:Western [Spatial Concept]

Phrase: "(369"

Phrase: ")"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "levels of both holo APP"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "CTFs in each APOE"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C1707271:C-Terminal [Amino Acid Sequence]
   753   C0205088:Terminal [Temporal Concept]
   753   C0332255:fragments [Functional Concept]
   753   C0486805:Fragments [Body Substance]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]
   719 E C1708096:Fragment [Qualitative Concept]

Phrase: ";R1.40 line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: "(n=5 for each line"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   760   C0205132:Line [Spatial Concept]
   760   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441922:N+ [Intellectual Product]
   760   C1550648:Line [Substance]
   760   C1552960:Line [Quantitative Concept]
   760   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "as well as in R1.40 animals"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0003062:Animals [Animal]
   748   C0205170:Well [Qualitative Concept]
   748   C0439509:/40 [Temporal Concept]
   748   C1335648:R1 [Gene or Genome]
   748   C1824685:R1 [Gene or Genome]
   748   C2697937:R1 [Quantitative Concept]
   748   C3146287:Well [Manufactured Object]

Phrase: "with endogenous Apoe"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "(n=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.146: A representative western blot is shown in (A). 

Phrase: "A representative western blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   901   C0949466:Western Blot [Laboratory Procedure]
   827   C1705493:Western [Spatial Concept]

Phrase: "is"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "in (A"

Phrase: ")."
Processing 00000000.tx.147: APP quantitation (B) is expressed as a ratio of APP abundance in each sample relative to endogenous levels in a wild-type extract of the same total protein concentration. 

Phrase: "APP quantitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709793:Quantitation [Quantitative Concept]

Phrase: "(B) is"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "expressed as a ratio of APP abundance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0456603:Ratio [Quantitative Concept]
   748   C1547037:Ratio [Intellectual Product]
   748   C2346714:Abundance [Qualitative Concept]
   748   C3538722:APP [Laboratory Procedure]

Phrase: "in each"

Phrase: "sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "relative to endogenous levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]

Phrase: "in a wild-type extract"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2828366:Extract [Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "of the same total protein concentration."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   861   C0427716:Protein concentration [Laboratory Procedure]
   861   C0555903:Total protein [Laboratory Procedure]
   861   C1261360:total protein [Laboratory or Test Result]
   861   C1304757:Protein concentration [Laboratory or Test Result]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086045:Concentration [Mental Process]
   812   C0439175:% total [Quantitative Concept]
   812   C0439810:Total [Qualitative Concept]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.148: Analysis of holo APP levels demonstrated no difference between lines (P>0.05, one-factor ANOVA). 

Phrase: "Analysis of holo APP levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "demonstrated"

Phrase: "no difference between lines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "(P>0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "one-factor ANOVA"

Phrase: ")."
Processing 00000000.tx.149: Relative ratios of CTF to total APP CTFs (C) were unaffected by APOE genotype (P>0.05, one-factor ANOVA; four or five animals per group).  

Phrase: "Relative ratios of CTF"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   816   C1264683:Relative ratio [Quantitative Concept]
   770   C0456603:Ratios [Quantitative Concept]
   770   C1610540:*Ratios [Quantitative Concept]
   737 E C1547037:Ratio [Intellectual Product]

Phrase: "to total APP CTFs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   840   C1707271:C-Terminal [Amino Acid Sequence]
   804   C0205088:Terminal [Temporal Concept]
   804   C0332255:fragments [Functional Concept]
   804   C0486805:Fragments [Body Substance]
   804   C1705314:Terminal [Manufactured Object]
   804   C1705315:Terminal [Spatial Concept]
   771 E C1708096:Fragment [Qualitative Concept]

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "were"

Phrase: "unaffected by APOE genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2986417:Unaffected [Conceptual Entity]

Phrase: "(P>0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "one-factor ANOVA"

Phrase: "; four"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205450:Four [Quantitative Concept]

Phrase: "or"

Phrase: "five animals per group"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C1642385:Animal group [Group]
   770   C0003062:Animals [Animal]

Phrase: ")."
Processing 00000000.tx.150: View larger version (20K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.151: Total cholesterol and brain A140 levels in APOE;R1.40 animals. 

Phrase: "Total cholesterol"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0201950:Total Cholesterol [Laboratory Procedure]
  1000   C0543421:Total cholesterol [Steroid]
   861   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]

Phrase: "and"

Phrase: "brain A140 levels in APOE"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: ";R1.40 animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]
Processing 00000000.tx.152: Measurements of total cholesterol in both serum and brain, and brain A levels were obtained from animals of 28 days of age. 

Phrase: "Measurements of total cholesterol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   865   C1445957:Cholesterol, total, measurement [Laboratory Procedure]
   819   C0201950:cholesterol measurements [Laboratory Procedure]
   802   C1293928:Total measurement [Quantitative Concept]
   770   C0242485:measurements [Functional Concept]

Phrase: "in both serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "A levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "obtained from animals of 28 days of age."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   744   C0001779:Age [Organism Attribute]
   744   C0003062:Animals [Animal]
   744   C0439228:days [Temporal Concept]
   744   C1301820:Obtained [Functional Concept]
   711 E C0332173:/day [Temporal Concept]
   711 E C0439505:/day [Temporal Concept]
   711 E C1706701:Obtain [Activity]
Processing 00000000.tx.153: (A) Serum cholesterol was assayed for APOE;R1.40 and R1.40 animals with endogenous Apoe by colorimetric assay (Thermotrace). 

Phrase: "(A) Serum cholesterol"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0587184:serum cholesterol [Laboratory Procedure]
   827   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   827   C0229671:Serum [Body Substance]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "was"

Phrase: "assayed for APOE"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0523511:APOE [Laboratory Procedure]
   790   C1412481:APOE [Gene or Genome]
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]

Phrase: ";R1.40"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439509:/40 [Temporal Concept]
   861   C1335648:R1 [Gene or Genome]
   861   C1824685:R1 [Gene or Genome]
   861   C2697937:R1 [Quantitative Concept]

Phrase: "and"

Phrase: "R1.40 animals with endogenous Apoe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0003062:Animals [Animal]

Phrase: "by colorimetric assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "(Thermotrace"

Phrase: ")."
Processing 00000000.tx.154: The results confirmed that the APP transgene does not affect serum cholesterol metabolism. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the APP transgene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282641:Transgene [Gene or Genome]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "serum cholesterol metabolism."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1156530:cholesterol metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]
   734   C0587184:serum cholesterol [Laboratory Procedure]
Processing 00000000.tx.155: 2;R1.40 animals have 2-fold higher levels of total cholesterol than 3;R1.40, 4;R1.40 and B6.R1.40 animals (P<0.001, one-factor ANOVA followed by post-Tukey). 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ";R1.40 animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "have"

Phrase: "2-fold higher levels of total cholesterol"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   778   C1522133:high cholesterol level [Finding]
   774   C0201950:cholesterol levels [Laboratory Procedure]
   774   C0428466:cholesterol levels [Laboratory or Test Result]
   774   C0456948:2 levels [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "than 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ";R1.40,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439509:/40 [Temporal Concept]
   861   C1335648:R1 [Gene or Genome]
   861   C1824685:R1 [Gene or Genome]
   861   C2697937:R1 [Quantitative Concept]

Phrase: "4"

Phrase: ";R1.40"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439509:/40 [Temporal Concept]
   861   C1335648:R1 [Gene or Genome]
   861   C1824685:R1 [Gene or Genome]
   861   C2697937:R1 [Quantitative Concept]

Phrase: "and"

Phrase: "B6.R1.40 animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "(P<0.001,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "one-factor ANOVA"

Phrase: "followed by post-Tukey"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0687676:Post [Temporal Concept]
   770   C1704687:Post [Manufactured Object]
   737 E C1719822:Follow [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.156: (B) Levels of total brain cholesterol were measured in 6M urea homogenates of half-brains by colorimetic assay (Thermotrace). 

Phrase: "(B) Levels of total brain cholesterol"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   783   C0201950:cholesterol levels [Laboratory Procedure]
   783   C0428466:cholesterol levels [Laboratory or Test Result]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "measured in 6M urea"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0041942:Urea [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   770   C0444706:Measured [Qualitative Concept]
   770   C3171719:6M [Quantitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
   715 E C0728794:Ureaphil [Organic Chemical,Pharmacologic Substance]

Phrase: "homogenates of half-brains"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0006104:Brains [Body Part, Organ, or Organ Component]
   770   C2825407:Half [Quantitative Concept]
   737 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "by colorimetic assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "(Thermotrace"

Phrase: ")."
Processing 00000000.tx.157: The presence of human APOE2 or 4 significantly increases brain cholesterol in R1.40 animals (P<0.05, one-factor ANOVA). 

Phrase: "The presence of human APOE2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "4 significantly"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "brain cholesterol in R1.40 animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "(P<0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "one-factor ANOVA"

Phrase: ")."
Processing 00000000.tx.158: E3;R1.40 brain cholesterol levels were also elevated compared to B6.R1.40 animals, although this was not significant (P>0.05, one-factor ANOVA). 

Phrase: "E3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1537525:E3 [Gene or Genome]

Phrase: ";R1.40 brain cholesterol levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   840   C0201950:cholesterol levels [Laboratory Procedure]
   840   C0428466:cholesterol levels [Laboratory or Test Result]
   804   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "also"

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "compared to B6.R1.40 animals,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0003062:Animals [Animal]
   753   C0439509:/40 [Temporal Concept]
   753   C0507115:B6 [Body Part, Organ, or Organ Component]
   753   C1335648:R1 [Gene or Genome]
   753   C1521751:B6 [Mammal]
   753   C1707455:Compared [Activity]
   753   C1824685:R1 [Gene or Genome]
   753   C2697937:R1 [Quantitative Concept]

Phrase: "although"

Phrase: "this"

Phrase: "was"

Phrase: "not significant"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1273937:Not significant [Finding]
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: "(P>0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "one-factor ANOVA"

Phrase: ")."
Processing 00000000.tx.159: (C) Levels of A140 in brain, measured in 5M guanidine extracts of half-brains by ELISA (Biosource), are not significantly different between APOE;R1.40 lines (P>0.05, one-factor ANOVA; n=8 for each line). 

Phrase: "(C) Levels of A140"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "measured in 5M guanidine extracts of half-brains"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   744   C0006104:Brains [Body Part, Organ, or Organ Component]
   744   C0018320:guanidine [Organic Chemical]
   744   C0120446:Guanidine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   744   C0444706:Measured [Qualitative Concept]
   744   C2825407:Half [Quantitative Concept]
   744   C3541902:MEASURED [Diagnostic Procedure]
   711 E C0079809:Measure [Quantitative Concept]
   711 E C0242485:Measure [Functional Concept]
   711 E C1269537:Brain [Body Part, Organ, or Organ Component]
   711   C2828366:Extract [Substance]

Phrase: "by ELISA (Biosource"

Phrase: ")"

Phrase: ","

Phrase: "are"

Phrase: "not significantly different between APOE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: ";R1.40 lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "(P>0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "one-factor ANOVA"

Phrase: "; n=8 for each line"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205132:Line [Spatial Concept]
   760   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441922:N+ [Intellectual Product]
   760   C1550648:Line [Substance]
   760   C1552960:Line [Quantitative Concept]
   760   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.160: All APOE;R1.40 lines have significantly increased A140 levels when compared with B6.R1.40 animals (n=11; P<0.01 for E2 versus B6; P<0.001 for E3 versus B6; P<0.05 for E4 versus B6, one-factor ANOVA with post-Tukey). 

Phrase: "All APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: ";R1.40 lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "have"

Phrase: "significantly increased A140 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "when"

Phrase: "compared with B6.R1.40 animals"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0003062:Animals [Animal]
   753   C0439509:/40 [Temporal Concept]
   753   C0507115:B6 [Body Part, Organ, or Organ Component]
   753   C1335648:R1 [Gene or Genome]
   753   C1521751:B6 [Mammal]
   753   C1707455:Compared [Activity]
   753   C1824685:R1 [Gene or Genome]
   753   C2697937:R1 [Quantitative Concept]

Phrase: "(n=11"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "; P<0.01 for E2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C2603361:P' [Clinical Attribute]
   760   C3539520:E2 [Gene or Genome]

Phrase: "versus"

Phrase: "B6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0507115:B6 [Body Part, Organ, or Organ Component]
  1000   C1521751:B6 [Mammal]

Phrase: "; P<0.001 for E3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C1537525:E3 [Gene or Genome]
   760   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "B6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0507115:B6 [Body Part, Organ, or Organ Component]
  1000   C1521751:B6 [Mammal]

Phrase: "; P<0.05 for E4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "B6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0507115:B6 [Body Part, Organ, or Organ Component]
  1000   C1521751:B6 [Mammal]

Phrase: "one-factor ANOVA with post-Tukey"

Phrase: ")."
Processing 00000000.tx.161: 2;R1.40 is increased by 30.7%, 3;R1.40 by 35.0% and 4;R1.40 by 25.7%.  

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ";R1.40"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439509:/40 [Temporal Concept]
   861   C1335648:R1 [Gene or Genome]
   861   C1824685:R1 [Gene or Genome]
   861   C2697937:R1 [Quantitative Concept]

Phrase: "is"

Phrase: "increased by 30.7%,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ";R1.40 by 35.0%"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439509:/40 [Temporal Concept]
   760   C1335648:R1 [Gene or Genome]
   760   C1824685:R1 [Gene or Genome]
   760   C2697937:R1 [Quantitative Concept]

Phrase: "and"

Phrase: "4"

Phrase: ";R1.40 by 25.7%."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439509:/40 [Temporal Concept]
   760   C1335648:R1 [Gene or Genome]
   760   C1824685:R1 [Gene or Genome]
   760   C2697937:R1 [Quantitative Concept]
Processing 00000000.tx.162: Levels of serum cholesterol in each APOE;R1.40 line at the N8 backcross generation were determined as previously mentioned. 

Phrase: "Levels of serum cholesterol"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   868   C0587184:cholesterol levels serum [Laboratory Procedure]
   868   C1287371:cholesterol levels serum [Laboratory or Test Result]
   819   C0201950:cholesterol levels [Laboratory Procedure]
   819   C0428466:cholesterol levels [Laboratory or Test Result]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in each APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: ";R1.40 line at the N8 backcross generation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0205132:Line [Spatial Concept]
   744   C1550648:Line [Substance]
   744   C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "determined as previously"

Phrase: "mentioned."
Processing 00000000.tx.163: Similar to our results in the absence of the R1.40 transgene, the 2.R1.40 mice had significantly higher cholesterol levels compared with all other lines. 

Phrase: "Similar to our results"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of the R1.40 transgene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0282641:Transgene [Gene or Genome]

Phrase: "the 2.R1.40 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "had"

Phrase: "significantly higher cholesterol levels"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   890   C1522133:high cholesterol level [Finding]
           high cholesterol
   861   C0201950:cholesterol levels [Laboratory Procedure]
   861   C0428466:cholesterol levels [Laboratory or Test Result]
   812   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "compared with all"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "other lines."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205132:lines [Spatial Concept]
   966 E C1550648:Line [Substance]
   966 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.164: However, the 4.R1.40 animals had slightly higher levels of cholesterol relative to 3.R1.40 animals and R1.40 animals with endogenous Apoe (Fig.4A). 

Phrase: "However,"

Phrase: "the 4.R1.40 animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "had"

Phrase: "slightly higher levels of cholesterol"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   813   C1522133:high cholesterol level [Finding]
   797   C0201950:cholesterol levels [Laboratory Procedure]
   797   C0428466:cholesterol levels [Laboratory or Test Result]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "relative to 3.R1.40 animals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "and"

Phrase: "R1.40 animals with endogenous Apoe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0003062:Animals [Animal]

Phrase: "(Fig.4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.165: This difference compared with the data in Table 1 for the N5 generation most likely illustrates a genetic background effect on cholesterol metabolism in 4 KI mice. 

Phrase: "This difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "compared with the data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1511726:Data [Idea or Concept]
   770   C1707455:Compared [Activity]
   770   C3245479:data [Medical Device]

Phrase: "in Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "for the N5 generation most likely"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   812   C0079411:Generation [Temporal Concept]
   812   C0332148:Likely [Qualitative Concept]
   812   C0442785:N5 [Finding]
   812   C0750492:Likely [Idea or Concept]
   812   C3146294:Generation [Activity]
   719 E C1414672:Genesis [Gene or Genome]
   719 E C2984892:Genesis [Gene or Genome]

Phrase: "illustrates"

Phrase: "a genetic background effect on cholesterol metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "in 4 KI mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1517676:Knock-in [Research Activity]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
Processing 00000000.tx.166: Levels of steady-state A140 were assessed by ELISA in half-brain extracts. 

Phrase: "Levels of steady-state A140"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   781   C0683927:state level [Spatial Concept]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "assessed by ELISA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0014441:ELISA [Laboratory Procedure]
   790   C1516048:Assessed [Activity]

Phrase: "in half-brain extracts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2828366:Extract [Substance]
Processing 00000000.tx.167: Given that increased serum cholesterol, conferred by diet, effectively increases A140 in the brain (14), the expectation was that the 2.R1.40 animals, with serum cholesterol levels nearly twice those of 3.R1.40 and 4.R1.40 animals, would have the greatest amount of A140. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that increased serum cholesterol,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0595929:Increased serum cholesterol [Finding]
   913   C3276464:Increased cholesterol [Finding]
   901   C0587184:serum cholesterol [Laboratory Procedure]
   827   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   827   C0229671:Serum [Body Substance]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "conferred by diet,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0012155:Diet [Food]
   790   C1442959:Diet [Organism Function]
   790   C1519433:DIET [Therapeutic or Preventive Procedure]
   790   C2983588:DIET [Food]
   718 E C2699635:DIETARY [Functional Concept]

Phrase: "effectively"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "A140 in the brain"

Phrase: "(14"

Phrase: ")"

Phrase: ","

Phrase: "the expectation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679138:Expectation [Idea or Concept]

Phrase: "was"

Phrase: "that"

Phrase: "the 2.R1.40 animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "with serum cholesterol levels nearly twice"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   851   C0587184:Serum cholesterol level [Laboratory Procedure]
           serum cholesterol
   851   C1287371:Serum cholesterol level [Laboratory or Test Result]
   840   C0201950:cholesterol levels [Laboratory Procedure]
   840   C0428466:cholesterol levels [Laboratory or Test Result]
   804   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   804   C0229671:Serum [Body Substance]
   804   C0441889:Levels [Qualitative Concept]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]
   804   C1720725:Twice [Intellectual Product]
   804   C1948050:Twice [Quantitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "those of 3.R1.40"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439509:/40 [Temporal Concept]
   760   C1335648:R1 [Gene or Genome]
   760   C1824685:R1 [Gene or Genome]
   760   C2697937:R1 [Quantitative Concept]

Phrase: "and"

Phrase: "4.R1.40 animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "would"

Phrase: "have"

Phrase: "the greatest amount of A140."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]
Processing 00000000.tx.168: However, no significant difference in A140 levels between the three APOE;R1.40 lines was observed (Fig.4C). 

Phrase: "However,"

Phrase: "no significant difference in A140 levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "between the three APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: ";R1.40 lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Fig.4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.169: These data suggest that there is a fundamental distinction between genetic and dietary control of cholesterol levels and their effects on A140 metabolism. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that there"

Phrase: "is"

Phrase: "a fundamental distinction between genetic"

Phrase: "and"

Phrase: "dietary control of cholesterol levels"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0743195:dietary control [Therapeutic or Preventive Procedure]
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "their effects on A140 metabolism."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.170: Interestingly, all three APOE;R1.40 lines demonstrated significantly increased levels of A140 relative to B6.R1.40 animals with endogenous Apoe. 

Phrase: "Interestingly,"

Phrase: "all three APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: ";R1.40 lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "demonstrated"

Phrase: "significantly increased levels of A140"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "relative to B6.R1.40 animals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "with endogenous Apoe."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]
Processing 00000000.tx.171: Thus, the presence of human APOE in the R1.40 line led to increased A140 steady-state levels at 28 days of age. 

Phrase: "Thus,"

Phrase: "the presence of human APOE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the R1.40 line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: "led to increased A140 steady-state levels"
Meta Candidates (Total=22; Excluded=9; Pruned=0; Remaining=13)
   789   C1318746:increased lead levels [Finding]
   778   C0678587:steady state [Natural Phenomenon or Process]
   762   C0683927:state level [Spatial Concept]
   757   C0428255:lead levels [Laboratory or Test Result]
   757   C0861064:increased lead [Finding]
   748   C0205217:Increased [Quantitative Concept]
   748   C0205361:Steady [Qualitative Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C1301808:State [Geographic Area]
   748   C1442792:State [Functional Concept]
   748   C1708698:LED [Manufactured Object]
   748   C3148680:State [Geographic Area]
   741 E C0524167:Lead level [Laboratory Procedure]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C0456079:Level [Classification]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C1522538:Lead [Functional Concept]
   714 E C1547707:Level [Geographic Area]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C2946261:Level [Pharmacologic Substance]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "at 28 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "of age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]
Processing 00000000.tx.172: Levels of total brain cholesterol were measured by enzymatic assay and normalized to the concentration of protein extracted (mg cholesterol/mg protein). 

Phrase: "Levels of total brain cholesterol"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   797   C0201950:cholesterol levels [Laboratory Procedure]
   797   C0428466:cholesterol levels [Laboratory or Test Result]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "measured by enzymatic assay"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C2717977:Enzymatic Assay [Laboratory Procedure]
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C1510438:Assay [Laboratory Procedure]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "normalized to the concentration of protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0427716:Protein concentration [Laboratory Procedure]
   783   C1304757:Protein concentration [Laboratory or Test Result]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]
   753   C1882115:Normalized [Research Activity]

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "(mg cholesterol/mg protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C1319635:mg/mg [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.173: The average levels of brain cholesterol in 2.R1.40, 3.R1.40 and 4.R1.40 animals were higher than the average brain cholesterol in R1.40 animals with endogenous Apoe (Fig.4B; P<0.05 for 2.R1.40 versus R1.40 and 4.R1.40 versus R1.40). 

Phrase: "The average levels of brain cholesterol"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   783   C0201950:cholesterol levels [Laboratory Procedure]
   783   C0428466:cholesterol levels [Laboratory or Test Result]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in 2.R1.40,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0439509:/40 [Temporal Concept]
   827   C0740116:+2 [Quantitative Concept]
   827   C1335648:R1 [Gene or Genome]
   827   C1824685:R1 [Gene or Genome]
   827   C2697937:R1 [Quantitative Concept]
   827   C2827735:2+ [Quantitative Concept]
   827   C2981700:2+ [Classification]

Phrase: "3.R1.40"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0439086:<3 [Quantitative Concept]
   827   C0439509:/40 [Temporal Concept]
   827   C1335648:R1 [Gene or Genome]
   827   C1824685:R1 [Gene or Genome]
   827   C2697937:R1 [Quantitative Concept]
   827   C2827736:3+ [Quantitative Concept]
   827   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "4.R1.40 animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "higher than the average brain cholesterol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1522133:high cholesterol [Finding]
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "in R1.40 animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "with endogenous Apoe"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "(Fig.4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: "; P<0.05 for 2.R1.40"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C0050854:P 40 [Organic Chemical,Pharmacologic Substance]
   774   C0608663:P-2 [Organic Chemical,Pharmacologic Substance]
   748   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0439509:/40 [Temporal Concept]
   748   C1335648:R1 [Gene or Genome]
   748   C1824685:R1 [Gene or Genome]
   748   C2603361:P' [Clinical Attribute]
   748   C2697937:R1 [Quantitative Concept]

Phrase: "versus"

Phrase: "R1.40"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439509:/40 [Temporal Concept]
   861   C1335648:R1 [Gene or Genome]
   861   C1824685:R1 [Gene or Genome]
   861   C2697937:R1 [Quantitative Concept]

Phrase: "and"

Phrase: "4.R1.40"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439509:/40 [Temporal Concept]
   827   C1335648:R1 [Gene or Genome]
   827   C1824685:R1 [Gene or Genome]
   827   C2697937:R1 [Quantitative Concept]

Phrase: "versus"

Phrase: "R1.40"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439509:/40 [Temporal Concept]
   861   C1335648:R1 [Gene or Genome]
   861   C1824685:R1 [Gene or Genome]
   861   C2697937:R1 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.174: This increase in brain cholesterol in APOE;R1.40 animals appeared to coincide with increased A140 levels, suggesting a link between APOE, brain cholesterol and A metabolism. 

Phrase: "This increase in brain cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "in APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: ";R1.40 animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "coincide with increased A140 levels,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0205217:Increased [Quantitative Concept]
   760   C0441889:Levels [Qualitative Concept]
   760   C0442805:Increased [Functional Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a link between APOE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1517892:Link [Intellectual Product]
   770   C1704666:Link [Intellectual Product]

Phrase: "brain cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "and"

Phrase: "A metabolism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.175: Despite high levels of serum cholesterol, 2.R1.40 animals had brain cholesterol levels indistinguishable from those in 3.R1.40 and 4.R1.40 animals. 

Phrase: "Despite high levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of serum cholesterol,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0587184:serum cholesterol [Laboratory Procedure]
   861   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "2.R1.40 animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "had"

Phrase: "brain cholesterol levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0201950:cholesterol levels [Laboratory Procedure]
   901   C0428466:cholesterol levels [Laboratory or Test Result]
   827   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "indistinguishable from those in 3.R1.40"

Phrase: "and"

Phrase: "4.R1.40 animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]
Processing 00000000.tx.176: These cholesterol data lend further evidence to the hypothesis that peripheral and brain cholesterol levels are independently regulated.  

Phrase: "These cholesterol data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "lend"

Phrase: "further evidence to the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "that peripheral"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205100:Peripheral [Spatial Concept]

Phrase: "and"

Phrase: "brain cholesterol levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0201950:cholesterol levels [Laboratory Procedure]
   901   C0428466:cholesterol levels [Laboratory or Test Result]
   827   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "independently"

Phrase: "regulated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]
Processing 00000000.tx.177: DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  The current study examines the effects of the three common human APOE alleles on APOE protein levels, cholesterol metabolism, and APP processing and A metabolism. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The current study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "examines"

Phrase: "the effects of the three common human APOE alleles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C1280500:effects [Qualitative Concept]
   708 E C2348382:Effect [Qualitative Concept]

Phrase: "on APOE protein levels,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   867   C0428479:Protein level [Laboratory or Test Result]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "cholesterol metabolism,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1156530:cholesterol metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "APP processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "A metabolism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.178: We show that APOE KI mice on the defined C57BL/6J background have significantly different levels of APOE in both serum and tissues, as well as significantly different cholesterol levels. 

Phrase: "We"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that APOE KI mice on the defined C57BL/6J background"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C1517676:Knock-in [Research Activity]
   754   C0025921:Mice, C57BL [Mammal]
   738   C0025914:Mice [Mammal]
   738   C0025929:mice [Mammal]
   738   C0026809:Mice [Mammal]

Phrase: "have"

Phrase: "significantly different levels of APOE"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in both serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "tissues,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "as well as"

Phrase: "significantly different cholesterol levels."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0201950:cholesterol levels [Laboratory Procedure]
   861   C0428466:cholesterol levels [Laboratory or Test Result]
   812   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.179: APOE increases A levels in a genomic-based APP transgenic mouse in the absence of changes in APP processing. 

Phrase: "APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "A levels in a genomic-based APP transgenic mouse"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "in APP processing."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]
Processing 00000000.tx.180: Unlike previously reported APOE transgenic models, which express normalized levels of APOE only in the brain, our genomic-based approach allows us to address two hypotheses surrounding the role of APOE 4 as a risk factor for AD. 

Phrase: "Unlike previously reported APOE transgenic models,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   823   C1519606:Transgenic Model [Experimental Model of Disease]
   804   C3161035:Models [Intellectual Product]

Phrase: "which"

Phrase: "express"

Phrase: "normalized levels of APOE only"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "our genomic-based approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449445:Approach [Spatial Concept]

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "two hypotheses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512571:Hypothesis [Idea or Concept]

Phrase: "surrounding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282914:Surrounding [Spatial Concept]

Phrase: "the role of APOE 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "as a risk factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035648:Risk factor [Quantitative Concept]
   861   C0035647:Risk [Qualitative Concept]
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "for AD."
Processing 00000000.tx.181: APOE genotype and AD risk in humans correlate with both serum cholesterol levels and steady-state levels of APOE protein. 

Phrase: "APOE genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "and"

Phrase: "AD risk in humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]

Phrase: "correlate with both serum cholesterol levels"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   820   C0587184:cholesterol levels serum [Laboratory Procedure]
           serum cholesterol
   820   C1287371:cholesterol levels serum [Laboratory or Test Result]
   790   C0201950:cholesterol levels [Laboratory Procedure]
   790   C0428466:cholesterol levels [Laboratory or Test Result]
   753   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   753   C0229671:Serum [Body Substance]
   753   C0441889:Levels [Qualitative Concept]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "steady-state levels of APOE protein."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   790   C0678587:steady state [Natural Phenomenon or Process]
   773   C0683927:state level [Spatial Concept]
   767   C0428479:Protein level [Laboratory or Test Result]
   753   C0205361:Steady [Qualitative Concept]
   753   C0441889:Levels [Qualitative Concept]
   753   C1301808:State [Geographic Area]
   753   C1442792:State [Functional Concept]
   753   C3148680:State [Geographic Area]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.182: APOE 4, the most significant genetic risk factor for AD, is associated with both high circulating cholesterol levels and reduced steady-state APOE levels. 

Phrase: "APOE 4,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0052201:Apo E-4 [Amino Acid, Peptide, or Protein]
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "the most significant genetic risk factor for AD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0814299:factor genetic risk [Qualitative Concept]
   770   C0035648:Risk factor [Quantitative Concept]
   744   C1521761:Factor [Functional Concept]
   744   C2827422:Factor [Conceptual Entity]

Phrase: "is"

Phrase: "associated with both high circulating cholesterol levels"
Meta Candidates (Total=17; Excluded=5; Pruned=0; Remaining=12)
   788   C1522133:high cholesterol level [Finding]
           high cholesterol
   778   C0201950:cholesterol levels [Laboratory Procedure]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C0428466:cholesterol levels [Laboratory or Test Result]
   748   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   748   C0175630:Circulating [Functional Concept]
   748   C0205250:High [Qualitative Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C1299351:High [Qualitative Concept]
   748   C2700149:HIGH [Intellectual Product]
   714 E C0456079:Level [Classification]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1547707:Level [Geographic Area]
   714 E C1706221:Associate [Professional or Occupational Group]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "steady-state APOE levels."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   858   C0683927:state level [Spatial Concept]
   812   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0441889:Levels [Qualitative Concept]
   812   C0523511:APOE [Laboratory Procedure]
   812   C1412481:APOE [Gene or Genome]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.183: In contrast, APOE 2 is protective against AD and incidentally confers both low serum cholesterol levels and high levels of APOE. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "APOE 2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0052198:Apo E-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "is"

Phrase: "protective against AD"

Phrase: "and"

Phrase: "incidentally"

Phrase: "confers"

Phrase: "both low serum cholesterol levels"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   923   C0856966:low cholesterol levels [Finding]
   890   C0587184:Serum cholesterol level [Laboratory Procedure]
           serum cholesterol
   890   C1287371:Serum cholesterol level [Laboratory or Test Result]
   875   C0860920:Low cholesterol [Finding]
   861   C0201950:cholesterol levels [Laboratory Procedure]
   861   C0428466:cholesterol levels [Laboratory or Test Result]
   812   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   812   C0229671:Serum [Body Substance]
   812   C0441889:Levels [Qualitative Concept]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "high levels of APOE."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.184: Thus, APOE may affect AD risk through its involvement in cholesterol metabolism, shown through diet studies in the mouse to directly affect A production. 

Phrase: "Thus,"

Phrase: "APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "may"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "AD risk through its involvement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0035647:Risk [Qualitative Concept]

Phrase: "in cholesterol metabolism,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1156530:cholesterol metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "shown through diet"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0012155:Diet [Food]
   790   C1442959:Diet [Organism Function]
   790   C1519433:DIET [Therapeutic or Preventive Procedure]
   790   C2983588:DIET [Food]
   756   C1547282:Show [Intellectual Product]
   718 E C2699635:DIETARY [Functional Concept]

Phrase: "studies in the mouse"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   770   C0557651:Study [Manufactured Object]
   770   C0947630:studies [Laboratory Procedure]
   770   C2603343:Study [Research Activity]

Phrase: "to directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "A production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]
Processing 00000000.tx.185: Alternatively, brain APOE levels may influence the clearance efficiency of the A peptide and its subsequent deposition. 

Phrase: "Alternatively,"

Phrase: "brain APOE levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C0523511:APOE [Laboratory Procedure]
   827   C1412481:APOE [Gene or Genome]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "may"

Phrase: "influence"

Phrase: "the clearance efficiency of the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0013682:Efficiency [Quantitative Concept]

Phrase: "A peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "its subsequent deposition."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposition [Functional Concept]
Processing 00000000.tx.186: APOE abundance Much is known about APOE biology in humans, particularly its role in lipid metabolism. 

Phrase: "APOE abundance Much"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2346714:Abundance [Qualitative Concept]

Phrase: "is"

Phrase: "known about APOE biology"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0005532:Biology [Biomedical Occupation or Discipline]
   770   C0205309:Known [Qualitative Concept]
   770   C0523511:APOE [Laboratory Procedure]
   770   C1412481:APOE [Gene or Genome]

Phrase: "in humans,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "particularly"

Phrase: "its role in lipid metabolism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.187: APOE is primarily synthesized in the liver and brain; 

Phrase: "APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "is"

Phrase: "primarily"

Phrase: "synthesized in the liver"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C1883254:Synthesized [Activity]
   770   C2346688:LIVER [Food]
   715 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.188: additional sites include the adrenal gland and kidney (38,39). 

Phrase: "additional sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the adrenal gland"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0001625:Adrenal gland [Body Part, Organ, or Organ Component]
  1000   C1268989:Adrenal gland [Body Part, Organ, or Organ Component]
  1000   C1515890:GLAND, ADRENAL [Tissue]
   861   C1285092:Gland [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "(38,"

Phrase: "39"

Phrase: ")."
Processing 00000000.tx.189: APOE genotype has been shown to correlate with APOE abundance in the periphery (33,4042); 

Phrase: "APOE genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "correlate with APOE abundance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0523511:APOE [Laboratory Procedure]
   770   C1412481:APOE [Gene or Genome]
   770   C2346714:Abundance [Qualitative Concept]

Phrase: "in the periphery"

Phrase: "(33,"

Phrase: "4042"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.190: the 2 allele confers high APOE, whereas the 4 allele confers low APOE, with respect to 3 levels. 

Phrase: "the 2 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "confers"

Phrase: "high APOE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "whereas"

Phrase: "the 4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "confers"

Phrase: "low APOE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "with respect to 3 levels."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0456949:3 levels [Intellectual Product]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.191: The effect of APOE alleles on APOE abundance in the brain and CSF is less clear owing to conflicting reports, with many studies concentrating on the abundance of APOE in AD brains relative to controls, irrespective of APOE genotype (35,43,44). 

Phrase: "The effect of APOE alleles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on APOE abundance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346714:Abundance [Qualitative Concept]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "CSF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "clear owing to conflicting reports,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0009671:conflicting [Individual Behavior]
   760   C0684224:Reports [Intellectual Product]
   760   C0700287:reports [Health Care Activity]
   760   C2963144:Clear [Qualitative Concept]
   726 E C1705242:Conflict [Qualitative Concept]
   726 E C3273238:Report [Intellectual Product]

Phrase: "with many studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "concentrating on the abundance of APOE"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0523511:APOE [Laboratory Procedure]
   753   C1412481:APOE [Gene or Genome]
   753   C2346714:Abundance [Qualitative Concept]
   719   C1880310:Concentrate [Manufactured Object]
   719   C2003864:Concentrate [Substance]

Phrase: "in AD brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "relative to controls,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "irrespective of APOE genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "(35,"

Phrase: "43,"

Phrase: "44"

Phrase: ")."
Processing 00000000.tx.192: We demonstrate by both western blot analysis and ELISA that the steady-state levels of APOE in tissues and serum from the three KI lines are genotype-dependent and reflect the human data for serum APOE levels. 

Phrase: "We"

Phrase: "demonstrate by both western blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   790   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   753   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "ELISA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014441:ELISA [Laboratory Procedure]

Phrase: "that"

Phrase: "the steady-state levels of APOE"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0678587:steady state [Natural Phenomenon or Process]
   773   C0683927:state level [Spatial Concept]
   753   C0205361:Steady [Qualitative Concept]
   753   C0441889:Levels [Qualitative Concept]
   753   C1301808:State [Geographic Area]
   753   C1442792:State [Functional Concept]
   753   C3148680:State [Geographic Area]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "serum from the three KI lines"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0229671:Serum [Body Substance]
   748   C1546774:Serum [Intellectual Product]
   748   C1550100:Serum [Body Substance]

Phrase: "are"

Phrase: "genotype-dependent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0851827:Dependent [Qualitative Concept]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the human data for serum APOE levels."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0596723:human data [Intellectual Product,Research Activity]
   748   C1511726:Data [Idea or Concept]
   748   C3245479:data [Medical Device]
Processing 00000000.tx.193: 2 KI animals have significantly higher levels of APOE in all tissues examined (P<0.001). 

Phrase: "2 KI animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "have"

Phrase: "significantly higher levels of APOE"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in all tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "(P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.194: Our findings, particularly the data from brain, illustrate the innate differences in the behavior of the three human APOE alleles in the mouse, arguing for the relevance of a genomic-based APOE model in understanding APOE function. 

Phrase: "Our findings,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "particularly"

Phrase: "the data from brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "illustrate"

Phrase: "the innate differences in the behavior of the three human APOE alleles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   703   C1705241:*Difference [Quantitative Concept]
   703   C1705242:Difference [Qualitative Concept]

Phrase: "in the mouse,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "arguing for the relevance of a genomic-based APOE model"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   739   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0017428:Genomic [Gene or Genome]
   739   C0523511:APOE [Laboratory Procedure]
   739   C0887950:genomic [Biomedical Occupation or Discipline]
   739   C1412481:APOE [Gene or Genome]
   739   C1527178:Based [Functional Concept]
   739   C1705938:Based [Idea or Concept]
   739   C2347946:Relevance [Qualitative Concept]
   739   C3161035:Model [Intellectual Product]
   706 E C0002055:base [Inorganic Chemical]
   706 E C0178499:Base [Chemical Viewed Functionally]
   706 E C1880279:Base [Biomedical or Dental Material]

Phrase: "in understanding APOE function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.195: The differences in brain APOE levels in our KI mice may have important implications for how APOE influences pathology development in an AD mouse model. 

Phrase: "The differences in brain APOE levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "in our KI mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1517676:Knock-in [Research Activity]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "may"

Phrase: "have"

Phrase: "important implications for how APOE"

Phrase: "influences"

Phrase: "pathology development in an AD mouse model."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0920595:development model [Intellectual Product]
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1527148:Development [Functional Concept]
Processing 00000000.tx.196: A recent report by Sullivan etal. 

Phrase: "A recent report by Sullivan etal."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0684224:Report [Intellectual Product]
   753   C0700287:Report [Health Care Activity]
   753   C3273238:Report [Intellectual Product]
Processing 00000000.tx.197: (45), showing that brain APOE levels are genotype-independent in a different set of APOE KI animals contradicts these data. 

Phrase: "(45"

Phrase: ")"

Phrase: ","

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that brain APOE levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C0523511:APOE [Laboratory Procedure]
   827   C1412481:APOE [Gene or Genome]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "genotype-independent in a different set of APOE KI animals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C0332291:Independent of [Functional Concept]
   738   C0085862:Independent [Idea or Concept]
   738   C1299583:Independent [Finding]

Phrase: "contradicts"

Phrase: "these data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]
Processing 00000000.tx.198: However, their reported APOE lines contain a neo cassette in the targeted allele that may affect protein expression. 

Phrase: "However,"

Phrase: "their reported APOE lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a neo cassette in the targeted allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0450240:Cassette [Medical Device]
   748   C1706210:Cassette [Manufactured Object]

Phrase: "that"

Phrase: "may"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "protein expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1171362:protein expression [Genetic Function]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.199: An additional difference is the inclusion of human APOE intron 1 in the targeted allele of their mice, which may contain additional endo genous regulatory elements. 

Phrase: "An additional difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "is"

Phrase: "the inclusion of human APOE intron 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1512693:Inclusion [Qualitative Concept]

Phrase: "in the targeted allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "of their mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "which"

Phrase: "may"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "additional endo genous regulatory elements."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Elements [Element, Ion, or Isotope]
   804   C0220905:regulatory [Regulation or Law]
   804   C1704735:Regulatory [Conceptual Entity]
   771 E C1705248:Element [Conceptual Entity]
Processing 00000000.tx.200: Further comparisons between their mice and ours will be necessary to determine the innate differences between the two models. 

Phrase: "Further comparisons between their mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "ours"

Phrase: "will"

Phrase: "be"

Phrase: "necessary to"

Phrase: "determine"

Phrase: "the innate differences between the two models."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.201: APOE and cholesterol metabolism in mice In addition to protein levels, we show that APOE genotype also impacts cholesterol levels in the periphery. 

Phrase: "APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "and"

Phrase: "cholesterol metabolism in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1156530:cholesterol metabolism [Molecular Function]
   770   C0025519:Metabolism [Organism Function]
   770   C0025520:metabolism [Functional Concept]

Phrase: "In addition to protein levels,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C0428479:Protein level [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that APOE genotype also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotype [Organism Attribute]

Phrase: "impacts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1825598:IMPACT [Gene or Genome]

Phrase: "cholesterol levels in the periphery."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C0201950:cholesterol levels [Laboratory Procedure]
   806   C0428466:cholesterol levels [Laboratory or Test Result]
   760   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.202: The 4 KI animals have fasted cholesterol levels that are slightly below those of B6 wild-type animals, whereas the 2 KI animals have 2-fold higher cholesterol levels. 

Phrase: "The 4 KI animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "have"

Phrase: "fasted cholesterol levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0201950:cholesterol levels [Laboratory Procedure]
   901   C0428466:cholesterol levels [Laboratory or Test Result]
   827   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "that"

Phrase: "are"

Phrase: "slightly below those of B6 wild-type animals,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C1883559:Wild Type [Organism Attribute]
   767   C0003070:Animals, Wild [Animal]
   744   C0003062:Animals [Animal]
   744   C0332307:Type [Qualitative Concept]
   744   C0445392:Wild [Intellectual Product]
   744   C0507115:B6 [Body Part, Organ, or Organ Component]
   744   C0750482:Slightly [Idea or Concept]
   744   C1521751:B6 [Mammal]
   744   C1547052:*Type [Quantitative Concept]

Phrase: "whereas"

Phrase: "the 2 KI animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "have"

Phrase: "2-fold higher cholesterol levels."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   897   C0456948:2 levels [Intellectual Product]
   851   C1522133:high cholesterol level [Finding]
           high cholesterol
   840   C0201950:cholesterol levels [Laboratory Procedure]
   840   C0428466:cholesterol levels [Laboratory or Test Result]
   804   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.203: The 3 KI and B6 wild-type cholesterol levels do not significantly differ. 

Phrase: "The 3 KI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1517676:Knock-in [Research Activity]

Phrase: "and"

Phrase: "B6 wild-type cholesterol levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   840   C0201950:cholesterol levels [Laboratory Procedure]
   840   C0428466:cholesterol levels [Laboratory or Test Result]
   804   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "do"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "differ."
Processing 00000000.tx.204: These data recapitulate what has been shown in other APOE KI models (4648), but are opposite from the findings in humans, where the 4 allele is associated with high and 2 with low cholesterol levels. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "recapitulate"

Phrase: "what"

Phrase: "has"

Phrase: "been"

Phrase: "shown in other APOE KI models"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C1517676:Knock-in [Research Activity]
   748   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0523511:APOE [Laboratory Procedure]
   748   C1412481:APOE [Gene or Genome]
   748   C3161035:Models [Intellectual Product]
   714   C1547282:Show [Intellectual Product]

Phrase: "(4648"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "are"

Phrase: "opposite from the findings"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1521805:Opposite [Spatial Concept]

Phrase: "in humans,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "where"

Phrase: "the 4 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "is"

Phrase: "associated with high"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0205250:High [Qualitative Concept]
   790   C1299351:High [Qualitative Concept]
   790   C2700149:HIGH [Intellectual Product]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "2 with low cholesterol levels."
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   862   C0856966:low cholesterol levels [Finding]
   806   C0201950:cholesterol levels [Laboratory Procedure]
   806   C0428466:cholesterol levels [Laboratory or Test Result]
   806   C0860920:Low cholesterol [Finding]
   797   C0456948:2 levels [Intellectual Product]
   760   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   760   C0205251:low [Qualitative Concept]
   760   C0441889:Levels [Qualitative Concept]
   760   C0740116:+2 [Quantitative Concept]
   760   C1299352:Low [Qualitative Concept]
   760   C1550472:low [Idea or Concept]
   760   C2827735:2+ [Quantitative Concept]
   760   C2981700:2+ [Classification]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.205: These data highlight the innate differences in mouse and human cholesterol metabolism, which include the utilization of different lipoproteins to transport cholesterol. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "highlight"

Phrase: "the innate differences in mouse"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "human cholesterol metabolism,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1156530:cholesterol metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]

Phrase: "which"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the utilization of different lipoproteins to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0042153:utilization [Functional Concept]

Phrase: "transport"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005528:Transport, NOS [Cell Function]
  1000   C1317949:Transport [Manufactured Object]
  1000   C3495449:transport [Medical Device]

Phrase: "cholesterol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]
Processing 00000000.tx.206: Our data also contrast with the initial report of the 4 KI mice by Hamanaka etal. 

Phrase: "Our data also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "contrast with the initial report of the 4 KI mice"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   756   C1517676:Knock-in [Research Activity]
   738   C0025914:Mice [Mammal]
   738   C0025929:mice [Mammal]
   738   C0026809:Mice [Mammal]
   738   C0205265:Initial [Temporal Concept]
   738   C0684224:Report [Intellectual Product]
   738   C0700287:Report [Health Care Activity]
   738   C1279901:Initial [Qualitative Concept]
   738   C1555582:Initial [Idea or Concept]
   738   C1705685:INITIAL [Functional Concept]
   738   C1979874:Contrast [Qualitative Concept]
   738   C3273238:Report [Intellectual Product]

Phrase: "by Hamanaka etal."
Processing 00000000.tx.207: (27), showing a 2.5-fold increase in levels of circulating cholesterol relative to wild-type controls. 

Phrase: "(27"

Phrase: ")"

Phrase: ","

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a 2.5-fold increase in levels of circulating cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0442805:Increase [Functional Concept]

Phrase: "relative to wild-type controls."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.208: This discrepancy in the data may be attributed to several factors. 

Phrase: "This discrepancy in the data"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1290905:Discrepancy [Finding]

Phrase: "may"

Phrase: "be"

Phrase: "attributed to several factors."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   737   C0449234:Attribute [Idea or Concept]
   737   C1521761:Factor [Functional Concept]
   737   C1704772:Attribute [Conceptual Entity]
   737   C1882133:Attribute [Qualitative Concept]
   737   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.209: The first, and perhaps most notable, is the difference in genetic background between these two studies. 

Phrase: "The first,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "and"

Phrase: "perhaps most notable,"

Phrase: "is"

Phrase: "the difference in genetic background"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "between these two studies."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
Processing 00000000.tx.210: Several lines of evidence demonstrate a strong genetic component to cholesterol metabolism in the mouse (4648). 

Phrase: "Several lines of evidence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205132:lines [Spatial Concept]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]

Phrase: "demonstrate"

Phrase: "a strong genetic component to cholesterol metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449432:Component [Manufactured Object]
   748   C1705248:Component [Conceptual Entity]

Phrase: "in the mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "(4648"

Phrase: ")."
Processing 00000000.tx.211: This complex trait involves genes that work both in an additive manner as well as epistatically (49). 

Phrase: "This complex trait"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0599883:Trait [Organism Attribute]

Phrase: "involves"

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "that"

Phrase: "work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "both in an additive manner"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0238767:Both [Spatial Concept]
   760   C0442796:Additive [Qualitative Concept]
   760   C1550602:Additive [Substance]
   760   C1706086:Both [Qualitative Concept]

Phrase: "as well as"

Phrase: "epistatically"

Phrase: "(49"

Phrase: ")."
Processing 00000000.tx.212: Our analysis of cholesterol in these KI mice over subsequent backcrosses further argues for background effects, as demonstrated by comparing the cholesterol levels in the 4.N5 animals and the 4.R1.40 animals at the N8 backcross generation (Table 1 versus Fig.4). 

Phrase: "Our analysis of cholesterol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "in these KI mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1517676:Knock-in [Research Activity]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "over subsequent backcrosses further"

Phrase: "argues for background effects,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1280500:effects [Qualitative Concept]
   770   C1706907:Background [Conceptual Entity]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "as"

Phrase: "demonstrated by comparing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1707455:Compare [Activity]

Phrase: "the cholesterol levels in the 4.N5 animals"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0201950:cholesterol levels [Laboratory Procedure]
   770   C0428466:cholesterol levels [Laboratory or Test Result]
   750   C0456950:Level 4 [Qualitative Concept]
   744   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "the 4.R1.40 animals at the N8 backcross generation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0003062:Animals [Animal]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "versus"

Phrase: "Fig.4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.213: Second, the KI mice that we report no longer transmit the neo cassette in the targeted allele. 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "the KI mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1517676:Knock-in [Research Activity]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "we"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "no longer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205166:Long [Qualitative Concept]
   966   C1706317:Long [Qualitative Concept]

Phrase: "transmit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332289:transmit [Functional Concept]

Phrase: "the neo cassette in the targeted allele."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0450240:Cassette [Medical Device]
   748   C1706210:Cassette [Manufactured Object]
Processing 00000000.tx.214: Although there is no direct evidence to suggest that the presence of neo affects the function of APOE or cholesterol metabolism in these mice, this cannot be ruled out. 

Phrase: "Although"

Phrase: "there"

Phrase: "is"

Phrase: "no direct evidence to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0332120:Evidence [Functional Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the presence of neo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the function of APOE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "or"

Phrase: "cholesterol metabolism in these mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1156530:cholesterol metabolism [Molecular Function]
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]

Phrase: "this"

Phrase: "cannot"

Phrase: "be"

Phrase: "ruled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1446409:ruled [Qualitative Concept]
   966 E C0805874:Rule [Idea or Concept]
   966 E C0870077:Rule [Intellectual Product]

Phrase: "out."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]
Processing 00000000.tx.215: Finally, the differences in diet or methodology between the two studies may also impact the reported cholesterol levels. 

Phrase: "Finally,"

Phrase: "the differences in diet"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "or"

Phrase: "methodology between the two studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0025662:Studies, Methodological [Occupational Activity]
   760   C0969625:methodology [Intellectual Product]
   760   C3266812:Methodology [Idea or Concept]

Phrase: "may"

Phrase: "also impact"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1825598:IMPACT [Gene or Genome]

Phrase: "the reported cholesterol levels."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0201950:cholesterol levels [Laboratory Procedure]
   901   C0428466:cholesterol levels [Laboratory or Test Result]
   827   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.216: Further characterization of lipoprotein profiles from our reported 3 and 4 KI mice demonstrated that the majority of cholesterol distributed to the HDL fraction, similar to B6 wild-type animals. 

Phrase: "Further characterization of lipoprotein profiles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "from our reported 3"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0684224:Reported [Intellectual Product]
   861   C0700287:Reported [Health Care Activity]
   861   C3496591:Reported [Clinical Attribute]
   827 E C3273238:Report [Intellectual Product]

Phrase: "and"

Phrase: "4 KI mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1517676:Knock-in [Research Activity]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the majority of cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680220:majority [Social Behavior]

Phrase: "distributed to the HDL fraction,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1264633:Fraction [Quantitative Concept]
   760   C1554103:Fraction [Idea or Concept]
   760   C1704711:Distributed [Functional Concept]

Phrase: "similar to B6 wild-type animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.217: These data suggest that the presence of human APOE 3 or 4 does not disrupt mouse cholesterol metabolism, an observation also made by Maeda and colleagues (5052). 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the presence of human APOE 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "4"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "mouse cholesterol metabolism,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1156530:cholesterol metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]

Phrase: "an observation also"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302523:Observation [Research Activity]
   861   C0700325:observation [Health Care Activity]
   861   C1964257:Observation [Diagnostic Procedure]
   789 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "made by Maeda"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1881534:Make [Functional Concept]

Phrase: "and"

Phrase: "colleagues"

Phrase: "(5052"

Phrase: ")."
Processing 00000000.tx.218: Comparison of these profiles with that published by Hamanaka etal. highlights a further distinction between their 4 KI model and that characterized here. 

Phrase: "Comparison of these profiles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Comparison [Activity]

Phrase: "with that"

Phrase: "published by Hamanaka etal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0034037:Published [Occupational Activity]
   770   C1704324:Published [Intellectual Product]

Phrase: "highlights"

Phrase: "a further distinction between their 4 KI model"

Phrase: "and"

Phrase: "that"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "here."
Processing 00000000.tx.219: In contrast to our data, Hamanaka etal. showed cholesterol distributed to all lipoprotein classes in the 4 KI mice, including VLDL and LDL. 

Phrase: "In contrast to our data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "Hamanaka etal."

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "distributed to all lipoprotein classes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0456387:Class [Intellectual Product]
   760   C1704711:Distributed [Functional Concept]
   760   C1705943:Class [Classification]

Phrase: "in the 4 KI mice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1517676:Knock-in [Research Activity]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "VLDL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0523560:VLDL [Laboratory Procedure]

Phrase: "and"

Phrase: "LDL."
Processing 00000000.tx.220: This profile is actually most similar to that of the 2 KI animals presented here. 

Phrase: "This profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1979963:Profile [Laboratory Procedure]
  1000   C2003903:Profile [Functional Concept]

Phrase: "is"

Phrase: "actually most similar to that of the 2 KI animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C2348205:Similar [Qualitative Concept]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here."
Processing 00000000.tx.221: These animals have significantly higher cholesterol levels and appear to transport the excess circulating cholesterol in the VLDL and LDL fractions, suggesting an impaired cholesterol metabolism. 

Phrase: "These animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "have"

Phrase: "significantly higher cholesterol levels"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   890   C1522133:high cholesterol level [Finding]
           high cholesterol
   861   C0201950:cholesterol levels [Laboratory Procedure]
   861   C0428466:cholesterol levels [Laboratory or Test Result]
   812   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "transport"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005528:Transport, NOS [Cell Function]
  1000   C1317949:Transport [Manufactured Object]
  1000   C3495449:transport [Medical Device]

Phrase: "the excess circulating cholesterol in the VLDL"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0023826:Cholesterol.in VLDL [Biologically Active Substance,Steroid]
           Cholesterol, VLDL
   774   C0523560:VLDL Cholesterol [Laboratory Procedure]
   748   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "and"

Phrase: "LDL fractions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "an impaired cholesterol metabolism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1156530:cholesterol metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.222: The noted increase in triglyceride levels in these 2 KI animals also suggests the development of type III hyperlipoproteinemia, a complex disorder characterized by high cholesterol and triglyceride levels, which affects 10% of humans homozygous for the 2 allele (53). 

Phrase: "The noted increase in triglyceride levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "in these 2 KI animals also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0003062:Animals [Animal]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the development of type III hyperlipoproteinemia,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243107:development [Physiologic Function]
   753   C0678723:Development [Organism Function]
   753   C1527148:Development [Functional Concept]

Phrase: "a complex disorder"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012634:Disorder [Disease or Syndrome]

Phrase: "characterized by high cholesterol"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1522133:high cholesterol [Finding]
   770   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   770   C0205250:High [Qualitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C1880022:Characterized [Activity]
   770   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "triglyceride levels,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C0428475:Triglyceride level [Laboratory or Test Result]
   861   C0041004:Triglyceride [Biologically Active Substance,Lipid]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "which"

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "10% of humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0086418:Humans [Human]

Phrase: "homozygous for the 2 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019904:Homozygous [Organism Attribute]

Phrase: "(53"

Phrase: ")."
Processing 00000000.tx.223: It has been suggested by Sullivan etal. and others (51,54) that this condition manifests itself in 2 KI mice owing to the presence of additional genetic factors in the mouse genome that interact with the 2 allele. 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "suggested by Sullivan etal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1705535:Suggest [Idea or Concept]

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "(51,"

Phrase: "54"

Phrase: ")"

Phrase: "that"

Phrase: "this condition"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   928 E C0009647:Conditioned [Mental Process]
   928 E C1701901:Conditional [Qualitative Concept]
   928 E C1963686:Conditional [Functional Concept]
   900 E C1519605:Conditionality [Conceptual Entity]

Phrase: "manifests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205319:Manifest [Functional Concept]

Phrase: "itself in 2 KI mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1517676:Knock-in [Research Activity]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]

Phrase: "owing to the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of additional genetic factors"
Meta Candidates (Total=18; Excluded=14; Pruned=0; Remaining=4)
   827   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   827   C0314603:Genetic [Functional Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
   771 E C0005615:Birth [Organism Function]
   771 E C0035150:Reproduction [Organism Function]
   771 E C0079946:origin [Classification]
   771 E C0439659:Origin [Temporal Concept]
   771 E C1550512:origin [Intellectual Product]
   771 E C1550722:birth [Idea or Concept]
   771 E C3245487:birth [Intellectual Product]
   743 E C0454729:Natal [Geographic Area]
   743 E C0559522:Genital [Body System]
   743 E C1546649:Genital [Intellectual Product]
   743 E C1550642:Genital [Body Substance]
   734 E C0205313:Original [Idea or Concept]
   734 E C2347409:Original [Occupational Activity]
   716 E C0598240:originality [Mental Process]

Phrase: "in the mouse genome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017428:Genome [Gene or Genome]
   861   C2338314:Genome [Conceptual Entity]

Phrase: "that"

Phrase: "interact with the 2 allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.224: Qualitative western blot analysis of 3 and 4 KI FPLC profiles demonstrated that the behavior of E3 in mice maintained on a low cholesterol diet follows that of endogenous Apoe, found mainly in the IDL/LDL, with some in the HDL fraction; 

Phrase: "Qualitative western blot analysis of 3"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   790   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   753   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "4 KI FPLC profiles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C1979963:Profile [Laboratory Procedure]
   771   C2003903:Profile [Functional Concept]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the behavior of E3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0004927:Behavior [Individual Behavior]
   770   C2707008:Behavior [Clinical Attribute]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "maintained on a low cholesterol diet"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   833   C0311170:Low cholesterol diet [Therapeutic or Preventive Procedure]
   833   C3536712:Low-cholesterol diet [Therapeutic or Preventive Procedure]
   790   C0860920:Low cholesterol [Finding]
   753   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   753   C0012155:Diet [Food]
   753   C0205251:low [Qualitative Concept]
   753   C1299352:Low [Qualitative Concept]
   753   C1314677:Maintained [Functional Concept]
   753   C1442959:Diet [Organism Function]
   753   C1519433:DIET [Therapeutic or Preventive Procedure]
   753   C1550472:low [Idea or Concept]
   753   C2983588:DIET [Food]
   748   C0008395:Cholesterol, Dietary [Steroid]
   719 E C0024501:Maintain [Activity]

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: "that of endogenous Apoe,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205227:Endogenous [Functional Concept]
   770   C0523511:APOE [Laboratory Procedure]
   770   C1412481:APOE [Gene or Genome]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "mainly in the IDL/LDL,"

Phrase: "with some"

Phrase: "in the HDL fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.225: E4 appears to be enriched in the HDL fraction. 

Phrase: "E4"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "enriched in the HDL fraction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0359583:enriched [Food]
   760   C1264633:Fraction [Quantitative Concept]
   760   C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.226: This observation may reflect another difference between mouse and human cholesterol metabolism. 

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "may"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "another difference between mouse"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "human cholesterol metabolism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1156530:cholesterol metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.227: The E4 isoform has a greater affinity for large lipoproteins, which in humans are chylomicrons and VLDL. 

Phrase: "The E4 isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "has"

Phrase: "a greater affinity for large lipoproteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "which in humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0086418:Humans [Human]

Phrase: "are"

Phrase: "chylomicrons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0008731:Chylomicrons [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   966 E C1325761:chylomicron [Cell Component]

Phrase: "and"

Phrase: "VLDL."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0523560:VLDL [Laboratory Procedure]
Processing 00000000.tx.228: E2 and E3, on the other hand, prefer smaller lipoproteins and are primarily found associated with HDL, the smallest lipoprotein class. 

Phrase: "E2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539520:E2 [Gene or Genome]

Phrase: "and"

Phrase: "E3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1537525:E3 [Gene or Genome]

Phrase: "on the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "prefer"

Phrase: "smaller lipoproteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023820:Lipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "are"

Phrase: "primarily"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "associated with HDL,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "the smallest lipoprotein class."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0456387:Class [Intellectual Product]
   827   C1705943:Class [Classification]
Processing 00000000.tx.229: Importantly, mouse plasma is enriched in a large, Apoe-rich HDL that is absent in normal human plasma (36). 

Phrase: "Importantly,"

Phrase: "mouse plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032105:Plasma [Body Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "is"

Phrase: "enriched in a large, Apoe-rich HDL"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0052207:HDL-APO E [Amino Acid, Peptide, or Protein]
   748   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0359583:enriched [Food]
   748   C0523511:APOE [Laboratory Procedure]
   748   C0549177:Large [Quantitative Concept]
   748   C0699759:Rich [Qualitative Concept]
   748   C1412481:APOE [Gene or Genome]

Phrase: "that"

Phrase: "is"

Phrase: "absent in normal human plasma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0332444:Normal absence [Qualitative Concept]
   760   C0332197:Absent [Quantitative Concept]
   760   C2699517:ABSENT [Finding]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.230: It may be that E4 has a preference for these particles over the other two isoforms. 

Phrase: "It"

Phrase: "may"

Phrase: "be"

Phrase: "that E4"

Phrase: "has"

Phrase: "a preference for these particles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0558295:preference [Idea or Concept]
   760   C1549513:Preference [Idea or Concept]

Phrase: "over the"

Phrase: "other two isoforms."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.231: Our mice do not show an enrichment of APOE in VLDL, as observed by Maeda and colleagues. 

Phrase: "Our mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "an enrichment of APOE"

Phrase: "in VLDL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0523560:VLDL [Laboratory Procedure]

Phrase: "as"

Phrase: "observed by Maeda"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "colleagues."
Processing 00000000.tx.232: This discrepancy with our data may be explained by differences in genetic background or diet. 

Phrase: "This discrepancy with our data"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1290905:Discrepancy [Finding]

Phrase: "may"

Phrase: "be"

Phrase: "explained by differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "in genetic background"
Meta Candidates (Total=17; Excluded=14; Pruned=0; Remaining=3)
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   861   C1706907:Background [Conceptual Entity]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "or"

Phrase: "diet."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0012155:Diet [Food]
  1000   C1442959:Diet [Organism Function]
  1000   C1519433:DIET [Therapeutic or Preventive Procedure]
  1000   C2983588:DIET [Food]
   928 E C2699635:DIETARY [Functional Concept]
Processing 00000000.tx.233: Further comparisons between these two sets of APOE KI models, including levels of protein, will be required to thoroughly explain these results. 

Phrase: "Further comparisons between these two sets of APOE KI models,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   704   C1707455:Comparison [Activity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "levels of protein,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   841   C0428479:Protein level [Laboratory or Test Result]
   790   C0441889:Levels [Qualitative Concept]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]

Phrase: "will"

Phrase: "be"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to thoroughly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "explain"

Phrase: "these results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]
Processing 00000000.tx.234: Cholesterol and APP processing In order to identify the effects of each APOE allele on APP processing and A production, particularly with regard to cholesterol metabolism and APOE abundance, we crossed the APOE KI animals to R1.40 APPSwe transgenic animals. 

Phrase: "Cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "and"

Phrase: "APP processing In order to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709694:Processing [Activity]

Phrase: "identify"

Phrase: "the effects of each APOE allele"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "on APP processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "A production,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "particularly with regard to cholesterol metabolism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1156530:cholesterol metabolism [Molecular Function]
   753   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "APOE abundance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346714:Abundance [Qualitative Concept]

Phrase: "we"

Phrase: "crossed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205203:Crossed [Spatial Concept]
   966 E C2828360:Cross [Conceptual Entity]

Phrase: "the APOE KI animals to R1.40 APPSwe transgenic animals."
Processing 00000000.tx.235: Several studies have established a link between cholesterol and APP processing (10,55,56). 

Phrase: "Several studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "a link between cholesterol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1517892:Link [Intellectual Product]
   770   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "APP processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]

Phrase: "(10,"

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "56"

Phrase: ")."
Processing 00000000.tx.236: Refolo etal. 

Phrase: "Refolo etal."
Processing 00000000.tx.237: (13) demonstrated that cholesterol influences the cleavage of APP by beta-secretase in vivo, with hypercholesterolemia increasing CTF levels. 

Phrase: "(13"

Phrase: ")"

Phrase: "demonstrated"

Phrase: "that cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "influences"

Phrase: "the cleavage of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]

Phrase: "by beta-secretase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1412727:SECRETASE, BETA [Gene or Genome]
  1000   C1454853:beta-Secretase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "with hypercholesterolemia increasing CTF levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.238: However, neither levels of holo APP nor CTFs were altered in the APOE;R1.40 animals at 28 days of age. 

Phrase: "However,"

Phrase: "neither levels of holo APP"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "nor"

Phrase: "CTFs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "altered in the APOE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0392747:Altered [Functional Concept]
   770   C0523511:APOE [Laboratory Procedure]
   770   C1412481:APOE [Gene or Genome]

Phrase: ";R1.40 animals at 28 days of age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0003062:Animals [Animal]
Processing 00000000.tx.239: The lack of an effect on APP processing in the 2 KI animals was unexpected, considering their high serum cholesterol levels. 

Phrase: "The lack of an effect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332268:lack [Qualitative Concept]

Phrase: "on APP processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]

Phrase: "in the 2 KI animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "was"

Phrase: "unexpected,"

Phrase: "considering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considering [Idea or Concept]

Phrase: "their high serum cholesterol levels."
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   906   C1522133:high cholesterol level [Finding]
           high cholesterol
   890   C0587184:Serum cholesterol level [Laboratory Procedure]
           serum cholesterol
   890   C1287371:Serum cholesterol level [Laboratory or Test Result]
   861   C0201950:cholesterol levels [Laboratory Procedure]
   861   C0428466:cholesterol levels [Laboratory or Test Result]
   812   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   812   C0229671:Serum [Body Substance]
   812   C0441889:Levels [Qualitative Concept]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.240: Analysis of A140 levels in these animals provided further evidence that serum cholesterol alone is not enough to affect APP processing at this young age. 

Phrase: "Analysis of A140 levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "in these animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "further evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that serum cholesterol"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0587184:serum cholesterol [Laboratory Procedure]
   861   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "is"

Phrase: "not enough to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "APP processing at this young age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709694:Processing [Activity]
Processing 00000000.tx.241: Given the strong evidence for high cholesterol levels increasing A production (13) we predicted that the 2 KI animals, with a 2-fold increase in total serum cholesterol, would demonstrate much higher levels of A than the 3 KI and 4 KI mice. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the strong evidence for high cholesterol levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0393009:evidence level [Finding]
   748   C0332120:Evidence [Functional Concept]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "A production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "(13"

Phrase: ")"

Phrase: "we"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "that"

Phrase: "the 2 KI animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "with a 2-fold increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442805:Increase [Functional Concept]

Phrase: "in total serum cholesterol,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   913   C0201950:Total Cholesterol [Laboratory Procedure]
   913   C0543421:Total cholesterol [Steroid]
   901   C0587184:serum cholesterol [Laboratory Procedure]
   827   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   827   C0229671:Serum [Body Substance]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "would"

Phrase: "demonstrate"

Phrase: "much higher levels of A than the 3 KI"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   741   C0456949:Level 3 [Intellectual Product]
   739   C0441889:Levels [Qualitative Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "4 KI mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1517676:Knock-in [Research Activity]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
Processing 00000000.tx.242: However, similar to the CTF data, the levels of A140 in brain were indistinguishable across lines. 

Phrase: "However,"

Phrase: "similar to the CTF data,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "the levels of A140"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "indistinguishable across lines."
Processing 00000000.tx.243: There are several possible explanations for these results. 

Phrase: "There"

Phrase: "are"

Phrase: "several possible explanations for these results."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0681841:Explanations [Intellectual Product]
Processing 00000000.tx.244: First, the data we present here come from 28-day-old animals, an age just post-weaning and prior to sexual maturity. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "we"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "here"

Phrase: "come from 28-day-old animals,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0003062:Animals [Animal]
   753   C0332173:/day [Temporal Concept]
   753   C0439228:day [Temporal Concept]
   753   C0439505:/day [Temporal Concept]
   753   C0580836:Old [Temporal Concept]

Phrase: "an age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "just post-weaning"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0043084:Weaning [Organism Function]
   827   C0687676:Post [Temporal Concept]
   827   C1704687:Post [Manufactured Object]
   755 E C1514253:Postal [Functional Concept]

Phrase: "and prior to sexual maturity."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0233891:Sexual maturity, NOS [Finding]
   806   C0332152:Prior to [Temporal Concept]
           Prior
   760   C0036864:Sexual [Behavior]
   760   C0449989:Maturity [Qualitative Concept]
   760   C0700597:Maturity [Temporal Concept]
   760   C1515981:And [Idea or Concept]
   760   C2826257:PRIOR [Event]
Processing 00000000.tx.245: It is possible that the ability of cholesterol to affect APP processing and A metabolism is time- or age-dependent. 

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "the ability of cholesterol to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "APP processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "A metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "is"

Phrase: "time-"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "or"

Phrase: "age-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "dependent."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0851827:Dependent [Qualitative Concept]
  1000   C1701901:Dependent [Qualitative Concept]
  1000   C3244310:dependent [Functional Concept]
Processing 00000000.tx.246: Successful diet studies have chronically fed mice high cholesterol diets for several weeks (13,14). 

Phrase: "Successful diet studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "chronically fed mice high cholesterol diets for several weeks"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   742   C0012155:Diets [Food]
   720   C0008395:Cholesterol, Dietary [Steroid]
   708 E C1442959:Diet [Organism Function]
   708 E C1519433:DIET [Therapeutic or Preventive Procedure]
   708 E C2983588:DIET [Food]

Phrase: "(13,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.247: Chronic exposure to high serum cholesterol levels for several weeks or months may be required to affect A metabolism in the APOE;R140 animals. 

Phrase: "Chronic exposure to high serum cholesterol levels"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0332157:Exposure to [Clinical Attribute]
           Exposure
   748   C0205191:chronic [Temporal Concept]
   748   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "for several weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "or"

Phrase: "months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0439231:months [Temporal Concept]
   966 E C0439507:/month [Temporal Concept]

Phrase: "may"

Phrase: "be"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "A metabolism in the APOE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]

Phrase: ";R140 animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]
Processing 00000000.tx.248: Assaying levels of A140 in older animals will be useful to further understand the age component of cholesterol effects and APOE on APP processing. 

Phrase: "Assaying levels of A140"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in older animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "will"

Phrase: "be"

Phrase: "useful to further"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C1517331:Further [Spatial Concept]
   793 E C0205108:far [Spatial Concept]
   755   C0042153:use [Functional Concept]
   755   C0457083:Use [Functional Concept]
   755   C1947944:Use [Intellectual Product]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the age component of cholesterol effects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "APOE on APP processing."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0523511:APOE [Laboratory Procedure]
   770   C1412481:APOE [Gene or Genome]
Processing 00000000.tx.249: Second, we show that peripheral cholesterol metabolism does not affect CNS cholesterol regulation. 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that peripheral cholesterol metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1156530:cholesterol metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "CNS cholesterol regulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0851285:Regulation [Governmental or Regulatory Activity]
   827   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.250: Despite the differences in serum cholesterol in the three APOE;R1.40 lines described in this manuscript, brain cholesterol levels are indistinguishable in these animals. 

Phrase: "Despite the differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "in serum cholesterol"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0587184:serum cholesterol [Laboratory Procedure]
   861   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "in the three APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: ";R1.40 lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "described in this manuscript,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0600659:Manuscript [Intellectual Product,Manufactured Object]
   770   C1552738:described [Idea or Concept]

Phrase: "brain cholesterol levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0201950:cholesterol levels [Laboratory Procedure]
   901   C0428466:cholesterol levels [Laboratory or Test Result]
   827   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "indistinguishable in these animals."
Processing 00000000.tx.251: This finding is supported by a large body of evidence demonstrating that cholesterol metabolism in the periphery is fundamentally different from and independent of that in the central nervous system, involving different lipoproteins and apolipoproteins (5759). 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "is"

Phrase: "supported by a large body of evidence"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   774   C0332120:Evidence of [Functional Concept]
           Evidence
   757   C0438854:Body support [Medical Device]
   748   C0242821:body [Human]
   748   C0460148:Body [Anatomical Structure]
   748   C0549177:Large [Quantitative Concept]
   748   C1268086:Body [Anatomical Structure]
   748   C1521721:Supported [Conceptual Entity]
   714 E C0183683:Support [Medical Device]

Phrase: "demonstrating"

Phrase: "that cholesterol metabolism in the periphery"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1156530:cholesterol metabolism [Molecular Function]
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]

Phrase: "is"

Phrase: "fundamentally different from"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1705242:Different [Qualitative Concept]
   718 E C1705241:*Difference [Quantitative Concept]

Phrase: "and independent of that"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0332291:Independent of [Functional Concept]
   770   C0085862:Independent [Idea or Concept]
   770   C1299583:Independent [Finding]
   770   C1515981:And [Idea or Concept]

Phrase: "in the central nervous system,"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "different lipoproteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023820:Lipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "apolipoproteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003591:Apolipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(5759"

Phrase: ")."
Processing 00000000.tx.252: This argues against an effect of peripheral cholesterol on processes in the brain. 

Phrase: "This"

Phrase: "argues against an effect of peripheral cholesterol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   748   C0205100:Peripheral [Spatial Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1184743:Process [Body Part, Organ, or Organ Component]
   966   C1522240:Process [Phenomenon or Process]

Phrase: "in the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.253: Importantly, E2;R1.40 and E4;R1.40 animals demonstrate significantly increased brain cholesterol levels over R1.40 animals with endogenous Apoe; 

Phrase: "Importantly,"

Phrase: "E2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539520:E2 [Gene or Genome]

Phrase: ";R1.40"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439509:/40 [Temporal Concept]
   861   C1335648:R1 [Gene or Genome]
   861   C1824685:R1 [Gene or Genome]
   861   C2697937:R1 [Quantitative Concept]

Phrase: "and"

Phrase: "E4"

Phrase: ";R1.40 animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "demonstrate"

Phrase: "significantly increased brain cholesterol levels over R1.40 animals"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   764   C0201950:cholesterol levels [Laboratory Procedure]
   764   C0428466:cholesterol levels [Laboratory or Test Result]
   762   C3276464:Increased cholesterol [Finding]
   745   C0441901:Level R1 [Qualitative Concept]
   742   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "with endogenous Apoe"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.254: brain cholesterol levels in the E3.R140 animals were also greater than those of R1.40, although the trend was not statistically significant. 

Phrase: "brain cholesterol levels in the E3.R140 animals"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0201950:cholesterol levels [Laboratory Procedure]
   770   C0428466:cholesterol levels [Laboratory or Test Result]
   744   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "also greater than those of R1.40,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   778   C0439093:Greater Than [Quantitative Concept]
   748   C0443228:greater [Quantitative Concept]
   748   C1704243:Greater [Quantitative Concept]
   714 E C0549177:Great [Quantitative Concept]

Phrase: "although"

Phrase: "the trend"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521798:trend [Temporal Concept]

Phrase: "was"

Phrase: "not statistically significant."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   913   C1273937:Not significant [Finding]
   901   C0237881:statistically significant [Quantitative Concept]
           significant
   829 E C1709380:Statistical Significance [Quantitative Concept]
   827   C0038215:Statistically [Occupation or Discipline]
   827   C0750502:Significant [Idea or Concept]
   827   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.255: These data correspond with significant increases in brain A140 levels in the APOE;R1.40 animals, suggesting that brain cholesterol levels in particular may have a significant impact on A production. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "correspond with significant increases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0237881:significant [Quantitative Concept]
   770   C0442805:increases [Functional Concept]
   770   C0750502:Significant [Idea or Concept]
   770   C1546944:Significant [Qualitative Concept]

Phrase: "in brain A140 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: ";R1.40 animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that brain cholesterol levels in particular"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0201950:cholesterol levels [Laboratory Procedure]
   790   C0428466:cholesterol levels [Laboratory or Test Result]
   753   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "may"

Phrase: "have"

Phrase: "a significant impact on A production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1825598:IMPACT [Gene or Genome]
Processing 00000000.tx.256: Notably, one diet study increased brain cholesterol in addition to A levels (14). 

Phrase: "Notably,"

Phrase: "one diet study increased brain cholesterol in addition to A levels"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   754   C0201950:cholesterol levels [Laboratory Procedure]
   754   C0428466:cholesterol levels [Laboratory or Test Result]
   754   C3276464:Increased cholesterol [Finding]
   738   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   718   C0008395:Cholesterol, Dietary [Steroid]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.257: Our data argue for the independent roles of APOE in peripheral and CNS cholesterol metabolism, and furthermore suggest a distinction between APOE and endogenous Apoe effects on both murine brain cholesterol metabolism and steady-state A levels. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "argue for the independent roles of APOE"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   774   C0332291:Independent of [Functional Concept]
   748   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0035820:Roles [Social Behavior]
   748   C0085862:Independent [Idea or Concept]
   748   C0523511:APOE [Laboratory Procedure]
   748   C1299583:Independent [Finding]
   748   C1412481:APOE [Gene or Genome]
   714 E C1705810:Role [Conceptual Entity]

Phrase: "in peripheral"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205100:Peripheral [Spatial Concept]

Phrase: "and"

Phrase: "CNS cholesterol metabolism,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1156530:cholesterol metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "furthermore"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a distinction between APOE"

Phrase: "and"

Phrase: "endogenous Apoe effects on both murine brain cholesterol metabolism"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C1280500:effects [Qualitative Concept]
   708 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "steady-state"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0678587:steady state [Natural Phenomenon or Process]
   861   C0205361:Steady [Qualitative Concept]
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "A levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.258: APOE and Alzheimer's disease This manuscript highlights the first report of an APOE mouse model that utilizes endogenous regulation to study native APOE levels and cholesterol metabolism in relation to Alzheimer's disease. 

Phrase: "APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "and"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "This manuscript"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600659:Manuscript [Intellectual Product,Manufactured Object]

Phrase: "highlights"

Phrase: "the first report of an APOE mouse model"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0684224:Report [Intellectual Product]
   744   C0700287:Report [Health Care Activity]
   744   C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "utilizes"

Phrase: "endogenous regulation to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0851285:Regulation [Governmental or Regulatory Activity]
   827   C1327622:Regulation [Biologic Function]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "native APOE levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C0523511:APOE [Laboratory Procedure]
   827   C1412481:APOE [Gene or Genome]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "cholesterol metabolism in relation to Alzheimer's disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1156530:cholesterol metabolism [Molecular Function]
   748   C0025519:Metabolism [Organism Function]
   748   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.259: Importantly, the correlation between APOE genotype, APOE steady-state levels and cholesterol metabolism observed in humans is uncoupled in the KI mice. 

Phrase: "Importantly,"

Phrase: "the correlation between APOE genotype,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707520:Correlation [Qualitative Concept]

Phrase: "APOE steady-state levels"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0678587:steady state [Natural Phenomenon or Process]
   844   C0683927:state level [Spatial Concept]
   812   C0205361:Steady [Qualitative Concept]
   812   C0441889:Levels [Qualitative Concept]
   812   C1301808:State [Geographic Area]
   812   C1442792:State [Functional Concept]
   812   C3148680:State [Geographic Area]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "cholesterol metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1156530:cholesterol metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "observed in humans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0086418:Humans [Human]
   790   C1441672:Observed [Functional Concept]

Phrase: "is"

Phrase: "uncoupled in the KI mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1517676:Knock-in [Research Activity]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
Processing 00000000.tx.260: This allows us to further dissect two aspects of APOE function that may impact the development of AD, cholesterol metabolism and A clearance. 

Phrase: "This"

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "us to further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "dissect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205239:dissect [Functional Concept]

Phrase: "two aspects of APOE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1547011:Aspect [Quantitative Concept]
   737   C1879746:Aspect [Qualitative Concept]

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "that"

Phrase: "may"

Phrase: "impact"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1825598:IMPACT [Gene or Genome]

Phrase: "the development of AD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]

Phrase: "cholesterol metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1156530:cholesterol metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "A clearance."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449297:Clearance [Qualitative Concept]
  1000   C1382187:Clearance [Clinical Attribute]
  1000   C2825073:Clearance [Natural Phenomenon or Process]
Processing 00000000.tx.261: APOE abundance in the brains of 4 KI animals is low, but these animals have normal serum cholesterol levels. 

Phrase: "APOE abundance in the brains of 4 KI animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C2346714:Abundance [Qualitative Concept]

Phrase: "is"

Phrase: "low,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "but"

Phrase: "these animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "have"

Phrase: "normal serum cholesterol levels."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   923   C0428467:Normal serum cholesterol [Finding]
   890   C0587184:Serum cholesterol level [Laboratory Procedure]
           serum cholesterol
   890   C1287371:Serum cholesterol level [Laboratory or Test Result]
   875   C0858309:Normal cholesterol [Finding]
   861   C0201950:cholesterol levels [Laboratory Procedure]
   861   C0428466:cholesterol levels [Laboratory or Test Result]
   812   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.262: These animals allow us to study the effects of low APOE levels in the absence of high cholesterol, which is often observed in humans who inherit an 4 allele. 

Phrase: "These animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the effects of low APOE levels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of high cholesterol,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1522133:high cholesterol [Finding]
   861   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "which"

Phrase: "is"

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "observed in humans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0086418:Humans [Human]
   790   C1441672:Observed [Functional Concept]

Phrase: "who"

Phrase: "inherit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439660:inherit [Functional Concept]

Phrase: "an 4 allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.263: Likewise, the 2 KI animals have both high serum cholesterol and high brain APOE levels. 

Phrase: "Likewise,"

Phrase: "the 2 KI animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "have"

Phrase: "both high serum cholesterol"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C1522133:high cholesterol [Finding]
   901   C0587184:serum cholesterol [Laboratory Procedure]
   827   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   827   C0229671:Serum [Body Substance]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "high brain APOE levels."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   812   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0441889:Levels [Qualitative Concept]
   812   C0523511:APOE [Laboratory Procedure]
   812   C1412481:APOE [Gene or Genome]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.264: These animals are useful to determine the effects of high cholesterol independent of low APOE levels. 

Phrase: "These animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "are"

Phrase: "useful to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0042153:use [Functional Concept]
   789   C0457083:Use [Functional Concept]
   789   C1947944:Use [Intellectual Product]

Phrase: "determine"

Phrase: "the effects of high cholesterol"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "independent of low APOE levels."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C0523511:APOE [Laboratory Procedure]
   827   C1412481:APOE [Gene or Genome]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.265: Future experiments will assess the effects of both age and diet in the APOE;R1.40 lines on cholesterol metabolism, particularly in brain, and APOE abundance, as well as A metabolism and amyloid deposition.  

Phrase: "Future experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "will"

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the effects of both age"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "diet in the APOE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0012155:Diet [Food]
   770   C1442959:Diet [Organism Function]
   770   C1519433:DIET [Therapeutic or Preventive Procedure]
   770   C2983588:DIET [Food]

Phrase: ";R1.40 lines on cholesterol metabolism,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0205132:lines [Spatial Concept]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]

Phrase: "particularly in brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0006104:Brain [Body Part, Organ, or Organ Component]
   790   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "APOE abundance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346714:Abundance [Qualitative Concept]

Phrase: "as well as"

Phrase: "A metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "amyloid deposition."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011560:Amyloid deposition [Pathologic Function]
  1000   C1705760:Amyloid Deposition [Finding]
   861   C0333562:Deposition [Functional Concept]
Processing 00000000.tx.266: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Mice The original stocks of APOE 2, 3 and 4 KI animals were produced at the Mitsubishi Kagaku Institute of Life Sciences; 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "The original stocks of APOE 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1710198:Stock [Idea or Concept]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "4 KI animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "produced at the Mitsubishi Kagaku Institute of Life Sciences"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0005526:Life Sciences [Occupation or Discipline]
   742   C0021622:institute [Organization]
   742   C0036397:Sciences [Occupation or Discipline]
   742   C0376558:Life [Idea or Concept]
   742   C1272753:Institute [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.267: the 4 KI animals were previously published (27). 

Phrase: "the 4 KI animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "previously"

Phrase: "published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.268: APOE characterization: male KI animals for each line were backcrossed two generations onto the C57BL/6J background. 

Phrase: "APOE characterization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1880022:Characterization [Activity]

Phrase: ":"

Phrase: "male KI animals for each line"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "backcrossed"

Phrase: "two generations onto the C57BL/6J background."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0079411:Generations [Temporal Concept]
   714 E C3146294:Generation [Activity]
Processing 00000000.tx.269: Male progeny of the N2 generation were then crossed to Zp3-cre transgenic animals congenic on the C57BL6/J background (31). 

Phrase: "Male progeny of the N2 generation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0680063:Progeny [Family Group]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "crossed to Zp3-cre transgenic animals"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0003069:Animals, Transgenic [Animal]
           Transgenic
   753   C0003062:Animals [Animal]
   753   C0205203:Crossed [Spatial Concept]
   753   C0597698:ZP3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1421866:ZP3 [Gene or Genome]
   753   C1511573:CRE [Gene or Genome]
   719 E C2828360:Cross [Conceptual Entity]

Phrase: "congenic on the C57BL6/J background"

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.270: Female progeny from this cross (N3 generation) were selected for on the basis of the presence of both the human APOE and the Zp3-cre transgene. 

Phrase: "Female progeny from this cross"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680063:Progeny [Family Group]

Phrase: "(N3 generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0079411:Generation [Temporal Concept]
   861   C3146294:Generation [Activity]
   768 E C1414672:Genesis [Gene or Genome]
   768 E C2984892:Genesis [Gene or Genome]

Phrase: ")"

Phrase: "were"

Phrase: "selected for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1707391:Select [Activity]

Phrase: "on the basis of the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of both"

Phrase: "the human APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "and"

Phrase: "the Zp3-cre transgene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0282641:Transgene [Gene or Genome]
Processing 00000000.tx.271: An additional backcross of these animals yielded progeny of the N4 generation that were selected for on the basis of the presence of APOE and the absence of the neo cassette in the targeted allele. 

Phrase: "An additional backcross of these animals"

Phrase: "yielded"

Phrase: "progeny of the N4 generation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680063:Progeny [Family Group]

Phrase: "that"

Phrase: "were"

Phrase: "selected for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1707391:Select [Activity]

Phrase: "on the basis of the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "and"

Phrase: "the absence of the neo cassette"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "in the targeted allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.272: Males from this cross were backcrossed to N5 before animals were intercrossed to obtain homozygous KI animals of each allele. 

Phrase: "Males from this cross"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0024554:Males [Finding]
   770   C0086582:Males [Population Group]
   737 E C1706180:Male [Qualitative Concept]
   737 E C1706428:Male [Qualitative Concept]
   737 E C1706429:Male [Organism Attribute]

Phrase: "were"

Phrase: "backcrossed to N5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0442785:N5 [Finding]

Phrase: "before animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "intercrossed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "homozygous KI animals of each allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0003062:Animals [Animal]
Processing 00000000.tx.273: These animals were used for the characterization studies of human APOE in the mouse, and no longer carried the ZP3-cre transgene. 

Phrase: "These animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "used for the characterization"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1273517:used [Finding]
   770   C1880022:Characterization [Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "studies of human APOE"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   819   C0178693:human studies [Research Activity]
   770   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0086418:Human [Human]
   770   C0523511:APOE [Laboratory Procedure]
   770   C0557651:Study [Manufactured Object]
   770   C0947630:studies [Laboratory Procedure]
   770   C1412481:APOE [Gene or Genome]
   770   C2603343:Study [Research Activity]

Phrase: "in the mouse,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "no longer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205166:Long [Qualitative Concept]
   966   C1706317:Long [Qualitative Concept]

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "the ZP3-cre transgene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0282641:Transgene [Gene or Genome]
Processing 00000000.tx.274: For analysis of APP processing and A metabolism, APOE KI animals backcrossed to the N7 generation were crossed to B6.R140 APP transgenic mice congenic on the C57BL6/J background, and subsequent progeny intercrossed to obtain mice homozygous for APOE and hemizygous for the APP transgene. 

Phrase: "For analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "of APP processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "A metabolism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "APOE KI animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "backcrossed to the N7 generation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079411:Generation [Temporal Concept]
   760   C3146294:Generation [Activity]

Phrase: "were"

Phrase: "crossed to B6.R140 APP transgenic mice"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   778   C0025936:Mice, Transgenic [Mammal]
   748   C0003069:Transgenic [Animal]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0205203:Crossed [Spatial Concept]
   748   C0507115:B6 [Body Part, Organ, or Organ Component]
   748   C1521751:B6 [Mammal]
   748   C3538722:APP [Laboratory Procedure]
   714 E C2828360:Cross [Conceptual Entity]

Phrase: "congenic on the C57BL6/J background,"

Phrase: "and"

Phrase: "subsequent progeny"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680063:Progeny [Family Group]

Phrase: "intercrossed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "homozygous for APOE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0019904:Homozygous [Organism Attribute]

Phrase: "and"

Phrase: "hemizygous for the APP transgene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1881036:Hemizygous [Qualitative Concept]
Processing 00000000.tx.275: All mice were maintained on a normal chow diet (LabDiets 5021; 9.5% fat) and in accordance with IACUC regulations. 

Phrase: "All mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "maintained on a normal chow diet"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   783   C0184625:Normal diet [Daily or Recreational Activity]
   783   C1550560:normal diet [Therapeutic or Preventive Procedure]
   753   C0012155:Diet [Food]
   753   C0205307:Normal [Qualitative Concept]
   753   C0324335:chow [Mammal]
   753   C0439166:% normal [Quantitative Concept]
   753   C1314677:Maintained [Functional Concept]
   753   C1442959:Diet [Organism Function]
   753   C1519433:DIET [Therapeutic or Preventive Procedure]
   753   C2347086:% Normal [Quantitative Concept]
   753   C2983588:DIET [Food]
   719 E C0024501:Maintain [Activity]

Phrase: "(LabDiets 5021"

Phrase: "; 9.5% fat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0424612:FAT [Organism Attribute]

Phrase: ")"

Phrase: "and in accordance with IACUC regulations."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0220905:regulations [Regulation or Law]
   753   C0851285:Regulations [Governmental or Regulatory Activity]
   753   C1136114:IACUC [Professional or Occupational Group]
   753   C1515981:And [Idea or Concept]
   753   C2983617:IACUC [Intellectual Product]
   719 E C1327622:Regulation [Biologic Function]
Processing 00000000.tx.276: Cholesterol and triglyceride measurements Serum for cholesterol and triglyceride measurements was obtained from animals fasted 6h by retro-ortbital sinus bleed. 

Phrase: "Cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "and"

Phrase: "triglyceride measurements Serum for cholesterol"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0542495:Serum Triglyceride Measurement [Laboratory Procedure]
           Triglyceride.serum
   824   C0587184:Serum cholesterol measurement [Laboratory Procedure]
           Cholesterol - serum
   760   C0229671:Serum [Body Substance]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "triglyceride measurements"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0202236:Triglyceride Measurement [Laboratory Procedure]
   861   C0242485:measurements [Functional Concept]

Phrase: "was"

Phrase: "obtained from animals"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0003062:Animals [Animal]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "fasted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015663:Fast [Finding]
   966   C0456962:Fast [Qualitative Concept]

Phrase: "6h by retro-ortbital sinus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1292428:6H [Temporal Concept]

Phrase: "bleed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019080:bleed [Pathologic Function]
Processing 00000000.tx.277: Measurements were obtained using the Infinity Cholesterol reagent and the Infinity Triglyceride reagent, respectively (Thermotrace, Arlington, TX, USA) according to the manufacturer's instructions. 

Phrase: "Measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:measurements [Functional Concept]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Infinity Cholesterol reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "the Infinity Triglyceride reagent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "respectively"

Phrase: "(Thermotrace,"

Phrase: "Arlington,"

Phrase: "TX,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "according to the manufacturer's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.278: Brain cholesterol from hemispheres was extracted by homogenization in 6M urea buffer (6M urea, 100mM Tris pH 7.4, 1mM DTT, 1mM EDTA, 0.5M AEBSF and 1% SDS) as reported by Levin-Allerhand etal. 

Phrase: "Brain cholesterol from hemispheres"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "was"

Phrase: "extracted by homogenization"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0185115:Extracted [Therapeutic or Preventive Procedure]
   790   C3541890:EXTRACTED [Finding]
   756 E C2828366:Extract [Substance]

Phrase: "in 6M urea buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(6M urea,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0041942:Urea [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   805 E C0728794:Ureaphil [Organic Chemical,Pharmacologic Substance]

Phrase: "100mM Tris pH 7.4,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   853   C2678549:PH-4 [Gene or Genome]
   840   C1882074:pH 7 [Qualitative Concept]
   804   C0020283:[pH] [Quantitative Concept]
   804   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   804   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   804   C0450407:ph+ [Finding]
   804   C0450408:ph++ [Finding]
   804   C0450409:ph+++ [Finding]
   804   C0814229:TRI [Intellectual Product]

Phrase: "1mM DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "1mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "0.5M AEBSF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0047895:AEBSF [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "1% SDS)"

Phrase: "as"

Phrase: "reported by Levin-Allerhand etal."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C1709908:Reported By [Group]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.279: (14). 

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.280: Brain cholesterol was measured using the Inifinity Cholesterol reagent (Thermotrace) after diluting the homogenates 1:1 in PBS. 

Phrase: "Brain cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Inifinity Cholesterol reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Thermotrace"

Phrase: ")"

Phrase: "after"

Phrase: "diluting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "the homogenates 1"

Phrase: ":"

Phrase: "1 in PBS."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   790   C2827734:1+ [Quantitative Concept]
   790   C2981698:1+ [Classification]
Processing 00000000.tx.281: Brain cholesterol concentrations are expressed as mg cholesterol relative to mg protein measured by BCA assay (Pierce, Rockford, IL, USA). 

Phrase: "Brain cholesterol concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "are"

Phrase: "expressed as mg cholesterol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   770   C0439269:mg% [Quantitative Concept]
   770   C1960952:mg % [Quantitative Concept]
   770   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "relative to mg protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]

Phrase: "measured by BCA assay"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C1332420:bca [Gene or Genome]
   770   C1510438:Assay [Laboratory Procedure]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "(Pierce,"

Phrase: "Rockford,"

Phrase: "IL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.282: FPLC For analysis of lipoprotein profiles and cholesterol distribution in the APOE KI animals, fasted serum from three animals of each genotype and of the same sex was pooled before fractionation on a Superose 6 column (Pharmacia, Kalamazoo, MI, USA) as previously described (60). 

Phrase: "FPLC For analysis of lipoprotein profiles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0599209:FPLC [Laboratory Procedure]

Phrase: "and"

Phrase: "cholesterol distribution in the APOE KI animals,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   750   C3494412:Animal Distribution [Social Behavior]
   744   C0520511:distribution [Idea or Concept]
   744   C1704711:Distribution [Functional Concept]

Phrase: "fasted serum from three animals of each genotype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0229671:Serum [Body Substance]
   744   C1546774:Serum [Intellectual Product]
   744   C1550100:Serum [Body Substance]

Phrase: "and of the same sex"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0009253:Sex [Organism Function]
   760   C0036864:Sex [Behavior]
   760   C0079399:sex [Organism Attribute]
   760   C0445247:Same [Qualitative Concept]
   760   C1314687:Sex [Finding]
   760   C1515981:And [Idea or Concept]
   760   C1522384:sex [Organism Attribute]

Phrase: "was"

Phrase: "pooled before fractionation"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0016640:fractionation [Laboratory Procedure]
   790   C0524811:fractionation [Therapeutic or Preventive Procedure]
   790   C1709595:Pooled [Conceptual Entity]
   790   C2349200:Pooled [Functional Concept]
   790   C3161031:Fractionation [Therapeutic or Preventive Procedure]
   756 E C0337051:Pool [Geographic Area]
   756 E C1509144:pool [Clinical Attribute]

Phrase: "on a Superose 6 column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]

Phrase: "(Pharmacia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331955:Pharmacia [Health Care Related Organization]

Phrase: "Kalamazoo,"

Phrase: "MI,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(60"

Phrase: ")."
Processing 00000000.tx.283: Western blot analysis For analysis of APOE levels from tissues, brain or liver homogenates were prepared in 1% CHAPS with protease inhibitors (1M pepstatin, 4.5g/ml leupeptin, 30g/ml aprotinin and 1mM AEBSF). 

Phrase: "Western blot analysis For analysis of APOE levels"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   800   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   770   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
   744   C1705493:Western [Spatial Concept]

Phrase: "from tissues,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "liver homogenates"

Phrase: "were"

Phrase: "prepared in 1% CHAPS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0047101:CHAPS [Pharmacologic Substance,Steroid]
   737 E C0950540:chap [Therapeutic or Preventive Procedure]
   737   C1521827:Prepare [Functional Concept]

Phrase: "with protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   966 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1947941:Protease [Enzyme]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(1M pepstatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "4.5g/ml leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "30g/ml aprotinin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "1mM AEBSF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0047895:AEBSF [Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.284: Brain and fasted liver homogenates were run on 412% BisTris gradient gels (Invitrogen, Carlsbad, CA, USA) under reducing conditions according to the manufacturer's instructions. 

Phrase: "Brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "fasted liver homogenates"

Phrase: "were"

Phrase: "run on 412% BisTris gradient gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0017243:Gels [Biomedical or Dental Material]
   766 E C1382104:Gel [Substance]

Phrase: "(Invitrogen,"

Phrase: "Carlsbad,"

Phrase: "CA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "under reducing conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "according to the manufacturer's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.285: Equal concentrations of protein, determined by BCA assay, were loaded on every gel. 

Phrase: "Equal concentrations of protein,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   802   C0427716:Protein concentration [Laboratory Procedure]
   802   C1304757:Protein concentration [Laboratory or Test Result]
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "determined by BCA assay,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C1332420:bca [Gene or Genome]
   770   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "loaded on every gel."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0017243:Gel [Biomedical or Dental Material]
   770   C1382104:Gel [Substance]
   770   C1708715:Loaded [Activity]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.286: A linear standard curve of a serially diluted control 3 KI of known concentration was run on every gel to normalize across gels (R20.90). 

Phrase: "A linear standard curve of a serially diluted control 3 KI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0205134:Curve [Spatial Concept]

Phrase: "of known concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "run on"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0035953:run [Daily or Recreational Activity]
   861   C0600140:run [Finding]
   861   C1704688:Run [Functional Concept]
   861   C2346414:Run [Finding]

Phrase: "every gel to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]

Phrase: "normalize across gels"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0017243:Gels [Biomedical or Dental Material]
   790   C1882115:Normalize [Research Activity]
   756 E C1382104:Gel [Substance]

Phrase: "(R20.90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.287: Protein was transferred to Immobilon-p membranes (Millipore, Bedford, MA, USA) and probed with an anti-human polyclonal APOE antibody (Calbiochem, LaJolla, CA, USA), followed by an HRP-conjugated secondary antibody and detected using ECL (Pierce) on film. 

Phrase: "Protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "transferred to Immobilon-p membranes"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   806   C0123400:Immobilon P [Organic Chemical]
   760   C0025255:Membranes [Tissue]
   760   C0063412:Immobilon [Organic Chemical,Pharmacologic Substance]
   760   C0348011:transferred [Functional Concept]
   726 E C0040671:Transfer [Mental Process]
   726 E C0596901:Membrane [Cell Component]
   726 E C1705822:Transfer [Activity]
   726 E C1706182:Membrane [Manufactured Object]

Phrase: "(Millipore,"

Phrase: "Bedford,"

Phrase: "MA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "probed with an anti-human polyclonal APOE antibody"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   767   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0086418:Human [Human]
   744   C0523511:APOE [Laboratory Procedure]
   744   C1412481:APOE [Gene or Genome]
   711   C0182400:Probe [Medical Device]
   711   C1704681:Probe [Gene or Genome]
   711   C2347609:Probe [Chemical Viewed Functionally]
   711   C3536729:Probe [Manufactured Object]

Phrase: "(Calbiochem,"

Phrase: "LaJolla,"

Phrase: "CA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "followed by an HRP-conjugated secondary antibody"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0019941:HRP [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0027627:secondary [Neoplastic Process]
   748   C0175668:Secondary [Temporal Concept]
   748   C0205436:Secondary [Quantitative Concept]
   748   C0522529:Conjugated [Spatial Concept]
   714 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ECL (Pierce"

Phrase: ")"

Phrase: "on film."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086296:Film [Manufactured Object]
  1000   C1561571:film [Biomedical or Dental Material]
  1000   C1561572:film [Substance]
Processing 00000000.tx.288: This APOE antibody has been used extensively to detect human APOE in mouse by immunohistochemistry, western blotting and ELISA (26,46,51,52). 

Phrase: "This APOE antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "extensively to"

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "human APOE in mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0523511:APOE [Laboratory Procedure]
   770   C1412481:APOE [Gene or Genome]

Phrase: "by immunohistochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "ELISA (26,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014441:ELISA [Laboratory Procedure]

Phrase: "46,"

Phrase: "51,"

Phrase: "52"

Phrase: ")."
Processing 00000000.tx.289: APOE protein levels in serum and tissue were quantitated by calculating the intensity of the sample relative to that of the standard of the same concentration. 

Phrase: "APOE protein levels in serum"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   797   C0036825:Serum protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1304893:Protein.serum [Laboratory or Test Result]
   773   C0428479:Protein level [Laboratory or Test Result]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "were"

Phrase: "quantitated by calculating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441506:Calculating [Activity]

Phrase: "the intensity of the sample"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0522510:Intensity [Qualitative Concept]

Phrase: "relative to that of the standard of the same concentration."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0080103:Relative [Family Group]
   739   C0205345:Relative [Qualitative Concept]
   739   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.290: ImageQuant software was used in the analysis of protein abundance. 

Phrase: "ImageQuant software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "was"

Phrase: "used in the analysis of protein abundance."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   774   C1514534:Protein Analysis [Molecular Biology Research Technique]
   757   C1524063:Use of [Functional Concept]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0936012:Analysis [Research Activity]
   748   C1273517:used [Finding]
   748   C1524024:analysis [Functional Concept]
   748   C2346714:Abundance [Qualitative Concept]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.291: The levels of APOE from unfractionated serum were determined by loading equal concentrations of protein from fasted serum samples (diluted in PBS) onto BisTris gels (under non-reducing conditions) and following the same analytical paradigm as for tissues. 

Phrase: "The levels of APOE"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "from unfractionated serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "were"

Phrase: "determined by loading equal concentrations of protein"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   757   C0427716:Protein concentration [Laboratory Procedure]
   757   C1304757:Protein concentration [Laboratory or Test Result]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0086045:Concentrations [Mental Process]
   748   C0205163:Equal [Qualitative Concept]
   748   C1549782:Equal [Idea or Concept]
   748   C1708715:Loading [Activity]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "from fasted serum samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0444266:Serum sample [Body Substance]
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]

Phrase: "("

Phrase: "diluted in PBS)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756   C1720119:Dilute [Functional Concept]
   756   C1948037:Dilute [Functional Concept]

Phrase: "onto BisTris gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0017243:Gels [Biomedical or Dental Material]
   827 E C1382104:Gel [Substance]

Phrase: "("

Phrase: "under non-reducing conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: ")"

Phrase: "and"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the same analytical paradigm as for tissues."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0681797:paradigm [Research Activity]
Processing 00000000.tx.292: APOE in serum fractionated by FPLC was analyzed qualitatively by combining equal volumes from the peak fraction, and 2 volumes above and below for each lipoprotein class. 

Phrase: "APOE in serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0523511:APOE [Laboratory Procedure]
   790   C1412481:APOE [Gene or Genome]

Phrase: "fractionated by FPLC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0599209:FPLC [Laboratory Procedure]
   790   C1979893:Fractionated [Qualitative Concept]

Phrase: "was"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "qualitatively by combining equal volumes"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0205163:Equal [Qualitative Concept]
   760   C0449468:volumes [Quantitative Concept]
   760   C1549782:Equal [Idea or Concept]
   726   C0336789:Combine [Manufactured Object]
   726 E C1690016:% volume [Qualitative Concept]
   726 E C1705102:Volume [Intellectual Product]
   726 E C2700258:Volume [Laboratory Procedure]

Phrase: "from the peak fraction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "2 volumes above"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   841   C0808397:Volume 2 [Quantitative Concept]
   790   C0449468:volumes [Quantitative Concept]
   756 E C1690016:% volume [Qualitative Concept]
   756 E C1705102:Volume [Intellectual Product]
   756 E C2700258:Volume [Laboratory Procedure]

Phrase: "and below"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1515981:And [Idea or Concept]

Phrase: "for each lipoprotein class."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456387:Class [Intellectual Product]
   861   C1705943:Class [Classification]
Processing 00000000.tx.293: APOE was detected using the same human-specific APOE antibody and visualized by ECL using film. 

Phrase: "APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same human-specific APOE antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "visualized by ECL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0234621:Visualized [Functional Concept]
   790   C1332684:ECL [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "film."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086296:Film [Manufactured Object]
  1000   C1561571:film [Biomedical or Dental Material]
  1000   C1561572:film [Substance]
Processing 00000000.tx.294: The relative levels of holo APP were determined using brain homogenates prepared in 6M urea (as mentioned earlier). 

Phrase: "The relative levels of holo APP"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "brain homogenates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "prepared in 6M urea"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0041942:Urea [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   770   C3171719:6M [Quantitative Concept]
   737   C1521827:Prepare [Functional Concept]
   715 E C0728794:Ureaphil [Organic Chemical,Pharmacologic Substance]

Phrase: "("

Phrase: "as"

Phrase: "mentioned"

Phrase: "earlier"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.295: Equal concentrations of protein from every sample were loaded onto 7% Trisacetate gels (Invitrogen) and run according to the manufacturer's instructions. 

Phrase: "Equal concentrations of protein"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   802   C0427716:Protein concentration [Laboratory Procedure]
   802   C1304757:Protein concentration [Laboratory or Test Result]
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "from every sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "loaded onto 7% Trisacetate gels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0017243:Gels [Biomedical or Dental Material]
   760   C1708715:Loaded [Activity]
   726 E C1382104:Gel [Substance]
   726 E C1550025:Load [Idea or Concept]
   726 E C1704782:Load [Manufactured Object]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "and"

Phrase: "run according to the manufacturer's instructions."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0035953:run [Daily or Recreational Activity]
   753   C0600140:run [Finding]
   753   C1704688:Run [Functional Concept]
   753   C2346414:Run [Finding]
Processing 00000000.tx.296: A linear standard curve of a serially diluted homogenate from a B6 non-transgenic animal was run on every gel to normalize across gels (R20.90). 

Phrase: "A linear standard curve of a serially diluted homogenate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205134:Curve [Spatial Concept]

Phrase: "from a B6 non-transgenic animal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003069:Transgenic Animal [Animal]
   812   C0003062:Animal [Animal]

Phrase: "was"

Phrase: "run on"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0035953:run [Daily or Recreational Activity]
   861   C0600140:run [Finding]
   861   C1704688:Run [Functional Concept]
   861   C2346414:Run [Finding]

Phrase: "every gel to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]

Phrase: "normalize across gels"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0017243:Gels [Biomedical or Dental Material]
   790   C1882115:Normalize [Research Activity]
   756 E C1382104:Gel [Substance]

Phrase: "(R20.90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.297: Protein was transferred as mentioned earlier and the membranes were probed with a C-terminal antibody to human APP (369, gift of Sam Gandy, Thomas Jefferson University). 

Phrase: "Protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "as"

Phrase: "mentioned"

Phrase: "earlier"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]

Phrase: "and"

Phrase: "the membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "probed with a C-terminal antibody"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C1707271:C-Terminal [Amino Acid Sequence]
   783   C0368815:antibody c [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0205088:Terminal [Temporal Concept]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]
   719   C0182400:Probe [Medical Device]
   719   C1704681:Probe [Gene or Genome]
   719   C2347609:Probe [Chemical Viewed Functionally]
   719   C3536729:Probe [Manufactured Object]

Phrase: "to human APP (369,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0086418:Human [Human]
   827   C3538722:APP [Laboratory Procedure]

Phrase: "gift of Sam Gandy,"

Phrase: "Thomas Jefferson University"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: ")."
Processing 00000000.tx.298: The intensity of the APP protein band was determined by ECL detected using a Fluor-S Max imaging machine (BioRad, Hercules, CA, USA) and quantitated by Quantity-one software (BioRad). 

Phrase: "The intensity of the APP protein band"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0522510:Intensity [Qualitative Concept]

Phrase: "was"

Phrase: "determined by ECL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1332684:ECL [Gene or Genome]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Fluor-S Max imaging machine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0336779:Machine [Manufactured Object]

Phrase: "(BioRad,"

Phrase: "Hercules,"

Phrase: "CA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "quantitated by Quantity-one software"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0037585:Software [Intellectual Product,Manufactured Object]
   760   C0205447:One [Quantitative Concept]
   760   C1265611:Quantity [Quantitative Concept]
   760   C1554108:Quantity [Intellectual Product]
   760   C1561573:Quantity [Intellectual Product]

Phrase: "(BioRad"

Phrase: ")."
Processing 00000000.tx.299: APP CTFs were determined from the same extracts run on 412% BisTris gradient gels (as mentioned earlier) using the 369 antibody. 

Phrase: "APP CTFs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C1707271:C-Terminal [Amino Acid Sequence]
   812   C0205088:Terminal [Temporal Concept]
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   812   C1705314:Terminal [Manufactured Object]
   812   C1705315:Terminal [Spatial Concept]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "determined from the same extracts run on 412% BisTris gradient gels"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   738   C0017243:Gels [Biomedical or Dental Material]
   738   C0035953:run [Daily or Recreational Activity]
   738   C0053809:Bis-Tris [Organic Chemical]
   738   C0439182:% gradient [Quantitative Concept]
   738   C0445247:Same [Qualitative Concept]
   738   C0600140:run [Finding]
   738   C0812409:Gradient [Quantitative Concept]
   738   C1704688:Run [Functional Concept]
   738   C2346414:Run [Finding]
   704 E C1382104:Gel [Substance]
   704   C2828366:Extract [Substance]

Phrase: "("

Phrase: "as"

Phrase: "mentioned"

Phrase: "earlier"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 369 antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.300: Quantitation was carried out on film as mentioned earlier. 

Phrase: "Quantitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantitation [Quantitative Concept]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out on film"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0086296:Film [Manufactured Object]
   790   C0439787:Out [Spatial Concept]
   790   C0849355:Out [Qualitative Concept]
   790   C1561571:film [Biomedical or Dental Material]
   790   C1561572:film [Substance]

Phrase: "as"

Phrase: "mentioned"

Phrase: "earlier."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]
Processing 00000000.tx.301: ELISA Levels of human APOE in brain were measured by a human-specific APOE ELISA (MBL International) according to the manufacturer's instructions. 

Phrase: "ELISA Levels of human APOE"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "measured by a human-specific APOE ELISA (MBL"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   744   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0014441:ELISA [Laboratory Procedure]
   744   C0086418:Human [Human]
   744   C0205369:Specific [Qualitative Concept]
   744   C0444706:Measured [Qualitative Concept]
   744   C0523511:APOE [Laboratory Procedure]
   744   C1412481:APOE [Gene or Genome]
   744   C1552740:specific [Intellectual Product]
   744   C3541902:MEASURED [Diagnostic Procedure]
   711 E C0079809:Measure [Quantitative Concept]
   711 E C0242485:Measure [Functional Concept]

Phrase: "International"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512888:International [Idea or Concept]

Phrase: ")"

Phrase: "according to the manufacturer's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.302: Homogenates made in 1% CHAPS (as mentioned earlier) were run in duplicate and detected using the PanAPOE antibody. 

Phrase: "Homogenates"

Phrase: "made in 1% CHAPS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0047101:CHAPS [Pharmacologic Substance,Steroid]
   737 E C0950540:chap [Therapeutic or Preventive Procedure]
   737   C1881534:Make [Functional Concept]

Phrase: "("

Phrase: "as"

Phrase: "mentioned"

Phrase: "earlier"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]

Phrase: ")"

Phrase: "were"

Phrase: "run in duplicate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205173:Duplicate [Functional Concept]
   827   C3539942:Duplicate [Intellectual Product]
   734   C3274438:RUN-IN [Temporal Concept]

Phrase: "and"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the PanAPOE antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.303: Standard curves of recombinant E2, E3 and E4 were run in duplicate on the same plate. 

Phrase: "Standard curves of recombinant E2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0205134:Curve [Spatial Concept]

Phrase: "E3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1537525:E3 [Gene or Genome]

Phrase: "and"

Phrase: "E4"

Phrase: "were"

Phrase: "run in duplicate on the same plate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205173:Duplicate [Functional Concept]
   748   C3539942:Duplicate [Intellectual Product]
Processing 00000000.tx.304: Levels of APOE were determined using the standard curve for each respective isoform. 

Phrase: "Levels of APOE"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0441889:Levels [Qualitative Concept]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the standard curve for each respective isoform."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205134:Curve [Spatial Concept]
Processing 00000000.tx.305: Levels of A140 were measured by a human-specific A140 ELISA (Biosource International) according to the manufacturer's instructions. 

Phrase: "Levels of A140"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0441889:Levels [Qualitative Concept]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "measured by a human-specific A140 ELISA (Biosource"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   744   C0014441:ELISA [Laboratory Procedure]
   744   C0086418:Human [Human]
   744   C0205369:Specific [Qualitative Concept]
   744   C0444706:Measured [Qualitative Concept]
   744   C1552740:specific [Intellectual Product]
   744   C3541902:MEASURED [Diagnostic Procedure]
   711 E C0079809:Measure [Quantitative Concept]
   711 E C0242485:Measure [Functional Concept]

Phrase: "International"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512888:International [Idea or Concept]

Phrase: ")"

Phrase: "according to the manufacturer's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.306: Half-brains were homogenized in 5M guanidine100mM Tris pH 8.0 and incubated at room temperature for 3.54h to ensure complete protein extraction. 

Phrase: "Half-brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "homogenized in 5M guanidine100mM Tris pH 8.0"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0020283:[pH] [Quantitative Concept]
   744   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   744   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   744   C0450407:ph+ [Finding]
   744   C0450408:ph++ [Finding]
   744   C0450409:ph+++ [Finding]
   744   C0814229:TRI [Intellectual Product]

Phrase: "and"

Phrase: "incubated at room temperature"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1547703:Room [Spatial Concept]

Phrase: "for 3.54h to"

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "complete protein extraction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185115:Extraction [Therapeutic or Preventive Procedure]
   827   C0684295:extraction [Laboratory Procedure]
Processing 00000000.tx.307: Samples were diluted in standard/sample buffer and centrifuged before loaded in triplicate onto the ELISA plate. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "diluted in standard/sample buffer"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0370003:Sample [Substance]
   760   C1442989:Standard [Qualitative Concept]
   760   C2347026:Sample [Conceptual Entity]
   760   C2828392:Standard [Intellectual Product]
   726   C1720119:Dilute [Functional Concept]
   726   C1948037:Dilute [Functional Concept]

Phrase: "and"

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "before"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332152:Before [Temporal Concept]
  1000   C1705850:Before [Intellectual Product]

Phrase: "loaded in triplicate"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205174:Triplicate [Quantitative Concept]
   790   C1708715:Loaded [Activity]
   756 E C1550025:Load [Idea or Concept]
   756 E C1704782:Load [Manufactured Object]

Phrase: "onto the ELISA plate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005971:Plate [Medical Device]
   861   C1139930:plate [Medical Device]
   861   C3537155:Plate [Manufactured Object]
Processing 00000000.tx.308: Statistics Statistical analysis was carried out using Prism Graphpad software (San Diego, CA, USA). 

Phrase: "Statistics Statistical analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   871   C0871424:statistical analysis [Research Activity]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Prism Graphpad software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.309: The specific test used for each analysis is indicated in the appropriate figure legend.  

Phrase: "The specific test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]

Phrase: "used for each analysis"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1273517:used [Finding]
   770   C1524024:analysis [Functional Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "is"

Phrase: "indicated in the appropriate figure legend."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1444656:Indicated [Finding]
   753   C1548787:Appropriate [Qualitative Concept]
   753   C2729544:Legend [Pharmacologic Substance]
Processing 00000000.tx.310: ACKNOWLEDGEMENTS  The authors acknowledge Minesuke Yokoyama, Rika Migishima, Yoshiko Motegi, Yoko Nakahara, Aya Takeshita and Mariko Kobayashi who were all involved in the initial generation of the APOE 2, 3 and 4 KI animals. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "acknowledge"

Phrase: "Minesuke Yokoyama,"

Phrase: "Rika Migishima,"

Phrase: "Yoshiko Motegi,"

Phrase: "Yoko Nakahara,"

Phrase: "Aya Takeshita"

Phrase: "and"

Phrase: "Mariko Kobayashi"

Phrase: "who"

Phrase: "were"

Phrase: "all"

Phrase: "involved in the initial generation of the APOE 2,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0052198:Apo E-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0079411:Generation [Temporal Concept]
   742   C0205265:Initial [Temporal Concept]
   742   C0523511:APOE [Laboratory Procedure]
   742   C1279901:Initial [Qualitative Concept]
   742   C1314939:Involved [Functional Concept]
   742   C1412481:APOE [Gene or Genome]
   742   C1555582:Initial [Idea or Concept]
   742   C1705685:INITIAL [Functional Concept]
   742   C3146294:Generation [Activity]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "4 KI animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]
Processing 00000000.tx.311: We thank Sam Gandy (Thomas Jefferson University) for providing the 369 APP antibody and Barbara Knowles (Jackson Labs) for the Zp3-Cre animals. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Sam Gandy (Thomas Jefferson University"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0041740:University [Manufactured Object,Organization]

Phrase: ")"

Phrase: "for providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "the 369 APP antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "Barbara Knowles"

Phrase: "(Jackson Labs"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1515351:Jackson Labs [Health Care Related Organization]
   861   C0587081:Labs [Finding]
   827 E C0022877:Lab [Manufactured Object,Organization]
   789 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: ")"

Phrase: "for the Zp3-Cre animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]
Processing 00000000.tx.312: We also thank the Ireland Cancer Center of the University Hospitals, Cleveland, Ohio for the use of their equipment. 

Phrase: "We also"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "the Ireland Cancer Center of the University Hospitals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1513817:Cancer Center [Health Care Related Organization]
   744   C0205099:Center [Spatial Concept]

Phrase: "Cleveland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454845:Cleveland [Geographic Area]

Phrase: "Ohio for the use of their equipment."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0028905:Ohio [Geographic Area]
Processing 00000000.tx.313: This work was supported by in part by NIH training grant GM08613 (K.M.M.); 

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1521721:Supported [Conceptual Entity]
   799 E C0183683:Support [Medical Device]

Phrase: "in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "by NIH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027468:NIH [Health Care Related Organization]

Phrase: "training"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
  1000   C0040607:Training [Educational Activity]
  1000   C0220931:Training [Educational Activity]
  1000   C2673163:training [Qualitative Concept]
   966 E C0336809:Train [Manufactured Object]
   966 E C1552514:Train [Manufactured Object]
   928 E C0009647:Conditioned [Mental Process]
   928 E C0012634:condition [Disease or Syndrome]
   928 E C0348080:Condition [Qualitative Concept]
   928 E C1705253:Condition [Conceptual Entity]

Phrase: "grant GM08613"

Phrase: "(K.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "M."

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.314: NIH grant R01 AG14451, Alzheimer's Association grant IIRG-02-3750 and an American Health Assistance Founding Grant (B.T.L.); 

Phrase: "NIH grant R01 AG14451,"

Phrase: "Alzheimer's Association grant IIRG-02-3750"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0004083:Association [Mental Process]
   799   C0018173:Grant [Quantitative Concept]
   799   C0439849:Association [Qualitative Concept]
   799   C0596306:Association [Phenomenon or Process]
   799   C0699792:association [Social Behavior]
   799   C1548284:Grant [Idea or Concept]

Phrase: "and"

Phrase: "an American Health Assistance Founding Grant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0018173:Grant [Quantitative Concept]
   804   C1548284:Grant [Idea or Concept]

Phrase: "(B.T.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1538923:B'-T [Gene or Genome]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.315: the University Memory and Aging Center (P50 AG08012); 

Phrase: "the University Memory"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025260:Memory [Mental Process]
   861   C0700327:memory [Finding]
   861   C1706377:Memory [Manufactured Object]
   805 E C0679055:mnemonic [Mental Process]

Phrase: "and"

Phrase: "Aging Center"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205099:Center [Spatial Concept]

Phrase: "(P50 AG08012"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.316: the Ireland Cancer Center (CA 43703) and NIH grant R01 HL32868 (D.L.W.).  

Phrase: "the Ireland Cancer Center"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1513817:Cancer Center [Health Care Related Organization]
   827   C0205099:Center [Spatial Concept]

Phrase: "(CA 43703"

Phrase: ")"

Phrase: "and"

Phrase: "NIH grant R01 HL32868"

Phrase: "("

Phrase: "D."

Phrase: "L.W."

Phrase: ")."
Processing 00000000.tx.317: FOOTNOTES  * To whom correspondence should be addressed at: Department of Genetics, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106-4955, USA. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed at"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0376649:Address [Intellectual Product]
   799   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Department of Genetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0587466:Genetics department [Health Care Related Organization]
   790   C1704729:Department [Organization]

Phrase: "Case Western Reserve University,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0041740:University [Manufactured Object,Organization]
   812   C0868928:Case [Functional Concept]
   812   C1705493:Western [Spatial Concept]
   812   C1706255:CASE [Medical Device]
   812   C1706256:Case [Conceptual Entity]
   812   C2347957:Reserve [Activity]

Phrase: "10900 Euclid Avenue,"

Phrase: "Cleveland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454845:Cleveland [Geographic Area]

Phrase: "OH 44106-4955,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0220853:OH- [Element, Ion, or Isotope]

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.318: Tel: +1 2163682979; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+1 2163682979"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.319: Fax: +1 2163683432; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+1 2163683432"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.320: Email: btl{at}cwru.edu  REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Weisgraber, K.H., Innerarity, T.L. and Mahley, R.W. 

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "btl{at}cwru.edu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Weisgraber,"

Phrase: "K.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Innerarity,"

Phrase: "T.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Mahley,"

Phrase: "R.W."
Processing 00000000.tx.321: (1982) Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteinearginine interchange at a single site. 

Phrase: "(1982"

Phrase: ")"

Phrase: "Abnormal lipoprotein receptor-binding activity of the human E apoprotein"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   777   C1152818:lipoprotein receptor activity [Molecular Function]
   760   C2266866:Binding Activity [Molecular Function]
   757   C0020115:Human Activity [Activity]
   757   C1152633:receptor activity [Molecular Function]
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1561536:*Activity [Idea or Concept]

Phrase: "due to cysteinearginine interchange"

Phrase: "at a single site."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]
Processing 00000000.tx.322: J. 

Phrase: "J."
Processing 00000000.tx.323: Biol. 

Phrase: "Biol."
Processing 00000000.tx.324: Chem., 257, 25182521.[Free FullText] Dong, L.M., Parkin, S., Trakhanov, S.D., Rupp, B., Simmons, T., Arnold, K.S., Newhouse, Y.M., Innerarity, T.L. and Weisgraber, K.H. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "257,"

Phrase: "25182521."

Phrase: "[Free FullText"

Phrase: "] Dong,"

Phrase: "L.M.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Parkin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "S."

Phrase: ","

Phrase: "Trakhanov,"

Phrase: "S.D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Rupp,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Simmons,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Arnold,"

Phrase: "K.S.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Newhouse,"

Phrase: "Y."

Phrase: "M."

Phrase: ","

Phrase: "Innerarity,"

Phrase: "T.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Weisgraber,"

Phrase: "K.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.325: (1996) Novel mechanism for defective receptor binding of apolipoprotein E2 in type III hyperlipoproteinemia. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Novel mechanism for defective receptor binding of apolipoprotein E2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0441712:Mechanism [Functional Concept]
   742   C1706376:Mechanism [Manufactured Object]

Phrase: "in type III hyperlipoproteinemia."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020479:Hyperlipoproteinemia, Type III [Disease or Syndrome]
   827   C0020476:Hyperlipoproteinaemia [Disease or Syndrome]
   734   C0441731:Type III [Classification]
Processing 00000000.tx.326: Nat. 

Phrase: "Nat."
Processing 00000000.tx.327: Struct. 

Phrase: "Struct."
Processing 00000000.tx.328: Biol., 3, 718722.[ISI][Medline] Menzel, H.J., Kladetzky, R.G. and Assmann, G. 

Phrase: "Biol.,"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "718722."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Menzel,"

Phrase: "H.J.,"

Phrase: "Kladetzky,"

Phrase: "R.G."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0439267:g% [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Assmann,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.329: (1983) Apolipoprotein E polymorphism and coronary artery disease. 

Phrase: "(1983"

Phrase: ")"

Phrase: "Apolipoprotein E polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "coronary artery disease."
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
  1000   C0010054:coronary artery disease [Disease or Syndrome]
  1000   C0010068:Coronary (artery) disease [Disease or Syndrome]
           Coronary Disease
  1000   C1956346:Coronary Artery Disease [Disease or Syndrome]
   901   C0205042:Coronary artery [Body Part, Organ, or Organ Component]
   901   C0852949:artery disease [Disease or Syndrome]
   901   C1269008:Coronary artery [Body Part, Organ, or Organ Component]
   827   C0003842:Artery [Body Part, Organ, or Organ Component]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0018787:coronary [Body Part, Organ, or Organ Component]
   827   C0226004:artery [Body System]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C0221464:Arterial [Spatial Concept]
Processing 00000000.tx.330: Arteriosclerosis, 3, 310315.[Abstract] Stengard, J.H., Zerba, K.E., Pekkanen, J., Ehnholm, C., Nissinen, A. and Sing, C.F. 

Phrase: "Arteriosclerosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003850:Arteriosclerosis [Disease or Syndrome]
   928 E C0333477:Arteriosclerotic [Functional Concept]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "310315."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Stengard,"

Phrase: "J.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Zerba,"

Phrase: "K.E.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014441:ELISA [Laboratory Procedure]

Phrase: "Pekkanen,"

Phrase: "J.,"

Phrase: "Ehnholm,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Nissinen,"

Phrase: "A."

Phrase: "and"

Phrase: "Sing, C.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.331: (1995) Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Apolipoprotein E polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "predicts"

Phrase: "death from coronary heart disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0011065:Death [Organism Function]
   760   C1306577:Death, NOS [Finding]

Phrase: "in a longitudinal study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023981:Longitudinal Study [Research Activity]
   861   C0205127:Longitudinal [Spatial Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "of elderly Finnish men."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   896   C0524337:Elderly man [Age Group]
   827   C0025266:Men [Population Group]
   793 E C0024554:MAN [Finding]
   793 E C0086418:Man [Human]
Processing 00000000.tx.332: Circulation, 91, 265269.[Abstract/Free FullText] Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L. and Pericak-Vance, M.A. 

Phrase: "Circulation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005775:Circulation [Physiologic Function]
  1000   C1516559:Circulation [Organism Function]

Phrase: "91,"

Phrase: "265269."

Phrase: "[Abstract/Free FullText"

Phrase: "] Corder,"

Phrase: "E.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Saunders,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Strittmatter,"

Phrase: "W.J.,"

Phrase: "Schmechel,"

Phrase: "D."

Phrase: "E.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014441:ELISA [Laboratory Procedure]

Phrase: "Gaskell,"

Phrase: "P.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "G.W., Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0035853:Roses [Plant]
   793 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "Haines,"

Phrase: "J.L."

Phrase: "and"

Phrase: "Pericak-Vance,"

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.333: (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Gene dose of apolipoprotein E type 4 allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0178602:Dose [Quantitative Concept]
   744   C0869039:Dose [Quantitative Concept]
   744   C1114758:Dose # [Clinical Attribute]

Phrase: "and"

Phrase: "the risk of Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]

Phrase: "in late onset families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.334: Science, 261, 921923.[ISI][Medline] Strittmatter, W.J., Saunders, A.M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G.S. and Roses, A.D. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "261,"

Phrase: "921923."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Strittmatter,"

Phrase: "W.J.,"

Phrase: "Saunders,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Schmechel,"

Phrase: "D."

Phrase: ","

Phrase: "Pericak-Vance,"

Phrase: "M."

Phrase: ","

Phrase: "Enghild,"

Phrase: "J.,"

Phrase: "Salvesen,"

Phrase: "G.S."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086903:G S [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827790:g/s [Quantitative Concept]
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.335: (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Apolipoprotein E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014441:ELISA [Laboratory Procedure]

Phrase: ":"

Phrase: "high-avidity binding to beta-amyloid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C1149161:beta-amyloid binding [Molecular Function]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "increased frequency of type 4 allele"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0017270:Allele Frequency [Quantitative Concept]
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]

Phrase: "in late-onset familial Alzheimer disease."
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
  1000   C0338448:Late onset familial Alzheimer disease [Disease or Syndrome]
   924   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   884   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   853   C0277558:Familial disease [Disease or Syndrome]
   840   C0002395:Alzheimer's Disease [Disease or Syndrome]
   840   C1521724:Alzheimer's Disease [Pathologic Function]
   817 E C0344339:family disease [Finding]
   804   C0012634:Disease [Disease or Syndrome]
   804   C0015576:familial [Family Group]
   804   C0241888:Familial [Functional Concept]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
   733 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.336: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.337: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.338: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.339: USA, 90, 19771981.[Abstract] Corder, E.H., Saunders, A.M., Risch, N.J., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Jr, Rimmler, J.B., Locke, P.A., Conneally, P.M., Schmader, K.E. etal. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "19771981."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Corder,"

Phrase: "E.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Saunders,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Risch,"

Phrase: "N.J.,"

Phrase: "Strittmatter,"

Phrase: "W.J.,"

Phrase: "Schmechel,"

Phrase: "D."

Phrase: "E.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014441:ELISA [Laboratory Procedure]

Phrase: "Gaskell,"

Phrase: "P.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Rimmler,"

Phrase: "J.B.,"

Phrase: "Locke,"

Phrase: "P.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Conneally,"

Phrase: "P.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Schmader,"

Phrase: "K.E. etal."
Processing 00000000.tx.340: (1994) Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Protective effect of apolipoprotein E type 2 allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "for late onset Alzheimer disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.341: Nat. 

Phrase: "Nat."
Processing 00000000.tx.342: Genet., 7, 180184.[ISI][Medline] Bodovitz, S. and Klein, W.L. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "7,"

Phrase: "180184."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bodovitz,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Klein,"

Phrase: "W.L."
Processing 00000000.tx.343: (1996) Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "alpha-secretase cleavage of amyloid precursor protein."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0597304:Protein Cleavage [Molecular Function]
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]
Processing 00000000.tx.344: J. 

Phrase: "J."
Processing 00000000.tx.345: Biol. 

Phrase: "Biol."
Processing 00000000.tx.346: Chem., 271, 44364440.[Abstract/Free FullText] Frears, E.R., Stephens, D.J., Walters, C.E., Davies, H. and Austen, B.M. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "271,"

Phrase: "44364440."

Phrase: "[Abstract/Free FullText"

Phrase: "] Frears,"

Phrase: "E.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Stephens,"

Phrase: "D.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Walters,"

Phrase: "C.E.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014441:ELISA [Laboratory Procedure]

Phrase: "Davies,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Austen,"

Phrase: "B.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.347: (1999) The role of cholesterol in the biosynthesis of beta-amyloid. 

Phrase: "(1999"

Phrase: ")"

Phrase: "The role of cholesterol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in the biosynthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005572:biosynthesis [Functional Concept]
  1000   C0220781:Biosynthesis [Biologic Function]

Phrase: "of beta-amyloid."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2825879:Amyloid, Beta [Laboratory Procedure]
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.348: Neuroreport, 10, 16991705.[ISI][Medline] Simons, M., Keller, P., De Strooper, B., Beyreuther, K., Dotti, C.G. and Simons, K. 

Phrase: "Neuroreport,"

Phrase: "10,"

Phrase: "16991705."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Simons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443058:simons [Intellectual Product]

Phrase: "M."

Phrase: ","

Phrase: "Keller,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "De Strooper,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Dotti,"

Phrase: "C.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Simons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443058:simons [Intellectual Product]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.349: (1998) Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Cholesterol depletion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0151718:cholesterol depletion [Pathologic Function]
   861   C0333668:Depletion [Functional Concept]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the generation of beta-amyloid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079411:Generation [Temporal Concept]
   760   C3146294:Generation [Activity]

Phrase: "in hippocampal neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.350: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.351: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.352: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.353: USA, 95, 64606464.[Abstract/Free FullText] Runz, H., Rietdorf, J., Tomic, I., de Bernard, M., Beyreuther, K., Pepperkok, R. and Hartmann, T. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "95,"

Phrase: "64606464."

Phrase: "[Abstract/Free FullText"

Phrase: "] Runz,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rietdorf,"

Phrase: "J.,"

Phrase: "Tomic,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "de Bernard,"

Phrase: "M."

Phrase: ","

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Pepperkok,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Hartmann,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.354: (2002) Inhibition of intracellular cholesterol transport alters presenilin localization and amyloid precursor protein processing in neuronal cells. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Inhibition of intracellular cholesterol transport"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C2245629:inhibition of intracellular cholesterol transport [Cell Function]
   900   C2245634:inhibition of intracellular transport [Cell Function]
   891   C2245614:inhibition of cholesterol transport [Organism Function]
   844   C2259163:inhibition of transport [Cell Function]
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "presenilin localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "amyloid precursor protein processing in neuronal cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0033666:protein processing [Molecular Function]
   757   C0230625:cell processing [Cell Component]
   748   C1709694:Processing [Activity]
Processing 00000000.tx.355: J. 

Phrase: "J."
Processing 00000000.tx.356: Neurosci., 22, 16791689.[Abstract/Free FullText] Wahrle, S., Das, P., Nyborg, A.C., McLendon, C., Shoji, M., Kawarabayashi, T., Younkin, L.H., Younkin, S.G. and Golde, T.E. 

Phrase: "Neurosci.,"

Phrase: "22,"

Phrase: "16791689."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wahrle,"

Phrase: "S."

Phrase: ","

Phrase: "Das,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0051767:DAS [Organic Chemical,Pharmacologic Substance]
  1000   C0057671:DAS [Organic Chemical,Pharmacologic Substance]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Nyborg,"

Phrase: "A.C.,"

Phrase: "McLendon,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Shoji,"

Phrase: "M."

Phrase: ","

Phrase: "Kawarabayashi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Younkin,"

Phrase: "L.H.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2346686:L/h [Quantitative Concept]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Younkin,"

Phrase: "S.G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439267:g% [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Golde,"

Phrase: "T.E."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014441:ELISA [Laboratory Procedure]
Processing 00000000.tx.357: (2002) Cholesterol-dependent gamma-secretase activity in buoyant cholesterol-rich membrane microdomains. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Cholesterol-dependent gamma-secretase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "in buoyant cholesterol-rich membrane microdomains."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   840   C0887868:Membrane Microdomains [Cell Component]
Processing 00000000.tx.358: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.359: Dis., 9, 1123.[CrossRef][ISI][Medline] Refolo, L.M., Malester, B., LaFrancois, J., Bryant-Thomas, T., Wang, R., Tint, G.S., Sambamurti, K., Duff, K. and Pappolla, M.A. 

Phrase: "Dis.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]

Phrase: "9,"

Phrase: "1123."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Refolo,"

Phrase: "L.M.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Malester,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "LaFrancois,"

Phrase: "J.,"

Phrase: "Bryant-Thomas,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Wang,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Tint,"

Phrase: "G.S.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086903:G S [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827790:g/s [Quantitative Concept]
   861   C0439267:g% [Quantitative Concept]

Phrase: "Sambamurti,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Duff,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Pappolla,"

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.360: (2000) Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Hypercholesterolemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020443:Hypercholesterolaemia [Disease or Syndrome]
  1000   C1522133:Hypercholesterolemia [Finding]

Phrase: "accelerates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "the Alzheimer's amyloid pathology in a transgenic mouse model."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0030664:Pathology [Biomedical Occupation or Discipline]
   742   C0205469:pathology [Functional Concept]
   742   C0677042:pathology [Pathologic Function]
Processing 00000000.tx.361: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.362: Dis., 7, 321331.[CrossRef][ISI][Medline] Levin-Allerhand, J.A., Lominska, C.E. and Smith, J.D. 

Phrase: "Dis.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]

Phrase: "7,"

Phrase: "321331."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Levin-Allerhand,"

Phrase: "J."

Phrase: "A.,"

Phrase: "Lominska,"

Phrase: "C.E."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014441:ELISA [Laboratory Procedure]

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "J.D."
Processing 00000000.tx.363: (2002) Increased amyloid-levels in APPSWE transgenic mice treated chronically with a physiological high-fat high-cholesterol diet. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Increased amyloid-levels in APPSWE transgenic mice"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "chronically with a physiological high-fat high-cholesterol diet."
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   784   C0521974:Diet, High-Fat [Therapeutic or Preventive Procedure]
   762   C0301585:Fat diet [Therapeutic or Preventive Procedure]
   762   C1522133:high cholesterol [Finding]
   742   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   742   C0012155:Diet [Food]
   742   C0205250:High [Qualitative Concept]
   742   C0205463:Physiological [Functional Concept]
   742   C0424612:FAT [Organism Attribute]
   742   C1299351:High [Qualitative Concept]
   742   C1442959:Diet [Organism Function]
   742   C1519433:DIET [Therapeutic or Preventive Procedure]
   742   C2700149:HIGH [Intellectual Product]
   742   C2983588:DIET [Food]
   726   C0008395:Cholesterol, Dietary [Steroid]
   726 E C0012171:Dietary Fat [Food]
   726 E C1527016:Dietary Fat [Research Activity]
Processing 00000000.tx.364: J. 

Phrase: "J."
Processing 00000000.tx.365: Nutr. 

Phrase: "Nutr."
Processing 00000000.tx.366: Health Aging, 6, 315319.[Medline] Austen, B., Christodoulou, G. and Terry, J.E. 

Phrase: "Health Aging,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   964   C2963171:Healthy Aging [Group Attribute]
   861   C0001811:Ageing [Organism Function]

Phrase: "6,"

Phrase: "315319."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Austen,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Christodoulou,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Terry,"

Phrase: "J.E."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014441:ELISA [Laboratory Procedure]
Processing 00000000.tx.367: (2002) Relation between cholesterol levels, statins and Alzheimer's disease in the human population. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Relation between cholesterol levels,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0080103:Relation [Family Group]
   770   C0869014:relation [Social Behavior]

Phrase: "statins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0360714:Statins [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "Alzheimer's disease in the human population."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   753   C0012634:Disease [Disease or Syndrome]
Processing 00000000.tx.368: J. 

Phrase: "J."
Processing 00000000.tx.369: Nutr. 

Phrase: "Nutr."
Processing 00000000.tx.370: Health Aging, 6, 377382.[Medline] Ishii, K., Tokuda, T., Matsushima, T., Miya, F., Shoji, S., Ikeda, S. and Tamaoka, A. 

Phrase: "Health Aging,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   964   C2963171:Healthy Aging [Group Attribute]
   861   C0001811:Ageing [Organism Function]

Phrase: "6,"

Phrase: "377382."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ishii,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tokuda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Matsushima,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Miya,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Shoji,"

Phrase: "S."

Phrase: ","

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Tamaoka,"

Phrase: "A."
Processing 00000000.tx.371: (2003) Pravastatin at 10 mg/day does not decrease plasma levels of either amyloid-beta (Abeta) 40 or Abeta 42 in humans. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Pravastatin at 10 mg/day"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085542:Pravastatin [Organic Chemical,Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "plasma levels of either amyloid-beta (Abeta) 40"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   748   C0032105:Plasma [Body Substance]
   748   C0441889:Levels [Qualitative Concept]
   748   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "or"

Phrase: "Abeta 42 in humans."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   862   C2827504:Amyloid Beta 42 [Laboratory Procedure]
   806   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   797 E C2825879:Amyloid, Beta [Laboratory Procedure]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0086418:Humans [Human]
   760   C0330390:Beta [Plant]
   760   C0439096:Beta [Intellectual Product]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C2004068:Beta [Qualitative Concept]
Processing 00000000.tx.372: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.373: Lett., 350, 161164.[CrossRef][ISI][Medline] Tokuda, T., Tamaoka, A., Matsuno, S., Sakurai, S., Shimada, H., Morita, H. and Ikeda, S. 

Phrase: "Lett.,"

Phrase: "350,"

Phrase: "161164."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tokuda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tamaoka,"

Phrase: "A.,"

Phrase: "Matsuno,"

Phrase: "S."

Phrase: ","

Phrase: "Sakurai,"

Phrase: "S."

Phrase: ","

Phrase: "Shimada,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Morita,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.374: (2001) Plasma levels of amyloid beta proteins did not differ between subjects taking statins and those not taking statins. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Plasma levels of amyloid beta proteins"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   783   C0032120:Plasma Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767 E C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767 E C1168405:protein plasma [Laboratory Procedure]
   753   C0032105:Plasma [Body Substance]
   753   C0441889:Levels [Qualitative Concept]
   753   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   750   C0428479:Protein level [Laboratory or Test Result]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "differ between subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "taking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515187:Take [Health Care Activity]

Phrase: "statins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0360714:Statins [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "those"

Phrase: "not taking statins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0360714:Statins [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.375: Ann. 

Phrase: "Ann."
Processing 00000000.tx.376: Neurol., 49, 546547.[CrossRef][ISI][Medline] Pappolla, M.A., Bryant-Thomas, T.K., Herbert, D., Pacheco, J., Fabra Garcia, M., Manjon, M., Girones, X., Henry, T.L., Matsubara, E., Zambon, D. etal. 

Phrase: "Neurol.,"

Phrase: "49,"

Phrase: "546547."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pappolla,"

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bryant-Thomas,"

Phrase: "T.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Herbert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331828:Herbert [Health Care Related Organization]

Phrase: "D."

Phrase: ","

Phrase: "Pacheco,"

Phrase: "J.,"

Phrase: "Fabra Garcia,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0442999:Garcia [Intellectual Product]
   861   C1621797:Garcia [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Manjon,"

Phrase: "M."

Phrase: ","

Phrase: "Girones,"

Phrase: "X.,"

Phrase: "Henry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582517:henry [Quantitative Concept]

Phrase: "T.L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "Matsubara,"

Phrase: "E.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014441:ELISA [Laboratory Procedure]

Phrase: "Zambon,"

Phrase: "D. etal."
Processing 00000000.tx.377: (2003) Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Mild hypercholesterolemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020443:Hypercholesterolaemia [Disease or Syndrome]
   861   C1522133:Hypercholesterolemia [Finding]

Phrase: "is"

Phrase: "an early risk factor for the development of Alzheimer amyloid pathology."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0035648:Risk factor [Quantitative Concept]
   738   C0035647:Risk [Qualitative Concept]
   738   C1521761:Factor [Functional Concept]
   738   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.378: Neurology, 61, 199205.[Abstract/Free FullText] Kuo, Y.M., Emmerling, M.R., Bisgaier, C.L., Essenburg, A.D., Lampert, H.C., Drumm, D. and Roher, A.E. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "61,"

Phrase: "199205."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kuo,"

Phrase: "Y."

Phrase: "M."

Phrase: ","

Phrase: "Emmerling,"

Phrase: "M."

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Bisgaier,"

Phrase: "C.L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Essenburg,"

Phrase: "A.D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "Lampert,"

Phrase: "H.C.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Drumm,"

Phrase: "D."

Phrase: "and"

Phrase: "Roher,"

Phrase: "A.E."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014441:ELISA [Laboratory Procedure]
Processing 00000000.tx.379: (1998) Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 142 levels. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "low-density lipoprotein in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   753   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0178587:density [Quantitative Concept]
   753   C0205251:low [Qualitative Concept]
   753   C1299352:Low [Qualitative Concept]
   753   C1550472:low [Idea or Concept]

Phrase: "correlates with brain abeta 142 levels."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0441889:Levels [Qualitative Concept]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   753   C1420510:A-BETA [Gene or Genome]
   753   C1705543:ABETA [Gene or Genome]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.380: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.381: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.382: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.383: Commun., 252, 711715.[CrossRef][ISI][Medline] Tan, Z.S., Seshadri, S., Beiser, A., Wilson, P.W., Kiel, D.P., Tocco, M., D'Agostino, R.B. and Wolf, P.A. 

Phrase: "Commun.,"

Phrase: "252,"

Phrase: "711715."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tan,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302595:tan [Individual Behavior]
  1000   C1537110:Tan [Clinical Attribute]
  1000   C3275241:Tan [Qualitative Concept]

Phrase: "Z.S.,"

Phrase: "Seshadri,"

Phrase: "S."

Phrase: ","

Phrase: "Beiser,"

Phrase: "A.,"

Phrase: "Wilson,"

Phrase: "P.W., Kiel,"

Phrase: "D.P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1512024:D.P. [Intellectual Product]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Tocco,"

Phrase: "M."

Phrase: ","

Phrase: "D'"

Phrase: "Agostino,"

Phrase: "R.B."

Phrase: "and"

Phrase: "Wolf,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325001:Wolf [Mammal]

Phrase: "P.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.384: (2003) Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Plasma total cholesterol level as a risk factor"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   833   C1272107:Plasma total cholesterol level [Laboratory Procedure]
   770   C0201950:Total Cholesterol [Laboratory Procedure]
           cholesterol level
   770   C0428466:Cholesterol level [Laboratory or Test Result]
   770   C0543421:Total cholesterol [Steroid]
   767   C0858034:cholesterol plasma [Laboratory Procedure]
   767 E C1442946:Cholesterol.total [Laboratory or Test Result]
   744   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   744   C0032105:Plasma [Body Substance]
   744   C0439175:% total [Quantitative Concept]
   744   C0439810:Total [Qualitative Concept]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "for Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "the Framingham Study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.385: Arch. 

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.386: Intern. 

Phrase: "Intern."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1144859:INTERN [Professional or Occupational Group]
Processing 00000000.tx.387: Med., 163, 10531057.[Abstract/Free FullText] Mann, D.M., Iwatsubo, T., Pickering-Brown, S.M., Owen, F., Saido, T.C. and Perry, R.H. 

Phrase: "Med.,"

Phrase: "163,"

Phrase: "10531057."

Phrase: "[Abstract/Free FullText"

Phrase: "] Mann,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Pickering-Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "S.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Owen,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Saido,"

Phrase: "T.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Perry,"

Phrase: "R.H."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0205090:R- [Spatial Concept]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.388: (1997) Preferential deposition of amyloid beta protein (Abeta) in the form Abeta40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Preferential deposition of amyloid beta protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0011560:Amyloid deposition [Pathologic Function]
   783   C0333584:Protein deposition [Pathologic Function]
   783   C1705760:Amyloid Deposition [Finding]
   753   C0333562:Deposition [Functional Concept]

Phrase: "(Abeta"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2004068:Beta [Qualitative Concept]

Phrase: ")"

Phrase: "in the form Abeta40"

Phrase: "in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "associated with a gene dosage effect of the apolipoprotein E E4 allele."
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   767   C3642141:Apolipoprotein E4 Allele [Gene or Genome]
   753   C0178655:Gene Dosage [Quantitative Concept]
   753   C0332281:Associated with [Qualitative Concept]
           Associated
   751   C0003592:Apolipoprotein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   751   C0052201:Apolipoprotein E4 [Amino Acid, Peptide, or Protein]
   751   C1445865:Apolipoprotein gene [Gene or Genome]
   736   C0002085:Allele [Gene or Genome]
           allelic gene
   736   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0014441:ELISA [Laboratory Procedure]
   736   C0017337:Gene [Gene or Genome]
   736   C0178602:Dosage [Quantitative Concept]
   736   C1280500:Effect [Qualitative Concept]
   736   C2348382:Effect [Qualitative Concept]
   703 E C0750490:Associate [Idea or Concept]
   703 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.389: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.390: Lett., 221, 8184.[CrossRef][ISI][Medline] Morishima-Kawashima, M., Oshima, N., Ogata, H., Yamaguchi, H., Yoshimura, M., Sugihara, S. and Ihara, Y. 

Phrase: "Lett.,"

Phrase: "221,"

Phrase: "8184."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Morishima-Kawashima,"

Phrase: "M."

Phrase: ","

Phrase: "Oshima,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Ogata,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yamaguchi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yoshimura,"

Phrase: "M."

Phrase: ","

Phrase: "Sugihara,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Ihara,"

Phrase: "Y."
Processing 00000000.tx.391: (2000) Effect of apolipoprotein E allele epsilon4 on the initial phase of amyloid beta-protein accumulation in the human brain. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Effect of apolipoprotein E allele epsilon4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on the initial phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]

Phrase: "of amyloid beta-protein accumulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0078939:Amyloid beta-Protein [Amino Acid, Peptide, or Protein]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "in the human brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.392: Am. 

Phrase: "Am."
Processing 00000000.tx.393: J. 

Phrase: "J."
Processing 00000000.tx.394: Pathol., 157, 20932099.[Abstract/Free FullText] Carter, D.B., Dunn, E., McKinley, D.D., Stratman, N.C., Boyle, T.P., Kuiper, S.L., Oostveen, J.A., Weaver, R.J., Boller, J.A. and Gurney, M.E. 

Phrase: "Pathol.,"

Phrase: "157,"

Phrase: "20932099."

Phrase: "[Abstract/Free FullText"

Phrase: "] Carter,"

Phrase: "D."

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Dunn,"

Phrase: "E.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014441:ELISA [Laboratory Procedure]

Phrase: "McKinley,"

Phrase: "D.D.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0112081:D-D [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Stratman,"

Phrase: "N.C.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2349138:N/C [Quantitative Concept]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "Boyle,"

Phrase: "T.P.,"

Phrase: "Kuiper,"

Phrase: "S.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439394:s l [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Oostveen,"

Phrase: "J."

Phrase: "A.,"

Phrase: "Weaver,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326812:Weaver [Bird]

Phrase: "R.J.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Boller,"

Phrase: "J."

Phrase: "A."

Phrase: "and"

Phrase: "Gurney,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150789:gurney [Medical Device]
  1000   C0183644:Gurney [Medical Device]

Phrase: "M."

Phrase: "E."
Processing 00000000.tx.395: (2001) Human apolipoprotein E4 accelerates beta-amyloid deposition in APPsw transgenic mouse brain. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Human apolipoprotein E4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "accelerates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "beta-amyloid deposition in APPsw transgenic mouse brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0011560:Amyloid deposition [Pathologic Function]
   770   C1705760:Amyloid Deposition [Finding]
   744   C0333562:Deposition [Functional Concept]
Processing 00000000.tx.396: Ann. 

Phrase: "Ann."
Processing 00000000.tx.397: Neurol., 50, 468475.[CrossRef][ISI][Medline] Holtzman, D.M., Bales, K.R., Wu, S., Bhat, P., Parsadanian, M., Fagan, A.M., Chang, L.K., Sun, Y. and Paul, S.M. 

Phrase: "Neurol.,"

Phrase: "50,"

Phrase: "468475."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Holtzman,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "Bales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2826220:BALE [Quantitative Concept]

Phrase: "K.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "S."

Phrase: ","

Phrase: "Bhat,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Parsadanian,"

Phrase: "M."

Phrase: ","

Phrase: "Fagan,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Chang,"

Phrase: "L.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "Y."

Phrase: "and"

Phrase: "Paul,"

Phrase: "S.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.398: (1999) Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Expression of human apolipoprotein E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "reduces"

Phrase: "amyloid-beta deposition in a mouse model of Alzheimer's disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0011560:Amyloid deposition [Pathologic Function]
   757   C1705760:Amyloid Deposition [Finding]
   739   C0333562:Deposition [Functional Concept]
Processing 00000000.tx.399: J. 

Phrase: "J."
Processing 00000000.tx.400: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.401: Invest., 103, R15R21.[ISI][Medline] Lesuisse, C., Xu, G., Anderson, J., Wong, M., Jankowsky, J., Holtz, G., Gonzalez, V., Wong, P.C., Price, D.L., Tang, F. etal. 

Phrase: "Invest.,"

Phrase: "103,"

Phrase: "R15R21."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lesuisse,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Xu,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Anderson,"

Phrase: "J.,"

Phrase: "Wong,"

Phrase: "M."

Phrase: ","

Phrase: "Jankowsky,"

Phrase: "J.,"

Phrase: "Holtz,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Gonzalez,"

Phrase: "V.,"

Phrase: "Wong,"

Phrase: "P.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."

Phrase: "L., Tang,"

Phrase: "F. etal."
Processing 00000000.tx.402: (2001) Hyper-expression of human apolipoprotein E4 in astroglia and neurons does not enhance amyloid deposition in transgenic mice. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Hyper-expression of human apolipoprotein E4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0424295:HYPER [Finding]

Phrase: "in astroglia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astroglia [Cell]

Phrase: "and"

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "amyloid deposition in transgenic mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0011560:Amyloid deposition [Pathologic Function]
   806   C1705760:Amyloid Deposition [Finding]
   760   C0333562:Deposition [Functional Concept]
Processing 00000000.tx.403: Hum. 

Phrase: "Hum."
Processing 00000000.tx.404: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.405: Genet., 10, 25252537.[Abstract/Free FullText] Sun, Y., Wu, S., Bu, G., Onifade, M.K., Patel, S.N., LaDu, M.J., Fagan, A.M. and Holtzman, D.M. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "10,"

Phrase: "25252537."

Phrase: "[Abstract/Free FullText"

Phrase: "] Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "Y.,"

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "S."

Phrase: ","

Phrase: "Bu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006463:BU [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Onifade,"

Phrase: "M."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Patel,"

Phrase: "S."

Phrase: "N., LaDu,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Fagan,"

Phrase: "A.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Holtzman,"

Phrase: "D."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.406: (1998) Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0025936:Mice, Transgenic [Mammal]
   793   C0003069:Transgenic [Animal]
   793   C0025914:Mice [Mammal]
   793   C0025929:mice [Mammal]
   793   C0026809:Mice [Mammal]

Phrase: ":"

Phrase: "astrocyte-specific expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "differing biological effects of astrocyte-secreted apoE3"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0005532:Biological [Biomedical Occupation or Discipline]
   748   C0205460:biological [Qualitative Concept]
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "apoE4 lipoproteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023820:Lipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.407: J. 

Phrase: "J."
Processing 00000000.tx.408: Neurosci., 18, 32613272.[Abstract/Free FullText] Hamanaka, H., Katoh-Fukui, Y., Suzuki, K., Kobayashi, M., Suzuki, R., Motegi, Y., Nakahara, Y., Takeshita, A., Kawai, M., Ishiguro, K. etal. 

Phrase: "Neurosci.,"

Phrase: "18,"

Phrase: "32613272."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hamanaka,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Katoh-Fukui,"

Phrase: "Y.,"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kobayashi,"

Phrase: "M."

Phrase: ","

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Motegi,"

Phrase: "Y.,"

Phrase: "Nakahara,"

Phrase: "Y.,"

Phrase: "Takeshita,"

Phrase: "A.,"

Phrase: "Kawai,"

Phrase: "M."

Phrase: ","

Phrase: "Ishiguro,"

Phrase: "K. etal."
Processing 00000000.tx.409: (2000) Altered cholesterol metabolism in human apolipoprotein E4 knock-in mice. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Altered cholesterol metabolism in human apolipoprotein E4 knock-in mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1156530:cholesterol metabolism [Molecular Function]
   739   C0025519:Metabolism [Organism Function]
   739   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.410: Hum. 

Phrase: "Hum."
Processing 00000000.tx.411: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.412: Genet., 9, 353361.[Abstract/Free FullText] Lehman, E.J., Kulnane, L.S., Gao, Y., Petriello, M.C., Pimpis, K.M., Younkin, L., Dolios, G., Wang, R., Younkin, S.G. and Lamb, B.T. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "9,"

Phrase: "353361."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lehman,"

Phrase: "E.J.,"

Phrase: "Kulnane,"

Phrase: "L.S.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439394:L/s [Quantitative Concept]
           l's
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Gao,"

Phrase: "Y.,"

Phrase: "Petriello,"

Phrase: "M.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Pimpis,"

Phrase: "K.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Younkin,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Dolios,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Wang,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Younkin,"

Phrase: "S.G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439267:g% [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Lamb,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0452875:Lamb [Food]
  1000   C1123019:lamb [Mammal]
  1000   C1145701:L-AmB [Antibiotic,Organic Chemical]
  1000   C3496086:Lamb [Organic Chemical,Pharmacologic Substance]

Phrase: "B.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538923:B'-T [Gene or Genome]
Processing 00000000.tx.413: (2003) Genetic background regulates beta-amyloid precursor protein processing and beta-amyloid deposition in the mouse. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Genetic background"
Meta Candidates (Total=17; Excluded=14; Pruned=0; Remaining=3)
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   861   C1706907:Background [Conceptual Entity]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "regulates"

Phrase: "beta-amyloid precursor protein processing"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   840   C0033666:protein processing [Molecular Function]
   804   C1709694:Processing [Activity]
   771   C0085151:beta amyloid precursor protein [Amino Acid, Peptide, or Protein]
           amyloid precursor protein
   722   C0078939:beta-Amyloid Protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1750295:beta protein [Genetic Function]
   708   C2362547:Beta protein [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "beta-amyloid deposition in the mouse."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011560:Amyloid deposition [Pathologic Function]
   790   C1705760:Amyloid Deposition [Finding]
   753   C0333562:Deposition [Functional Concept]
Processing 00000000.tx.414: Hum. 

Phrase: "Hum."
Processing 00000000.tx.415: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.416: Genet., 12, 29492956.[Abstract/Free FullText] Xu, X., Li, C., Garrett-Beal, L., Larson, D., Wynshaw-Boris, A. and Deng, C.X. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "12,"

Phrase: "29492956."

Phrase: "[Abstract/Free FullText"

Phrase: "] Xu,"

Phrase: "X.,"

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Garrett-Beal,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Larson,"

Phrase: "D."

Phrase: ","

Phrase: "Wynshaw-Boris,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424110:BORIS [Gene or Genome]

Phrase: "A."

Phrase: "and"

Phrase: "Deng,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1549988:DEng [Intellectual Product]

Phrase: "C.X."
Processing 00000000.tx.417: (2001) Direct removal in the mouse of a floxed neo gene from a three-loxP conditional knockout allele by two novel approaches. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "removal in the mouse of a floxed neo gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0015252:Removal [Therapeutic or Preventive Procedure]
   742   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "from a three-loxP conditional knockout allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0002085:Allele [Gene or Genome]

Phrase: "by two novel approaches."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449445:Approaches [Spatial Concept]
   827   C1292724:Approaches [Functional Concept]
Processing 00000000.tx.418: Genesis, 30, 16.[CrossRef][ISI][Medline] Hirotsune, S., Fleck, M.W., Gambello, M.J., Bix, G.J., Chen, A., Clark, G.D., Ledbetter, D.H., McBain, C.J. and Wynshaw-Boris, A. 

Phrase: "Genesis,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1414672:Genesis [Gene or Genome]
  1000   C2984892:Genesis [Gene or Genome]
   907 E C0079411:Generation [Temporal Concept]
   907 E C3146294:Generation [Activity]

Phrase: "30,"

Phrase: "16."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hirotsune,"

Phrase: "S."

Phrase: ","

Phrase: "Fleck,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165528:fleck [Biomedical or Dental Material,Inorganic Chemical]

Phrase: "M."

Phrase: "W., Gambello,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Bix,"

Phrase: "G.J.,"

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "A.,"

Phrase: "Clark,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Ledbetter,"

Phrase: "D."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "McBain,"

Phrase: "C.J."

Phrase: "and"

Phrase: "Wynshaw-Boris,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424110:BORIS [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.419: (1998) Graded reduction of Pafah1b1 (Lis1) activity results in neuronal migration defects and early embryonic lethality. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Graded reduction of Pafah1b1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "(Lis1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0431375:LIS1 [Congenital Abnormality,Disease or Syndrome]
  1000   C1418245:LIS1 [Gene or Genome]
  1000   C2698684:LIS1 [Gene or Genome]

Phrase: ")"

Phrase: "activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "results in neuronal migration defects"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   851   C2750249:Neuronal migration defect [Finding]
   806   C1326504:neuronal migration [Cell Function]
   806   C1837249:Migration Defects [Disease or Syndrome]
   760   C0243067:defects [Functional Concept]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C0600210:Migration [Social Behavior]
   760   C1274040:Result [Functional Concept]
   760   C1533574:Migration [Physiologic Function]
   760   C1546471:Result [Idea or Concept]
   760   C1881827:MIGRATION [Phenomenon or Process]
   760   C2825142:Result [Finding]
   726 E C1457869:Defect [Functional Concept]
   726 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "and"

Phrase: "early embryonic lethality."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1836107:Early lethality [Finding]
   755   C3151529:Lethal [Finding]
Processing 00000000.tx.420: Nat. 

Phrase: "Nat."
Processing 00000000.tx.421: Genet., 19, 333339.[CrossRef][ISI][Medline] de Vries, W.N., Binns, L.T., Fancher, K.S., Dean, J., Moore, R., Kemler, R. and Knowles, B.B. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "19,"

Phrase: "333339."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] de Vries,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "W.N., Binns,"

Phrase: "L.T.,"

Phrase: "Fancher,"

Phrase: "K.S.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Dean,"

Phrase: "J.,"

Phrase: "Moore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443030:moore [Intellectual Product]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kemler,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Knowles,"

Phrase: "B.B."
Processing 00000000.tx.422: (2000) Expression of Cre recombinase in mouse oocytes: a means to study maternal effect genes. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Expression of Cre recombinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in mouse oocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029045:Oocytes [Cell]

Phrase: ":"

Phrase: "a means to"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1704970:Means [Conceptual Entity]
   827 E C0444504:Mean [Quantitative Concept]
   827 E C2347634:Mean [Quantitative Concept]
   827 E C2348143:Mean [Quantitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "maternal effect genes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.423: Genesis, 26, 110112.[CrossRef][ISI][Medline] Silver, L.M. 

Phrase: "Genesis,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1414672:Genesis [Gene or Genome]
  1000   C2984892:Genesis [Gene or Genome]
   907 E C0079411:Generation [Temporal Concept]
   907 E C3146294:Generation [Activity]

Phrase: "26,"

Phrase: "110112."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Silver,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0037125:Silver [Element, Ion, or Isotope]
  1000   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
  1000   C1305285:Silver [Qualitative Concept]
  1000   C1318876:Silver [Indicator, Reagent, or Diagnostic Aid]
   916 E C0079853:Moon [Geographic Area]
   907 E C0003782:Argyria [Injury or Poisoning]
   907 E C3463959:Argyria [Eukaryote]

Phrase: "L.M."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.424: (1995) Mouse genetics. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Mouse genetics."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]
Processing 00000000.tx.425: In Mouse Genetics: Concepts and Applications. 

Phrase: "In Mouse Genetics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]

Phrase: ":"

Phrase: "Concepts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0178566:concepts [Idea or Concept]

Phrase: "and"

Phrase: "Applications."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0185125:applications [Health Care Activity]
   966 E C1947919:Application [Intellectual Product]
   966 E C2347934:Application [Intellectual Product]
   966 E C3539080:APPLICATION [Quantitative Concept]
Processing 00000000.tx.426: Oxford University Press, New York, pp. 

Phrase: "Oxford University Press,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "pp."
Processing 00000000.tx.427: 4649. 

Phrase: "4649."
Processing 00000000.tx.428: Sing, C.F. and Davignon, J. 

Phrase: "Sing, C.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Davignon,"

Phrase: "J."
Processing 00000000.tx.429: (1985) Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Role of the apolipoprotein E polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in determining normal plasma lipid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0853610:normal lipid [Finding]
   861   C1278073:plasma lipid [Laboratory Procedure]
   812   C0023779:Lipid [Lipid]

Phrase: "and"

Phrase: "lipoprotein variation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variation [Qualitative Concept]
Processing 00000000.tx.430: Am. 

Phrase: "Am."
Processing 00000000.tx.431: J. 

Phrase: "J."
Processing 00000000.tx.432: Hum. 

Phrase: "Hum."
Processing 00000000.tx.433: Genet., 37, 268285.[ISI][Medline] Beffert, U., Cohn, J.S., Petit-Turcotte, C., Tremblay, M., Aumont, N., Ramassamy, C., Davignon, J. and Poirier, J. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "37,"

Phrase: "268285."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Beffert,"

Phrase: "U.,"

Phrase: "Cohn,"

Phrase: "J.S.,"

Phrase: "Petit-Turcotte,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Tremblay,"

Phrase: "M."

Phrase: ","

Phrase: "Aumont,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Ramassamy,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Davignon,"

Phrase: "J."

Phrase: "and"

Phrase: "Poirier,"

Phrase: "J."
Processing 00000000.tx.434: (1999) Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Apolipoprotein E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014441:ELISA [Laboratory Procedure]

Phrase: "and"

Phrase: "beta-amyloid levels in the hippocampus"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "frontal cortex of Alzheimer's disease subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   753   C0007776:Cortex [Body Part, Organ, or Organ Component]
   753   C0205123:Frontal [Spatial Concept]
   753   C1176472:Cortex [Body Part, Organ, or Organ Component]
   753   C2700441:Cortex [Plant]

Phrase: "are"

Phrase: "disease-related"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0439849:Related [Qualitative Concept]
   861   C0445223:Related [Finding]
   789 E C0080103:Relation [Family Group]
   789 E C0869014:Relations [Social Behavior]

Phrase: "and"

Phrase: "apolipoprotein E genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotype [Organism Attribute]

Phrase: "dependent."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0851827:Dependent [Qualitative Concept]
  1000   C1701901:Dependent [Qualitative Concept]
  1000   C3244310:dependent [Functional Concept]
Processing 00000000.tx.435: Brain Res., 843, 8794.[CrossRef][ISI][Medline] Bertrand, P., Poirier, J., Oda, T., Finch, C.E. and Pasinetti, G.M. 

Phrase: "Brain Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "843,"

Phrase: "8794."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bertrand,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Poirier,"

Phrase: "J.,"

Phrase: "Oda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0057642:ODA [Organic Chemical,Pharmacologic Substance]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Finch,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326915:Finch [Bird]

Phrase: "C.E."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014441:ELISA [Laboratory Procedure]

Phrase: "and"

Phrase: "Pasinetti,"

Phrase: "G.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456715:g m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.436: (1995) Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Association of apolipoprotein E genotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "with brain levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0441889:Levels [Qualitative Concept]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of apolipoprotein E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014441:ELISA [Laboratory Procedure]

Phrase: "and"

Phrase: "apolipoprotein J"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0055966:Apolipoprotein J [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1413514:APOLIPOPROTEIN J [Gene or Genome]
  1000   C2609437:Apolipoprotein J [Laboratory Procedure]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(clusterin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0055966:Clusterin [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1413514:CLUSTERIN [Gene or Genome]

Phrase: ")"

Phrase: "in Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.437: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.438: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.439: Brain Res., 33, 174178.[CrossRef][ISI][Medline] de Silva, H.V., Mas-Oliva, J., Taylor, J.M. and Mahley, R.W. 

Phrase: "Brain Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "33,"

Phrase: "174178."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] de Silva,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   789   C0144237:Silvan [Organic Chemical]
   768 E C0043217:Wood [Substance]
   768 E C0442548:Woods [Geographic Area]

Phrase: "H.V., Mas-Oliva,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0228539:oliva [Body Part, Organ, or Organ Component]
   812   C0228540:Oliva [Body Part, Organ, or Organ Component]
   812   C0262254:oliva [Body Part, Organ, or Organ Component]
   812   C1020282:Oliva [Eukaryote]

Phrase: "J.,"

Phrase: "Taylor,"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Mahley,"

Phrase: "R.W."
Processing 00000000.tx.440: (1994) Identification of apolipoprotein B-100 low density lipoproteins, apolipoprotein B-48 remnants, and apolipoprotein E-rich high density lipoproteins in the mouse. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Identification of apolipoprotein B-100 low density lipoproteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0020792:Identification [Mental Process]
   744   C0205396:Identification [Qualitative Concept]

Phrase: "apolipoprotein B-48 remnants,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C3272697:Remnant [Embryonic Structure]
   756   C0103839:Apolipoprotein B-48 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "apolipoprotein E-rich high density lipoproteins in the mouse."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0023821:High Density Lipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   745   C0003591:Lipoprotein apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0023820:Lipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0178587:density [Quantitative Concept]
   742   C0205250:High [Qualitative Concept]
   742   C1299351:High [Qualitative Concept]
   742   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.441: J. 

Phrase: "J."
Processing 00000000.tx.442: Lipid Res., 35, 12971310.[Abstract] Lamb, B.T., Call, L.M., Slunt, H.H., Bardel, K.A., Lawler, A.M., Eckman, C.B., Younkin, S.G., Holtz, G., Wagner, S.L., Price, D.L. etal. 

Phrase: "Lipid Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "35,"

Phrase: "12971310."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Lamb,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0452875:Lamb [Food]
  1000   C1123019:lamb [Mammal]
  1000   C1145701:L-AmB [Antibiotic,Organic Chemical]
  1000   C3496086:Lamb [Organic Chemical,Pharmacologic Substance]

Phrase: "B.T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538923:B'-T [Gene or Genome]

Phrase: "Call,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0679006:Call [Mental Process]
  1000   C1292769:c-ALL [Neoplastic Process]
  1000   C1947967:Call [Functional Concept]

Phrase: "L.M.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Slunt,"

Phrase: "H.H.,"

Phrase: "Bardel,"

Phrase: "K.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Lawler,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Eckman,"

Phrase: "C.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Younkin,"

Phrase: "S.G.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439267:g% [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Holtz,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Wagner,"

Phrase: "S.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439394:s l [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."

Phrase: "L. etal."
Processing 00000000.tx.443: (1997) Altered metabolism of familial Alzheimer's disease-linked amyloid precursor protein variants in yeast artificial chromosome transgenic mice. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Altered metabolism of familial Alzheimer's disease-linked amyloid precursor protein variants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   792   C1327340:amyloid precursor protein metabolism [Molecular Function]
   754   C0597299:Protein Metabolism [Molecular Function]
   738   C0025519:Metabolism [Organism Function]
   738   C0025520:metabolism [Functional Concept]

Phrase: "in yeast artificial chromosome transgenic mice."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0025936:Mice, Transgenic [Mammal]
   804   C0003069:Transgenic [Animal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   717   C0206665:Yeast Artificial Chromosome [Research Device]
Processing 00000000.tx.444: Hum. 

Phrase: "Hum."
Processing 00000000.tx.445: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.446: Genet., 6, 15351541.[Abstract/Free FullText] Elshourbagy, N.A., Liao, W.S., Mahley, R.W. and Taylor, J.M. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "6,"

Phrase: "15351541."

Phrase: "[Abstract/Free FullText"

Phrase: "] Elshourbagy,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "A.,"

Phrase: "Liao,"

Phrase: "W.S.,"

Phrase: "Mahley,"

Phrase: "R.W."

Phrase: "and"

Phrase: "Taylor,"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.447: (1985) Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Apolipoprotein E mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "abundant in the brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2346714:Abundant [Qualitative Concept]

Phrase: "and"

Phrase: "adrenals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001625:Adrenals [Body Part, Organ, or Organ Component]

Phrase: "as well as in the liver,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0023884:Liver [Body Part, Organ, or Organ Component]
   753   C0205170:Well [Qualitative Concept]
   753   C0736268:LIVER [Body Part, Organ, or Organ Component]
   753   C1278929:Liver [Body Part, Organ, or Organ Component]
   753   C2346688:LIVER [Food]
   753   C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "is"

Phrase: "present in other peripheral tissues of rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "marmosets."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006764:Marmosets [Mammal]
Processing 00000000.tx.448: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.449: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.450: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.451: USA, 82, 203207.[Abstract] Blue, M.L., Williams, D.L., Zucker, S., Khan, S.A. and Blum, C.B. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "82,"

Phrase: "203207."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Blue,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260957:Blue [Qualitative Concept]

Phrase: "M.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Williams,"

Phrase: "D."

Phrase: "L., Zucker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2700303:Zucker [Mammal]

Phrase: "S."

Phrase: ","

Phrase: "Khan,"

Phrase: "S.A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Blum,"

Phrase: "C.B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.452: (1983) Apolipoprotein E synthesis in human kidney, adrenal gland, and liver. 

Phrase: "(1983"

Phrase: ")"

Phrase: "Apolipoprotein E synthesis in human kidney,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0220781:synthesis [Biologic Function]
   753   C1883254:Synthesis [Activity]

Phrase: "adrenal gland,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0001625:Adrenal gland [Body Part, Organ, or Organ Component]
  1000   C1268989:Adrenal gland [Body Part, Organ, or Organ Component]
  1000   C1515890:GLAND, ADRENAL [Tissue]
   861   C1285092:Gland [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "liver."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.453: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.454: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.455: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.456: USA, 80, 283287.[Abstract] Gregg, R.E., Zech, L.A., Schaefer, E.J. and Brewer, H.B., Jr (1984) Apolipoprotein E metabolism in normolipoproteinemic human subjects. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "80,"

Phrase: "283287."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Gregg,"

Phrase: "R.E.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014441:ELISA [Laboratory Procedure]

Phrase: "Zech,"

Phrase: "L.A.,"

Phrase: "Schaefer,"

Phrase: "E.J."

Phrase: "and"

Phrase: "Brewer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402217:Brewer [Professional or Occupational Group]

Phrase: "H.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0919534:H-B [Gene or Genome]

Phrase: "Jr (1984"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: ")"

Phrase: "Apolipoprotein E metabolism in normolipoproteinemic human subjects."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0025519:Metabolism [Organism Function]
   748   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.457: J. 

Phrase: "J."
Processing 00000000.tx.458: Lipid Res., 25, 11671176.[Abstract] Gregg, R.E., Zech, L.A., Schaefer, E.J., Stark, D., Wilson, D. and Brewer, H.B., Jr (1986) Abnormal in vivo metabolism of apolipoprotein E4 in humans. 

Phrase: "Lipid Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "25,"

Phrase: "11671176."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Gregg,"

Phrase: "R.E.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014441:ELISA [Laboratory Procedure]

Phrase: "Zech,"

Phrase: "L.A.,"

Phrase: "Schaefer,"

Phrase: "E.J.,"

Phrase: "Stark,"

Phrase: "D."

Phrase: ","

Phrase: "Wilson,"

Phrase: "D."

Phrase: "and"

Phrase: "Brewer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402217:Brewer [Professional or Occupational Group]

Phrase: "H.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0919534:H-B [Gene or Genome]

Phrase: "Jr (1986"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: ")"

Phrase: "Abnormal in vivo metabolism of apolipoprotein E4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0025519:Metabolism [Organism Function]
   748   C0025520:metabolism [Functional Concept]

Phrase: "in humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.459: J. 

Phrase: "J."
Processing 00000000.tx.460: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.461: Invest., 78, 815821.[ISI][Medline] Larson, I.A., Ordovas, J.M., DeLuca, C., Barnard, J.R., Feussner, G. and Schaefer, E.J. 

Phrase: "Invest.,"

Phrase: "78,"

Phrase: "815821."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Larson,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "A.,"

Phrase: "Ordovas,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "DeLuca,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Barnard,"

Phrase: "J.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Feussner,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Schaefer,"

Phrase: "E.J."
Processing 00000000.tx.462: (2000) Association of apolipoprotein (Apo)E genotype with plasma apo E levels. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Association of apolipoprotein (Apo)E genotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "with plasma apo E levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.463: Atherosclerosis, 148, 327335.[CrossRef][ISI][Medline] Pirttila, T., Soininen, H., Heinonen, O., Lehtimaki, T., Bogdanovic, N., Paljarvi, L., Kosunen, O., Winblad, B., Riekkinen, P., Sr, Wisniewski, H.M. etal. 

Phrase: "Atherosclerosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004153:Atherosclerosis [Disease or Syndrome]
   928 E C0333482:Atherosclerotic [Functional Concept]

Phrase: "148,"

Phrase: "327335."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pirttila,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Soininen,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Heinonen,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Lehtimaki,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Bogdanovic,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Paljarvi,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Kosunen,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Winblad,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Riekkinen,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Sr,"

Phrase: "Wisniewski,"

Phrase: "H.M. etal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C2348952:H/m [Quantitative Concept]
Processing 00000000.tx.464: (1996) Apolipoprotein E (apoE) levels in brains from Alzheimer disease patients and controls. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Apolipoprotein E (apoE) levels in brains"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   774   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "from Alzheimer disease patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "and"

Phrase: "controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.465: Brain Res., 722, 7177.[CrossRef][ISI][Medline] Artiga, M.J., Bullido, M.J., Frank, A., Sastre, I., Recuero, M., Garcia, M.A., Lendon, C.L., Han, S.W., Morris, J.C., Vazquez, J. etal. 

Phrase: "Brain Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "722,"

Phrase: "7177."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Artiga,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Bullido,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Frank,"

Phrase: "A.,"

Phrase: "Sastre,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Recuero,"

Phrase: "M."

Phrase: ","

Phrase: "Garcia,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442999:Garcia [Intellectual Product]
  1000   C1621797:Garcia [Plant]

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lendon,"

Phrase: "C.L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Han,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Han [Language]

Phrase: "S.W.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Morris,"

Phrase: "J.C., Vazquez,"

Phrase: "J. etal."
Processing 00000000.tx.466: (1998) Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Risk for Alzheimer's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   819   C1281905:disease risk [Finding]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0035647:Risk [Qualitative Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "correlates with transcriptional activity of the APOE gene."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C1412481:APOE gene [Gene or Genome]
           APOE
   744   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0017337:Gene [Gene or Genome]
   744   C0040649:Transcriptional [Genetic Function]
           Gene Transcription
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C0523511:APOE [Laboratory Procedure]
   744   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.467: Hum. 

Phrase: "Hum."
Processing 00000000.tx.468: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.469: Genet., 7, 18871892.[Abstract/Free FullText] Sullivan, P.M., Mace, B.E., Maeda, N. and Schmechel, D.E. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "7,"

Phrase: "18871892."

Phrase: "[Abstract/Free FullText"

Phrase: "] Sullivan,"

Phrase: "P.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Mace,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0349381:Mace [Food]
  1000   C0949745:mace [Plant]
  1000   C1445339:MACE [Organic Chemical,Pharmacologic Substance]

Phrase: "B.E.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014441:ELISA [Laboratory Procedure]

Phrase: "Maeda,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Schmechel,"

Phrase: "D."

Phrase: "E."
Processing 00000000.tx.470: (2004) Marked regional differences of brain human apolipoprotein e expression in targeted replacement mice. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: "regional differences of brain human apolipoprotein e expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0682132:regional differences [Finding]
   711   C1705241:*Difference [Quantitative Concept]
   711   C1705242:Difference [Qualitative Concept]

Phrase: "in targeted replacement mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.471: Neuroscience, 124, 725733.[CrossRef][ISI][Medline] Paigen, B., Morrow, A., Brandon, C., Mitchell, D. and Holmes, P. 

Phrase: "Neuroscience,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027910:Neuroscience [Biomedical Occupation or Discipline]
  1000   C1552241:Neuroscience [Professional or Occupational Group]
  1000   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "124,"

Phrase: "725733."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Paigen,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Morrow,"

Phrase: "A.,"

Phrase: "Brandon,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Mitchell,"

Phrase: "D."

Phrase: "and"

Phrase: "Holmes,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.472: (1985) Variation in susceptibility to atherosclerosis among inbred strains of mice. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Variation in susceptibility"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205419:Variation [Qualitative Concept]

Phrase: "to atherosclerosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004153:Atherosclerosis [Disease or Syndrome]
   928 E C0333482:Atherosclerotic [Functional Concept]

Phrase: "among inbred strains"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C1512692:Inbred Strain [Organism]
   861   C0080194:Strains [Injury or Poisoning]
   861   C0456178:strains [Intellectual Product]
   827 E C1518614:Strain [Organism]
   827 E C2987481:Strain [Mental Process]

Phrase: "of mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.473: Atherosclerosis, 57, 6573.[ISI][Medline] Lyons, M.A., Wittenburg, H., Li, R., Walsh, K.A., Churchill, G.A., Carey, M.C. and Paigen, B. 

Phrase: "Atherosclerosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004153:Atherosclerosis [Disease or Syndrome]
   928 E C0333482:Atherosclerotic [Functional Concept]

Phrase: "57,"

Phrase: "6573."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lyons,"

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Wittenburg,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Walsh,"

Phrase: "K.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Churchill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538463:CHURCHILL [Gene or Genome]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A.,"

Phrase: "Carey,"

Phrase: "M.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Paigen,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.474: (2003) Quantitative trait loci that determine lipoprotein cholesterol levels in DBA/2J and CAST/Ei inbred mice. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Quantitative trait loci"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597336:Quantitative Trait Loci [Gene or Genome]
   827   C0392762:Quantitative [Quantitative Concept]
   827   C0599883:Trait [Organism Attribute]
   793   C1708726:Locus [Gene or Genome]

Phrase: "that"

Phrase: "determine"

Phrase: "lipoprotein cholesterol levels in DBA/2J"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0065055:lipoprotein cholesterol [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   790   C0201950:cholesterol levels [Laboratory Procedure]
   790   C0428466:cholesterol levels [Laboratory or Test Result]
   753   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "CAST/Ei inbred mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   912   C1511402:CAST/Ei Mouse [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
Processing 00000000.tx.475: J. 

Phrase: "J."
Processing 00000000.tx.476: Lipid Res., 44, 953967.[Abstract/Free FullText] Ordovas, J.M. and Schaefer, E.J. 

Phrase: "Lipid Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "44,"

Phrase: "953967."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ordovas,"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Schaefer,"

Phrase: "E.J."
Processing 00000000.tx.477: (1999) Genes, variation of cholesterol and fat intake and serum lipids. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "variation of cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205419:Variation [Qualitative Concept]

Phrase: "and"

Phrase: "fat intake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0489488:Fat intake [Clinical Attribute]
   861   C1512806:Intake [Functional Concept]

Phrase: "and"

Phrase: "serum lipids."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0428462:Serum lipids NOS [Laboratory Procedure]
   861   C0023779:Lipids [Lipid]
Processing 00000000.tx.478: Curr. 

Phrase: "Curr."
Processing 00000000.tx.479: Opin. 

Phrase: "Opin."
Processing 00000000.tx.480: Lipidol., 10, 1522.[CrossRef][ISI][Medline] Ishimori, N., Li, R., Kelmenson, P.M., Korstanje, R., Walsh, K.A., Churchill, G.A., Forsman-Semb, K. and Paigen, B. 

Phrase: "Lipidol.,"

Phrase: "10,"

Phrase: "1522."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ishimori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kelmenson,"

Phrase: "P.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Korstanje,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Walsh,"

Phrase: "K.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Churchill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538463:CHURCHILL [Gene or Genome]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A.,"

Phrase: "Forsman-Semb,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419947:SEMB [Gene or Genome]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Paigen,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.481: (2004) Quantitative trait loci analysis for plasma HDL-cholesterol concentrations and atherosclerosis susceptibility between inbred mouse strains C57BL/6J and 129S1/SvImJ. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Quantitative trait loci analysis for plasma HDL-cholesterol concentrations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "atherosclerosis susceptibility between inbred mouse"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1531719:ATHEROSCLEROSIS SUSCEPTIBILITY [Finding]
   760   C0012655:Susceptibility [Clinical Attribute]
   760   C0220898:Susceptibility [Organism Attribute]
   760   C1264642:Susceptibility [Functional Concept]
   760   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "strains"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
  1000   C0080194:Strain [Injury or Poisoning]
  1000   C0456178:strain [Intellectual Product]
  1000   C1518614:Strain [Organism]
  1000   C2987481:Strain [Mental Process]
   944 E C0180860:Filter [Manufactured Object]
   944 E C0581406:Filter [Medical Device]
   944 E C1522664:Filter [Intellectual Product]
   944 E C1704449:Filter [Conceptual Entity]
   944 E C1704684:Filter [Medical Device]
   944 E C1875155:FILTER [Medical Device]
   916 E C0442694:Straining [Physiologic Function]

Phrase: "C57BL/6J"

Phrase: "and"

Phrase: "129S1/SvImJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1520423:129S1/SvImJ [Mammal]
Processing 00000000.tx.482: Arterioscler. 

Phrase: "Arterioscler."
Processing 00000000.tx.483: Thromb. 

Phrase: "Thromb."
Processing 00000000.tx.484: Vasc. 

Phrase: "Vasc."
Processing 00000000.tx.485: Biol., 24, 161166.[Abstract/Free FullText] Sullivan, P.M., Mezdour, H., Aratani, Y., Knouff, C., Najib, J., Reddick, R.L., Quarfordt, S.H. and Maeda, N. 

Phrase: "Biol.,"

Phrase: "24,"

Phrase: "161166."

Phrase: "[Abstract/Free FullText"

Phrase: "] Sullivan,"

Phrase: "P.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Mezdour,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Aratani,"

Phrase: "Y.,"

Phrase: "Knouff,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Najib,"

Phrase: "J.,"

Phrase: "Reddick,"

Phrase: "R.L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Quarfordt,"

Phrase: "S."

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Maeda,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.486: (1997) Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Targeted replacement of the mouse apolipoprotein E gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0872178:gene replacement [Therapeutic or Preventive Procedure]
   744   C0035139:Replacement [Therapeutic or Preventive Procedure]
   744   C0559956:Replacement [Functional Concept]
   744   C1555302:Replacement [Idea or Concept]

Phrase: "with the common human APOE3 allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0002085:Allele [Gene or Genome]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "diet-induced hypercholesterolemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0020443:Hypercholesterolaemia [Disease or Syndrome]
   827   C1522133:Hypercholesterolemia [Finding]

Phrase: "and"

Phrase: "atherosclerosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004153:Atherosclerosis [Disease or Syndrome]
   928 E C0333482:Atherosclerotic [Functional Concept]
Processing 00000000.tx.487: J. 

Phrase: "J."
Processing 00000000.tx.488: Biol. 

Phrase: "Biol."
Processing 00000000.tx.489: Chem., 272, 1797217980.[Abstract/Free FullText] Sullivan, P.M., Mezdour, H., Quarfordt, S.H. and Maeda, N. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "272,"

Phrase: "1797217980."

Phrase: "[Abstract/Free FullText"

Phrase: "] Sullivan,"

Phrase: "P.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Mezdour,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Quarfordt,"

Phrase: "S."

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Maeda,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.490: (1998) Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Type III hyperlipoproteinemia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020479:Hyperlipoproteinemia, Type III [Disease or Syndrome]
   827   C0020476:Hyperlipoproteinaemia [Disease or Syndrome]
   734   C0441731:Type III [Classification]

Phrase: "and"

Phrase: "spontaneous atherosclerosis in mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0004153:Atherosclerosis [Disease or Syndrome]

Phrase: "resulting from gene replacement of mouse Apoe"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   778   C0872178:gene replacement [Therapeutic or Preventive Procedure]
   774   C1412481:APOE gene [Gene or Genome]
           APOE
   748   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0017337:Gene [Gene or Genome]
   748   C0025914:Mouse [Mammal]
   748   C0025929:mouse [Mammal]
   748   C0026809:Mouse [Mammal]
   748   C0035139:Replacement [Therapeutic or Preventive Procedure]
   748   C0523511:APOE [Laboratory Procedure]
   748   C0559956:Replacement [Functional Concept]
   748   C0678226:resulting [Functional Concept]
   748   C1555302:Replacement [Idea or Concept]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C2825142:Result [Finding]

Phrase: "with human Apoe"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "*2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.491: J. 

Phrase: "J."
Processing 00000000.tx.492: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.493: Invest., 102, 130135.[Abstract/Free FullText] Knouff, C., Hinsdale, M.E., Mezdour, H., Altenburg, M.K., Watanabe, M., Quarfordt, S.H., Sullivan, P.M. and Maeda, N. 

Phrase: "Invest.,"

Phrase: "102,"

Phrase: "130135."

Phrase: "[Abstract/Free FullText"

Phrase: "] Knouff,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Hinsdale,"

Phrase: "M."

Phrase: "E.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014441:ELISA [Laboratory Procedure]

Phrase: "Mezdour,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Altenburg,"

Phrase: "M."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Watanabe,"

Phrase: "M."

Phrase: ","

Phrase: "Quarfordt,"

Phrase: "S."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sullivan,"

Phrase: "P.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Maeda,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.494: (1999) Apo E structure determines VLDL clearance and atherosclerosis risk in mice. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Apo E structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:Structure [Spatial Concept]

Phrase: "determines"

Phrase: "VLDL clearance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2612555:VLDL clearance [Cell Function]
   861   C0449297:Clearance [Qualitative Concept]
   861   C1382187:Clearance [Clinical Attribute]
   861   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "atherosclerosis risk in mice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.495: J. 

Phrase: "J."
Processing 00000000.tx.496: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.497: Invest., 103, 15791586.[Abstract/Free FullText] Mahley, R.W., Huang, Y. and Rall, S.C., Jr (1999) Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). 

Phrase: "Invest.,"

Phrase: "103,"

Phrase: "15791586."

Phrase: "[Abstract/Free FullText"

Phrase: "] Mahley,"

Phrase: "R.W., Huang,"

Phrase: "Y."

Phrase: "and"

Phrase: "Rall,"

Phrase: "S.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Jr (1999"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: ")"

Phrase: "Pathogenesis of type III hyperlipoproteinemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0543483:pathogenesis [Functional Concept]
   760   C0699748:Pathogenesis [Pathologic Function]

Phrase: "(dysbetalipoproteinemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020479:Dysbetalipoproteinaemia [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.498: Questions, quandaries, and paradoxes. 

Phrase: "Questions,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1522634:Question [Intellectual Product]

Phrase: "quandaries,"

Phrase: "and"

Phrase: "paradoxes."
Processing 00000000.tx.499: J. 

Phrase: "J."
Processing 00000000.tx.500: Lipid Res., 40, 19331949.[Abstract/Free FullText] Huang, Y., Rall, S.C., Jr and Mahley, R.W. 

Phrase: "Lipid Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "19331949."

Phrase: "[Abstract/Free FullText"

Phrase: "] Huang,"

Phrase: "Y.,"

Phrase: "Rall,"

Phrase: "S.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Jr"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "and"

Phrase: "Mahley,"

Phrase: "R.W."
Processing 00000000.tx.501: (1997) Genetic factors precipitating type III hyperlipoproteinemia in hypolipidemic transgenic mice expressing human apolipoprotein E2. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Genetic factors"
Meta Candidates (Total=18; Excluded=14; Pruned=0; Remaining=4)
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "precipitating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "type III hyperlipoproteinemia in hypolipidemic transgenic mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   814   C0020479:Hyperlipoproteinemia, Type III [Disease or Syndrome]
   748   C0020476:Hyperlipoproteinaemia [Disease or Syndrome]

Phrase: "expressing"

Phrase: "human apolipoprotein E2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0052198:Apolipoprotein E2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C3539520:E2 [Gene or Genome]
Processing 00000000.tx.502: Arterioscler. 

Phrase: "Arterioscler."
Processing 00000000.tx.503: Thromb. 

Phrase: "Thromb."
Processing 00000000.tx.504: Vasc. 

Phrase: "Vasc."
Processing 00000000.tx.505: Biol., 17, 28172824.[Abstract/Free FullText] Ehehalt, R., Keller, P., Haass, C., Thiele, C. and Simons, K. 

Phrase: "Biol.,"

Phrase: "17,"

Phrase: "28172824."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ehehalt,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Keller,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Thiele,"

Phrase: "C."

Phrase: "and"

Phrase: "Simons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443058:simons [Intellectual Product]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.506: (2003) Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0033666:protein processing [Molecular Function]
   742   C1709694:Processing [Activity]

Phrase: "depends on lipid rafts."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1167250:lipid rafts [Cell Component]
   770   C0023779:Lipid [Lipid]
   770   C0725813:depend [Medical Device]
   737   C0336849:Raft [Manufactured Object]
Processing 00000000.tx.507: J. 

Phrase: "J."
Processing 00000000.tx.508: Cell Biol., 160, 113123.[Abstract/Free FullText] Kojro, E., Gimpl, G., Lammich, S., Marz, W. and Fahrenholz, F. 

Phrase: "Cell Biol.,"

Phrase: "160,"

Phrase: "113123."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kojro,"

Phrase: "E.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014441:ELISA [Laboratory Procedure]

Phrase: "Gimpl,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lammich,"

Phrase: "S."

Phrase: ","

Phrase: "Marz,"

Phrase: "W."

Phrase: "and"

Phrase: "Fahrenholz,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.509: (2001) Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM 10. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Low cholesterol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0860920:Low cholesterol [Finding]
   861   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "stimulates"

Phrase: "the nonamyloidogenic pathway by its effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]

Phrase: "on the alpha-secretase ADAM 10."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1412181:ADAM10 [Gene or Genome]
   861   C2984597:ADAM 10 [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.510: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.511: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.512: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.513: USA, 98, 58155820.[Abstract/Free FullText] Koch, S., Donarski, N., Goetze, K., Kreckel, M., Stuerenburg, H.J., Buhmann, C. and Beisiegel, U. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "98,"

Phrase: "58155820."

Phrase: "[Abstract/Free FullText"

Phrase: "] Koch,"

Phrase: "S."

Phrase: ","

Phrase: "Donarski,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Goetze,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kreckel,"

Phrase: "M."

Phrase: ","

Phrase: "Stuerenburg,"

Phrase: "H.J.,"

Phrase: "Buhmann,"

Phrase: "C."

Phrase: "and"

Phrase: "Beisiegel,"

Phrase: "U."
Processing 00000000.tx.514: (2001) Characterization of four lipoprotein classes in human cerebrospinal fluid. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Characterization of four lipoprotein classes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "in human cerebrospinal fluid."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0007806:Cerebrospinal Fluid [Body Substance]
   901   C0007807:cerebrospinal fluid [Functional Concept]
   827   C0005889:FLUID [Body Substance]
   827   C0302908:fluid [Substance]
   827   C0444611:Fluid [Qualitative Concept]
   827   C1704353:Fluid [Substance]
Processing 00000000.tx.515: J. 

Phrase: "J."
Processing 00000000.tx.516: Lipid Res., 42, 11431151.[Abstract/Free FullText] Pitas, R.E., Boyles, J.K., Lee, S.H., Hui, D. and Weisgraber, K.H. 

Phrase: "Lipid Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "42,"

Phrase: "11431151."

Phrase: "[Abstract/Free FullText"

Phrase: "] Pitas,"

Phrase: "R.E.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014441:ELISA [Laboratory Procedure]

Phrase: "Boyles,"

Phrase: "J.K.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346601:J/K [Quantitative Concept]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Lee,"

Phrase: "S."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hui,"

Phrase: "D."

Phrase: "and"

Phrase: "Weisgraber,"

Phrase: "K.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.517: (1987) Lipoproteins and their receptors in the central nervous system. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Lipoproteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023820:Lipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "their receptors in the central nervous system."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   713   C0034837:Receptors, Neural [Cell Component]
Processing 00000000.tx.518: Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. 

Phrase: "Characterization of the lipoproteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880022:Characterization [Activity]

Phrase: "in cerebrospinal fluid"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007806:Cerebrospinal Fluid [Body Substance]
  1000   C0007807:cerebrospinal fluid [Functional Concept]
   861   C0005889:FLUID [Body Substance]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]

Phrase: "and"

Phrase: "identification of apolipoprotein B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]

Phrase: "E(LDL) receptors in the brain."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0034821:Receptors, LDL [Amino Acid, Peptide, or Protein,Receptor]
   756 E C1149327:LDL receptor [Molecular Function]
   753   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.519: J. 

Phrase: "J."
Processing 00000000.tx.520: Biol. 

Phrase: "Biol."
Processing 00000000.tx.521: Chem., 262, 1435214360.[Abstract/Free FullText] Roheim, P.S., Carey, M., Forte, T. and Vega, G.L. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "262,"

Phrase: "1435214360."

Phrase: "[Abstract/Free FullText"

Phrase: "] Roheim,"

Phrase: "P.S.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0234833:P s [Organ or Tissue Function]
  1000   C0722388:P & S [Organic Chemical,Pharmacologic Substance]

Phrase: "Carey,"

Phrase: "M."

Phrase: ","

Phrase: "Forte,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Vega,"

Phrase: "G.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439294:g l [Quantitative Concept]
Processing 00000000.tx.522: (1979) Apolipoproteins in human cerebrospinal fluid. 

Phrase: "(1979"

Phrase: ")"

Phrase: "Apolipoproteins in human cerebrospinal fluid."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0003591:Apolipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.523: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.524: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.525: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.526: USA, 76, 46464649.[Abstract] Thorngate, F.E., Rudel, L.L., Walzem, R.L. and Williams, D.L. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "76,"

Phrase: "46464649."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Thorngate,"

Phrase: "F.E.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014441:ELISA [Laboratory Procedure]

Phrase: "Rudel,"

Phrase: "L.L., Walzem,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C3539687:L/L [Quantitative Concept]

Phrase: "R.L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Williams,"

Phrase: "D."

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.527: (2000) Low levels of extrahepatic nonmacrophage ApoE inhibit atherosclerosis without correcting hypercholesterolemia in ApoE-deficient mice. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Low levels of extrahepatic nonmacrophage ApoE"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "atherosclerosis without correcting hypercholesterolemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0004153:Atherosclerosis [Disease or Syndrome]

Phrase: "in ApoE-deficient mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.528: Arterioscler. 

Phrase: "Arterioscler."
Processing 00000000.tx.529: Thromb. 

Phrase: "Thromb."
Processing 00000000.tx.530: Vasc. 

Phrase: "Vasc."
Processing 00000000.tx.531: Biol., 20, 19391945.[Abstract/Free FullText] This Article Abstract FREE Full Text (PDF) All Versions of this Article: 13/17/1959 most recent ddh199v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to citation manager Search for citing articles in: ISI Web of Science (2) Request Permissions Google Scholar Articles by Mann, K. 

Phrase: "Biol.,"

Phrase: "20,"

Phrase: "19391945."

Phrase: "[Abstract/Free FullText"

Phrase: "]"

Phrase: "This Article Abstract FREE Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1527021:Text [Intellectual Product]
   804   C1554111:Text [Idea or Concept]
   804   C1705606:Text [Intellectual Product]
   804   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "All Versions of this Article"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: ":"

Phrase: "13/17/1959 most recent ddh199v1"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0557854:Services [Occupational Activity]
   966 E C2825316:Service [Manufactured Object]
   966 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in ISI Web"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282111:Web [Manufactured Object]

Phrase: "of Science Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0162443:Journal [Intellectual Product,Manufactured Object]
   748   C0205314:New [Temporal Concept]
   714   C0033213:Issue [Finding]
   714   C1706387:Issue [Intellectual Product]

Phrase: "Add to My Personal Archive Download"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0003738:archive [Manufactured Object]
   753   C0024552:MY [Geographic Area]
   753   C1519021:Personal [Organism Attribute]
   753   C1554162:Archive [Idea or Concept]
   753   C1883712:Add [Functional Concept]

Phrase: "to citation manager Search"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1552603:search [Intellectual Product]
   827   C1706202:Search [Activity]

Phrase: "for citing articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1706852:Article [Intellectual Product]

Phrase: "in"

Phrase: ":"

Phrase: "ISI Web of Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0282111:Web [Manufactured Object]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "Request Permissions Google Scholar Articles by Mann,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1706852:Article [Intellectual Product]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.532: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.533: Articles by Lamb, B. 

Phrase: "Articles by Lamb,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.534: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.535: PubMed PubMed Citation Articles by Mann, K. 

Phrase: "PubMed PubMed Citation Articles by Mann,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1706852:Article [Intellectual Product]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.536: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.537: Articles by Lamb, B. 

Phrase: "Articles by Lamb,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.538: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.539: Online ISSN 1460-2083 - Print ISSN 0964-6906 Copyright  2006 Oxford University Press Oxford Journals Oxford University Press Site Map Privacy Policy Frequently Asked Questions Other Oxford University Press sites: Oxford University Press American National Biography Booksellers' Information Service Children's Fiction and Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights and Permissions Science School Books Social Sciences Very Short Introductions World's Classics

Phrase: "Online ISSN 1460-2083 - Print ISSN 0964-6906 Copyright  2006 Oxford University Press Oxford Journals Oxford University Press Site Map Privacy Policy Frequently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   788   C2735290:Privacy policy [Intellectual Product]
   782   C0242456:Policy [Intellectual Product]

Phrase: "Asked"

Phrase: "Questions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "Other Oxford University Press sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205145:Sites [Spatial Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: ":"

Phrase: "Oxford University Press American National Biography Booksellers' Information Service Children's Fiction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0887933:fiction [Intellectual Product]

Phrase: "and"

Phrase: "Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary"

Phrase: "of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   852   C0947619:Finger.right [Body Part, Organ, or Organ Component]
   782   C0035621:Rights [Qualitative Concept]
   782   C0205090:Right [Spatial Concept]

Phrase: "and"

Phrase: "Permissions Science School Books Social Sciences Very Short Introductions World's Classics"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   788   C0439658:classics [Qualitative Concept]
   755 E C0439858:Classic [Qualitative Concept]

